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Abstract 
Regulation of gene expression is critical to govern distinct transcriptional programs 
for a cell type, lineage specification and developmental stage. Transcription is the 
first step in gene expression wherein RNA Polymerase II (RNAPII) transcribes 
protein-coding genes. Transcription is a highly coordinated process that involves a 
range of chromatin interactions including transcription machinery, chromatin 
remodellers and co-transcriptional RNA processing. Embryonic stem (ES) cells are 
pluripotent, self-renewing cells that can differentiate to give rise to all lineages making 
them an invaluable tool to study early development and in therapy. Genome-wide 
analysis in murine mES cells has identified 30% of known genes harbouring bivalent 
chromatin modifications along with repressive Polycomb complexes and a novel 
variant of RNAPII (modified as S5p+S7p-S2p-) with mechanistic implications in stem 
cell pluripotency, differentiation potential and lineage specification.   
To explore chromatin composition associated with different variants of RNAPII, I 
developed an unbiased method, ‘Proteome-ChIP’ (pChIP) wherein crosslinked 
chromatin is purified by immunoprecipitation followed by protein extraction and 
identification by Mass Spectrometry. Using an unbiased comprehensive experimental 
strategy and a novel systems biology approach, I qualitatively and quantitatively 
dissect the proteome composition and dependencies on RNAPII modifications during 
different stages of the transcription cycle. The work done in this thesis provides an 
invaluable resource of RNAPII chromatin interactions. We identify known and novel 
components of the co-transcriptional machinery, chromatin remodelling and RNA 
processing machinery. The work also uncovers novel processes associated with 
unusual RNAPII (S5p+S7p-S2p-) including DNA replication, Polycomb proteins and 
chromatin remodellers; many of these processes critical for stem cell viability and 
regulation.  
Extending the RNAPII-pChIP analysis on low complexity samples by Native-pChIP 
and Gradient-pChIP highlights the versatility of robustness of our method. The work 
described in this sheds light on regulatory chromatin processes specific to mES cells, 
which informs our understanding of stem cell biology and reprogramming.  
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Abbreviations 
ABL  Abelson tyrosine kinase 
ab  antibody 
ac  acetylation 
AP  alkaline phosphatase 
ATP  adenosine tri-phosphate 
Bmi1  B lymphoma Mo-MLV insertion region 1 
BRD4  bromodomain-containing protein 4 
BSA  bovine serum albumin 
CAK  CDK-activating kinase 
CDK  cyclin dependent kinase 
cDNA  complementary DNA 
ChIP  chromatin immunoprecipitation 
CKII  casein kinase II 
CTD  carboxy-terminal domain 
CUT  cryptic unstable transcripts 
Dig  digoxigenin 
DNase deoxyribonuclease 
DNA  deoxyribonucleic acid 
DRB  5,6-dichloro-1-b-D-ribofuranosylbenimidazole 
DSIF  DRB-sensitivity inducing factor 
EDTA  ethylenediaminetetraacetic acid 
Eed  embryonic ectoderm development 
ERK  extracellular-regulated kinase 
ES  embryonic stem 
Ezh2  enhancer of zeste homolog 2 
FCP1  transcription factor IIF-associated CTD phosphatase 1 
FCS  fetal calf serum 
FGF  fibroblast growth factor  
G  guanosine 
GO  gene ontology 
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GTF  general transcription factors 
H  histone 
HAT  Histone acetyltransferase 
HDAC  Histone deacetylase 
HMT  histone methyl transferase 
Hox  homeobox 
hsp  heat shock protein 
ICM  inner cell mass 
JMJD3 Jumonji domain-containing protein 3 
ICM  inner cell mass 
Ig  immunoglobulin 
IP  immunoprecipitation 
K  lysine 
LIF  leukemia inhibitory factor 
LINE  long interspersed nuclear element 
m7G  7-methyl guanosine 
me  methylation 
mRNA messenger RNA 
miRNA micro RNA 
ncRNA non-coding RNA 
MN  micrococcal nuclease  
NEAA  non-essential amino acids 
NEDD4 neural precursor cell expressed, developmentally down-
regulated 4 
NELF  negative elongation factor 
Oct4  octamer-4 
O-GlcNAc O-linked N-acetylglucosamine 
OGT  O-linked N-acetylglucosamine transferase 
p  phosphorylation 
P  proline 
PAGE  polyacrylamide gel electrophoresis 
PBS  phosphate-buffered saline 
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Pcl  Polycomb-like 
PCR  polymerase chain reaction 
Pho  pleiohomeotic 
PIC  pre-initiation complex 
PIN1  protein interacting with NIMA (never in mitosis A)-1 
PMSF  phenylmethyl-sulphonyl fluoride 
polyA  polyadenylation 
PRC  Polycomb repressive complex 
PRE  Polycomb response element 
PRCi  PRC-intermediate cluster 
PRCo  PRC-only cluster 
PRCr  PRC-repressed cluster 
Psc  posterior sex combs 
P-TEFb positive transcription elongation factor b 
RA  retinoic acid 
Rpb1  RNA polymerase II subunit B1 
REST  RE-1 silencing transcription factor 
Ring  really interesting new gene 
RNA  ribonucleic acid 
RNAP  RNA polymerase 
RNAPII S2p RNAPII phosphorylated on serine 2 residues of the CTD 
RNAPII S5p RNAPII phosphorylated on serine 5 residues of the CTD 
RNAPII S7p RNAPII phosphorylated on serine 7 residues of the CTD 
RNAPII Y1p RNAPII phosphorylated on tyrosine 1 residues of the CTD 
RNAPII T4p RNAPII phosphorylated on threonine 4 residues of the CTD 
rRNA  ribosomal RNA 
Rpap  RNA polymerase associated protein 
rpm  revolutions per minute 
RT  real-time 
Rtr  regulator of transcription 
S  serine 
Scp  small CTD phosphatase 
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Seq  sequencing 
Set  suppressor of variegation, enhancer of zeste and trithorax 
Setdb1 SET domain bifurcated 1 
SINE  short interspersed nuclear element 
snRNA small nuclear RNA 
snoRNA small nucleolar RNA 
Sox2  SRY (sex determining region Y)-box 2 
SPT  suppressor of Ty 
Ssu72  suppressors of sua7 protein 2 
SUMO small ubiquitin-related modifier 
Suz12  suppressor of zeste 12 
SWI/SNF switch/sucrose non-fermentable 
UTX  ubiquitously transcribed tetratricopeptide repeat, X chromosome 
T  threonine 
T  thymidine 
TBP  TATA-binding protein 
TE  trophectoderm 
TF  transcription factor 
TFIIH  transcription factor II H 
tRNA  transfer RNA 
TS  trophoblast stem 
TSS  transcription start site 
ub  ubiquitination 
USP  ubiquitin-specific protease 
UTR  un-translated region 
UV  ultraviolet 
WT  wild-type 
WWP2 WW domain containing E3 ubiquitin protein ligase 2 
XEN  extra-embryonic endoderm  
Y  tyrosine 
YY1  yin-yang-1 
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1. Literature review and thesis overview 
1.1. Gene regulation and control of gene expression 
Every major developmental process is driven by changes in the pattern of 
gene expression.  This tightly regulated dynamic process governs distinct 
transcriptional programs whereby genes are activated or silenced, conferring 
specificity to a cell type, to its distinct stage in lineage specification and to 
developmental stage. Temporal control of gene expression allows cells to 
remain responsive to external cues (including developmental or 
environmental) and mediate appropriate changes in transcription. Genome 
regulation and control of gene expression can be observed, visualised and 
understood at different scales of genome resolution. These include from the 
large scale positioning of chromatin to the local chromatin regulation effects: 
chromosomal associations with nuclear landmarks, long-range chromatin 
interactions, recruitment of transcription factors, master regulators, chromatin 
remodellers, sequence specific factors and the transcription and co-
transcriptional RNA processing machinery. Transcription is the first step in 
gene expression and a major target of regulation; establishment of a 
permissive chromatin architecture allows RNA polymerases to transcribe the 
genome, producing RNA molecules that, after complex co-transcriptional 
processing, act as template message for translation to protein product or 
serve independently with its structural and functional roles. Thus, the 
interactions at different levels allow us to understand the full range of 
complexities that result in transcriptional control. 
1.1.1. Genome and its packaging. 
In three-dimensional nuclei of each cell of an organism, the genetic 
information that specifies protein instruction for functioning and development 
is encoded in the DNA. The DNA is highly folded, constrained and compacted 
at several levels and the dynamics of higher-order structures play crucial roles 
in transcription and biological processes inherent to DNA. 
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Histone and non-histone proteins hierarchically package the genomic DNA 
into chromatin in the eukaryotic nucleus. The first level of chromatin 
organisation involves packaging of DNA around octamer of histone proteins 
forming nucleosome monomer. Packaging of nucleosomal array in a ‘beads-
on-a-string’ conformation and binding with linker histone (H1 or H5) further 
organizes the nucleosome arrays into a more condensed chromatin fibre and 
finally into chromosomes (Jenuwein and Allis 2001; Kouzarides 2007).   
 
At the sequence level, DNA features like gene density, base composition, 
CpG levels, intron/exon density, repeats and motifs, all influence gene 
regulation and further coordinate with enhancers and insulators to influence 
the transcriptional status. In addition, epigenetic modifications that heritably 
influence gene expression without affecting the underlying DNA sequence 
layer additional levels of complexity and regulation. The local chromatin 
architecture composed of underlying DNA sequence with features and 
epigenetic modifications dynamically facilitate binding of transcription factors, 
chromatin remodellers and master regulators thereby regulating the 
transcriptional states. Other mechanisms that influence and govern 
transcription include histone modifications, nucleosome positioning, higher-
order chromatin structure and genome architecture inside the three-
dimensional nucleus (Strahl and Allis 2000; Branco and Pombo 2007; Segal 
and Widom 2009; Bannister and Kouzarides 2011). 
1.1.2. Chromatin and epigenetic regulation 
The chromatin inside cells is a diverse molecular ensemble consisting of DNA 
bound together with all directly or indirectly associating proteins or RNA 
molecules. These include histones, DNA-binding factors, RNA molecules, 
transcriptional machinery, co-transcriptional factors and nascent transcripts, 
replication and repair machineries that copy and maintain DNA molecules, 
and regulate their interactions. Remarkably, all the components on chromatin 
are thought to act in a concerted fashion responding to local architectural cues 
(van Steensel 2011).  
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Chromatin consists of nucleosomes, in which DNA (147bp) is wrapped around 
a protein octamer of histones composed of two subunits of H2A, H2B, H3 and 
H4. The intervening, linker DNA (20-50bp) can also associate with the 
nucleosome through interactions with linker histone H1 that sits on top of 
nucleosomal bead. Histones and their post-translational modifications have 
structural roles that control the chromatin topology and compaction, but also 
help recruit chromatin remodellers that utilize the energy derived from the 
hydrolysis of ATP to reposition nucleosomes. In addition, these modifications 
can influence transcription and other DNA processes occurring on chromatin 
such as repair, replication and recombination. Histone acetylation is regulated 
by histone acetyltransferases (HAT) and histone deacetylases (HDAC). 
Phosphorylation of histone tails is quite dynamic occurring on Serine, 
Threonine and Tyrosine residues and catalysed reversibly by kinases and 
phosphatases. Methylation of histones is better understood and occurs on 
Lysine and Arginine residues. Lysine methylation is reversible and regulated 
by activity histone methyltransferases (HKMT) and histone demethylases 
(Bannister and Kouzarides 2011; Follmer et al. 2012; Leeb and Wutz 2012; 
Luis et al. 2012). In this thesis, I will predominantly discuss active histone 
modifications H3K4me3, H3K36me3 enriched at actively, transcriptionally 
permissive chromatin and Polycomb-dependent repressive histone 
modifications H3K27me3 and H2Aub associated at silenced loci (Wang et al. 
2004; Mikkelsen et al. 2007). 
1.1.3. Chromatin proteome 
The abundance and diversity of chromatin proteins is quite remarkable. For 
example, a human cell is thought to contain 1010 protein molecules; assuming 
10% nuclear distribution. We are still left with 109 molecules that in a nucleus 
consist of 103-105 molecules of transcription factors, histones, high-mobility 
group proteins and components of transcription and co-transcriptional RNA 
processing (van Steensel 2011).  
It has also been reported that human nuclei contain roughly 8000 different 
proteins and ~1400 DNA binding factors (Vaquerizas et al. 2009). Considering 
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the abundance and diversity of proteins, their respective interactions are also 
amplified with suggestion that the human interactome may contain 130 000 
interactions which would include protein-protein, protein-RNA and protein-
DNA (Venkatesan et al. 2009).   
 
The myriad of chromatin proteins and their interactions that regulate 
chromatin have led to identification of distinct chromatin states (van Steensel 
et al. 2001; Bernstein et al. 2006; Brookes et al. 2012), but inevitably depends 
on the a priori knowledge of chromatin marks and known factors for which 
probes, such as antibodies, have already been developed. Mapping of all 
possible components bound to chromatin at the different states is challenging 
and expensive; moreover it does not inform about which proteins 
simultaneously bind to chromatin and functionally interplay. With the aim of 
identifying the proteome of specific chromatin states, it was my aim to develop 
a novel unbiased method that identifies and dissects the chromatin-bound 
proteome associated with a protein of interest.  
1.1.4. Transcription, RNA polymerases and co-transcriptional regulation 
Transcription is the process where the genetic information encoded in the 
DNA is transcribed into RNA by large molecular subunit machines called RNA 
polymerases (RNAP; (Fuda et al. 2009). Eukaryotes have three distinct 
nuclear RNAPs with each transcribing a separate set of genes (Roeder 2005). 
RNAPI (RNA polymerase I) transcribes abundant ribosomal RNAs (rRNA) 
encoded on a multicopy single gene, 45S rRNA, and RNAPIII (RNA 
polymerase III) transcribes structural RNAs such as transfer RNA (tRNA), 5S 
rRNA and U6 spliceosomal small nuclear RNA (snRNA) (Dieci et al. 2007; 
Pagano et al. 2007). RNAPII (RNA polymerase II) transcribes all protein-
coding genes and many structural and non-coding RNAs including snRNA, 
small nucleolar RNA (snoRNA), microRNA (miRNA) precursor and cryptic 
unstable transcripts (CUTs). The process of transcription consists of three 
steps: initiation, elongation and termination that are highly coordinated and 
involving co-association with a range of co-factors.  
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RNAPII transcription at individual genes is highly modulated and specific 
regulation is critical for the development of an organism. Transcriptional 
regulation is achieved by a complex combinatorial set of molecular 
interactions occurring on chromatin between RNAPII, co-factors, specific DNA 
sequences and additional machineries that inherently are regulated by local 
chromatin architecture. Some examples of transcriptional machinery and 
interactions include general transcription factors (Gtfs) that facilitate 
recruitment of RNAPII on DNA, sequence-specific transcription factors, 
regulatory co-factors, Mediator complex, Integrator complex and co-
transcriptional processing machinery. Co-transcription and post-transcriptional 
regulatory mechanisms include maturation and processing of RNA to produce 
stable mRNA, its export from the nucleus by specific transport factors and 
finally localisation of sites of translation. Gene expression is additionally 
regulated by components at different steps including mRNA levels and 
feedback, RNA interference (small interfering RNA, microRNA, etc.), long 
non-coding RNA and a variety of other mechanisms (Chen and Carmichael 
2010; Lee 2012).    
1.1.5. Gene regulation in mES cells 
Embryonic stem (ES) cells are pluripotent, self-renewing cells that are derived 
from the inner cell mass (ICM) of the developing blastocyst in the early 
embryo. Pluripotency is the capacity of a single cell to generate all cell 
lineages of the developing adult organism and ES cells inherit this property 
from the ICM that in vivo goes on to form all cells of the proper embryo. Self-
renewal is the ability of a cell to proliferate in the same state and indefinitely in 
culture (Young 2011; Fong et al. 2012; Li et al. 2012). These properties of ES 
cells makes them an invaluable tool to study early development in organisms 
and understand the control mechanism associated with defects in 
development and disease that open the horizon to devise cell therapeutic 
possibilities.  
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The ES cell transcriptome is regulated by a gene expression network that 
allows them to self-renew while retaining the potential to differentiate into 
essentially all lineages upon appropriate cues. The complex chromatin 
network of ES cells is regulated by master transcription factors (including 
Oct4, Sox2 and Nanog), their regulatory circuit, chromatin remodellers, 
RNAPII transcription and DNA-binding factors that cascade a plethora of 
downstream pathways (Orkin et al. 2008; Young 2011). Owing to its dynamic 
and complex gene regulatory network, the ES cell chromatin maintains open, 
more permissive state allowing activation of specific combination of genes 
essential for housekeeping functions and importantly the ES cell state while 
repressing lineage specific genes. Open chromatin architecture of ES cells 
contributes to its plasticity (and hyperactive transcription) and undergoes a 
rapid shift upon cell commitment to suit the needs to specific lineage 
specification (Efroni et al. 2008; Jaenisch and Young 2008). 
 
The mES cell core circuitry consists of master transcription factors (Oct4, 
Sox2 and Nanog), their transcriptional network and protein interaction network 
that control the pluripotency in mES cells (Wang et al. 2006; Orkin et al. 2008; 
Wang and Orkin 2008). These master regulators co-occupy sites of other 
essential transcription factors and signalling pathways (including LIF, Wnt, 
Bmp4, Stat3, Smad1) thereby allowing direct control of genes to regulate their 
downstream transcription and maintain chromatin states (Chen et al. 2008a; 
Chen et al. 2008b). Specific analysis of mES cell proteins and their 
association with the core pluripotency network has further unravelled novel 
roles in pluripotency and mES cell survival. 
 
In this project and thesis, I will focus on regulation of RNAPII in mES cells in 
particular understanding and unravelling the chromatin state at developmental 
regulator genes (under the control of a master regulator) and with aim of 
identifying novel protein associations in mES cell chromatin.  
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1.2. The RNA Polymerase II complex (RNAPII) 
RNAPII protein transcribes protein-coding genes and many non-coding RNAs 
on chromatin and coordinates a cascade of interactions with a range of 
nuclear processes including transcription factors, chromatin remodellers, co-
transcriptional machinery and other factors to mediate the proper control of 
gene expression allowing cells to grow, divide and respond appropriately to 
environmental and developmental cues.  
1.2.1. Core subunits 
RNAPII is a multi-subunit protein complex composed of 12 subunits (Rpb1-12 
or Polr2a-l). Five of these subunits are shared with other RNA polymerases 
(Polr2e, Polr2f, Polr2h, Polr2k, Polr2l). Regulation of RNAPII and control of 
gene expression is mediated by a complex set of post-translational 
modifications that occur on the C-terminal domain (CTD) of the Rpb1 (Polr2a), 
the largest subunit of RNAPII. Modifications of the RNAPII integrate 
transcriptional process with a multitude of co-regulatory processes catalysed 
by a diverse range of modifying proteins. 
1.2.2. Rpb1 and CTD 
The largest subunit of RNAPII, Rpb1, has a unique highly repetitive CTD 
consisting of multiple tandem hepta-peptides that plays a central role in 
complex regulation of gene expression. The evolutionary conserved 
consensus motif of the CTD consists of Y1 – S2 – P3 – T4 – S5 – P6 – S7  
(Tyrosine – Serine – Proline – Threonine – Serine – Proline – Serine; Fig. 1.1) 
(Corden et al. 1985). CTD length differs depending on the complexity of 
organism. In humans and murine cells the CTD sequence is repeated 52 
times, 44 times in D. melanogaster, 26 times in yeast, wherein all repeats 
almost obey consensus (Egloff and Murphy 2008b; Egloff and Murphy 2008a; 
Heidemann et al. 2012). Deletion of the CTD is lethal in yeast, D. 
melanogaster and in mouse, however mutations have revealed a dispensable 
role for CTD in transcription (Meininghaus et al. 2000). 
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Figure 1.1 Simplified representation of Rpb1 subunit and its CTD. The largest 
subunit of RNAPII, Rpb1 is composed of CTD consisting or multi-heptad repeat of 
above consensus sequence. Number of tandem hepta-peptide repeats varies with 
the complexity of the organism with mouse and human protein having 52 repeats. 
Distal part of CTD contains amino acids that can diverge from consensus, including 
lysine, arginine and threonine residues. 
 
The non-consensus repeats of the CTD (31 repeats) are mostly distally 
placed at C-terminal part of CTD and with changes at positions 3,4,5 and 7. 
Serine at position 7 is most substituted and interestingly lysine residues 
replace the serine residues at distal repeats (position 7). Theoretically, the 
presence of lysine at the CTD allows digestion with trypsin and MS detection 
of peptides. However, remarkably, the structure of CTD and complex 
modification of the heptad repeats makes detection of peptides increasingly 
difficult. From purified RNAPII protein (samples kindly provided by Dr. Andre 
Moeller; our laboratory) and using MS analysis after trypsin digestion, we 
observed all predicted CTD residues as listed in Table 1.1. The last CTD 
peptide contains an unusual extension that includes unique constitutive 
binding site for phosphorylated casein kinase II site (CKII) and binding sites 
for tyrosine kinases c-abl1, a-abl2 (Baskaran et al. 1996; Baskaran et al. 
1997; Chapman et al. 2004). Remarkably, removal of this domain impairs thr 
stability of Rpb1, cellular viability and nascent RNA processing (Fong et al. 
2003; Chapman et al. 2004).  
 
 
 
 
 
 
 
 
N-terminal! Carboxy terminal domain (CTD)!
Y1–S2–P3–T4–S5–P6–S7!RPB1! n=52!
Heptad repeat!
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Table 1.1 List of Rpb1-CTD peptides. 
 
 
The Rpb1-CTD is thought to act as a binding scaffold for a variety of nuclear 
proteins including histone modifications, RNA processing and components of 
co-transcriptional machinery. Since the bound factors physically associate 
with RNAPII, their processes inherently become linked to transcription 
(Phatnani and Greenleaf 2006). In addition, the pattern of modifications on the 
CTD couple the recruitment and binding of different protein factors on 
chromatin with RNAPII. These modifications include phosphorylation, 
isomerisation, methylation, ubiquitination and glycosylation.  
The enormous combinatorial potential of post-translational modifications on 
the Rpb1-CTD could allow existence of several individual RNAPII’s (with 
distinct combinations) linked to several stages of transcription and RNA 
processing in living cells. This has led to the hypothesis of the CTD code 
(Kelly et al. 1993; Buratowski 2003; Egloff and Murphy 2008a) 
 
The structure of the CTD is a largely disordered, flexible and free hanging, 
which enables interaction with a variety of proteins.  The combination of post-
translational modifications occurring on the CTD is thought to alter its 3D 
conformation thereby allowing accessibility of DNA binding sites and CTD to 
recruit additional factors. The free structure (linearized; 375 amino acids) of 
the Rpb1-CTD is likely to extend several diameters of the RNAPII globular 
structure and owing to its long structure, it can provide a surface for 
DNA-directed RNA polymerase II subunit RPB1 Coordinates Length
Polr2a 1 – 1970 1970
Repeat 52; approximate 1954 – 1960 7
Region (52 X 7 AA approximate tandem repeats of Y-[ST]-P-[STQ]-[ST]-P-[SRNTEVKGN]52 X 7 AA 
approximate tandem repeats of Y-[ST]-P-[STQ]-[ST]-P-[SRNTEVKGN] ) 1593 – 1960 368
CTD starts from 1593
Sequence Length
YGMEIPTNIPGLGAAGPTGMFFGSAPSPMGGISPAMTPWNQGATPAYGAWSPSVGSGMTPGAAGFS
PSAASDASGFSPGYSPAWSPTPGSPGSPGPSSPYIPSPGGAMSPSYSPTSPAYEPR 122
SPGGYTPQSPSYSPTSPSYSPTSPSYSPTSPNYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPS
YSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTS
PSYSPTSPNYSPTSPNYTPTSPSYSPTSPSYSPTSPNYTPTSPNYSPTSPSYSPTSPSYSPTSPSYSP
SSPR 207
YTPQSPTYTPSSPSYSPSSPSYSPTSPK 28
YTPTSPSYSPSSPEYTPASPK 21
YSPTSPK 7
YSPTSPTYSPTSPVYTPTSPK 21
YSPTSPTYSPTSPK 14
GSTYSPTSPGYSPTSPTYSLTSPAISPDDSDEEN 34
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simultaneous binding of several co-factors, RNA and interaction with 
chromatin.  
1.2.3. CTD modifications 
1.2.4. Serine 5 phosphorylation 
Phosphorylation of serine at position 5 of the Rpb1-CTD heptad (S5p) was 
initially identified at promoter regions (5’ end) of actively transcribing protein-
coding genes that suggested a role in transcription initiation (Komarnitsky et 
al. 2000). This modification (S5p) is thought to allow RNAPII promoter escape, 
dissociation from the pre-initiation complex and recruitment of appropriate 
factors for proper transcription initiation.  
 
The general transcription factor TFIIH subunit Cdk7 (kin28 in yeast), mediates 
phosphorylation of S5p. The CDK-activating kinase (CAK) is formed by 
association of Cdk7 with ‘cyclin-H’ and ‘Mat1’, which is incorporated into the 
TFIIH complex and further phosphorylates RNAPII-associated with DNA. 
Mediator subunit Cdk8 (Srb10 in yeast) is another enzyme that can 
phosphorylate S5p and has roles in gene activation (Galbraith et al. 2010) and 
also repressive roles (Hengartner et al. 1998). 
 
The CTD containing S5p is thought to be landing pad that recruits and 
activates the capping enzyme to add cap structure to 5’ end of the newly 
synthesised RNA. S5p is found at promoters of mRNA and snRNA genes. 
Mutation of S5 residue to Alanine (non-phosphoacceptor) causes a drastic 
reduction in steady state levels of RNA (Egloff et al. 2007), and is thought to 
be an essential step for protection of 5’ end of RNA from exonucleases (Egloff 
and Murphy 2008b). Along with recruitment of capping enzyme, S5p is also 
required for interaction with Nrd1 which mediates 3’-end formation and 
premature termination at non-polyadenylated transcripts in yeast (Heidemann 
et al. 2012). S5p also links histone modifications and chromatin remodellers. 
S5p interacts with Set1 (histone methyltransferase) that catalysis H3K4me3; a 
mark of open chromatin and transcription initiation. In addition, S5p is also 
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involved in recruitment of Rpd3C, histone H3 and H4 deacetylase (Govind et 
al. 2010). 
 
Various enzymes are involved in removing the S5p mark from RNAPII-CTD. 
Ssu72 (suppressor of sua7 protein) is known to dephosphorylate S5p and has 
additional roles in mRNA elongation and termination. Ssu72 is the primary 
S5p phosphatase in yeast and its activity is regulated through proline 
isomerisation (at positions 3 and 5 of Rpb1-CTD) (Krishnamurthy et al. 2009). 
Scp1-3 (small CTD phosphatases) are known to cooperate with REST 
chromatin remodelling complex and dephosphorylate S5p at REST-target 
genes (Yeo et al. 2005). Scps act as transcription regulators, silencing 
neuronal expression in non-neuronal genes and have also been hypothesised 
to play a role in general transcription (Yeo et al. 2005; Heidemann et al. 
2012). Rtr1 (regulator of transcription) is an atypical S5p phosphatase 
identified in yeast. Rtr1 deletion in yeast is not lethal and the lack of an active 
phosphatase site in Rtr1 has suggested its non-catalytical role in 
dephosphorylation. Rtr1 deletions also lead to high S5p levels during 
elongation (Mosley et al. 2009). Rpap2 (RNA-associated protein) is the 
human homolog of Rtr1 and is also associated with S5p dephosphorylation. 
Rpap2 is detected at 5’ ends of actively transcribed genes and is essential for 
appropriate 3’ end formation of snRNA transcripts (Egloff et al. 2007). 
 
1.2.5. Serine 7 phosphorylation 
Phosphorylation of serine at position 7 (S7p) occurs both in yeast and in 
mammalian cells (Chapman et al. 2007; Egloff et al. 2007; Kim et al. 2010; 
Hajheidari et al. 2012). S7p is identified at promoters and coding regions of 
protein-coding genes and snRNA genes. Substitution of S7 to alanine (non-
phospho acceptor) is not lethal is yeast but impairs viability of human cells. 
Mutations to the S7p residue donot affect the expression of protein-coding 
genes, however the drastic effect is observed on transcription and processing 
of snRNA genes (Egloff et al. 2007). snRNAs contain a conserved 3’ box for 
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3’ end RNA processing recognised by the integrator complex and this, in 
association with Rtr1/Rpap2, facilitates interactions with PTEF-b and 
appropriate transcription elongation and snRNA processing (Egloff et al. 2007; 
Heidemann et al. 2013). This has led to the suggestion of CTD modifications 
having gene-specific functions.  
 
In protein coding genes, S7p is placed early in transcription and the 
modification can be detected on RNAPII until polyadenylation site. S7p is 
phosphorylated by Cdk7 (kin28 in yeast), the S5p kinase, and chemical 
inhibition of cdk7 results in a drastic decrease of both S5p and S7p at 5’ 
regions of genes. Interestingly, S7p is though to influence the extent of S5p 
and both the marks are added synchronously during thr early stages of 
transcription. The role of S7p is thought as a transition from S5p (initiation) to 
S2p (elongation). Additional S7p kinases have been suggested, including 
Bur1 (yeast internal S7p kinase) (Boeing et al. 2010; Zhang et al. 2012b). In 
contrast to alanine mutants, S7 to glutamate (phospho-mimic) substitutions 
are lethal in human and in yeast. Owing to the distribution of S5p and S7p 
modifications and their catalysis by cdk7, the only known phosphatase acting 
on S7p is Ssu72 that removes S7p immediately after the polyadenylation site 
and reconstitutes RNAPII to hypo-phosphorylated state (Bataille et al. 2012; 
Zhang et al. 2012a). 
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Figure 1.1 Diagrams representing phosphorylation events on Rpb1-CTD during 
the transcription cycle. (A) RNAPII is recruited at the gene promoters in hypo-
phosphorylated form, when it undergoes modification at S5p that initiates the 
RNAPII. Modification at S7p and subsequently at S2p accompanies the transition of 
RNAPII from initiation to elongation further producing stable mRNA for export, while 
the RNAPII is de-phosphorylated and recycled. (B) A simplified pattern of RNAPII 
occupancy and histone modifications across a typical active gene.  
1.2.6. Serine 2 phosphorylation 
Phosphorylation of S2 (S2p) of Rpb1-CTD is identified at coding regions of 
actively transcribing genes and is associated with productive elongation 
(Komarnitsky et al. 2000; Morris et al. 2005) and recruitment of chromatin 
remodellers (for H3K36me3; hallmark of elongation), RNA processing factors, 
co-transcriptional machinery and splicing factors (Kim et al. 2002; Proudfoot 
et al. 2002; Li et al. 2005).  
 
Cdk9 (Bur1 and Ctk1 in yeast) phosphorylates Serine 2 of the RPb1-CTD 
(S2p). Cdk9 is also the catalytic subunit of the PTEF-b complex (positive 
transcription elongation factor). The Spt5 subunit of DSIF (DRB sensitivity-
inducing factor) is a non-CTD substrate of Bur1/Cdk9 containing a C-terminal 
repeat region (CTR). DSIF complexes with NELF (negative regulation of 
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transcription) and phosphorylation of this complex by Cdk9 (PTEF-b) and S2p 
allow progression in transcriptional elongation (Bartkowiak et al. 2011; 
Nechaev and Adelman 2011). PTEF-b is also recruited by sequence-specific 
TFs, such as TNFα and c-Myc (Rahl et al. 2010). Additionally, BRD4 interacts 
with P-TEFb, recruiting the kinase activity to sites of acetylated histones (Jang 
et al. 2005). More recently, other S2p kinases have been identified in higher 
eukaryotes. Cdk12 and Cdk13 are important for human genes, additionally 
Brd4 (bromodomain protein) has been shown to be atypical S2p CTD kinase 
in vitro and in vivo (Bartkowiak et al. 2010; Devaiah et al. 2012). S2p is 
thought to recruit Set2 methyltransferase, that catalyses H3K36me3 that 
marks transcriptionally active, elongating genes and inhibits inappropriate 
transcription from cryptic promoters through recruitment of repressive Rpd3s 
histone deacetylase complex (Carrozza et al. 2005; Keogh et al. 2005; Kizer 
et al. 2005). S2p is also required for global and gene-associated levels of 
histone H2B ubiquitination and correct 3’ processing of replication dependent 
histone mRNA (Pirngruber et al. 2009). 
 
Removal of S2p from the Rpb1-CTD is catalysed by evolutionarily conserved 
FCP1 (TFIIH associating C-terminal domain phosphatase). Fcp1 is thought to 
travel along with RNAPII till the end of the gene and remove S2p allowing the 
next round of transcription (Cho et al. 2001; Ghosh et al. 2008). Cdc14 is 
another phosphatase that is required for S5p and S2p dephosphorylation 
during mitosis and inhibition of sub-telomeric elements (Clemente-Blanco et 
al. 2011). Substitution of S2 to Alanine in Rpb1-CTD leads to defects in 3’ end 
processing of genes consistent with roles in processing and maturation of 
RNA and transcriptional regulation(Medlin et al. 2005; Egloff et al. 2007). 
1.2.7. Other CTD modifications 
The highly dynamic nature of CTD modifications and combination of potential 
post-translational modifications allow existence of several RNAPII molecules 
each with distinct combinatorial code and this hypothesis has led to the 
suggestion of CTD code (Buratowski 2003; Egloff and Murphy 2008a) 
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The other phosphorylation on the CTD include Tyrosine phosphorylation (Y1p) 
(Baskaran et al. 1993; Baskaran et al. 1997; Baskaran et al. 1999) and 
Threonine phosphorylation (T4p) (Hsin et al. 2011; Hintermair et al. 2012). 
The tyrosine kinases include c-Abl1 and c-Abl2 and these modifications are 
known to increase transcription elongation rates. Threonine phosphorylation is 
present in gene bodies and substitution to Alanine (or valine) is non-lethal in 
yeast but lethal in chicken and human cells. T4p is associated with elongation 
and consistently roles are identified in RNA processing and 3’ end processing. 
No specific kinase has been identified, although Plk1 (polo-like kinase) can 
catalyse T4p in human cells (Hintermair et al. 2012).  
 
Each CTD repeat contains proline residues in positions 3 and 6 between the 
phosphorylation sites on the Rpb1-CTD. Proline residues can be isomerised 
to undergo conformational changes in cis/trans conformation by peptidyl-prolyl 
cis-trans isomerases (PPiases) (Egloff and Murphy 2008a; Dai et al. 2012). 
Pin1 (Ess1 in yeast) is known to specifically recognise the 
S(phospho)/T(phospho)–Proline motif and provide binding sites for the co-
transcriptional machinery. Ssu72 (S5p phosphatase) preferentially 
dephosphorylates S5p in the Proline-6 in cis-conformation (Werner-Allen et al. 
2011). 
 
Glycosylation of serine and threonine residues can also occur on the Rpb1-
CTD by addition of O-linked N-acetyl-glucosamine (O-GlcNAc)(Kelly et al. 
1993). Phosphorylation and O-GlcNAcylation are mutually exclusive and the 
dynamic interplay is thought to be maintained by the concerted action of Ogt 
(O-GlcNAc transferase) and Oga (O-GlcNAc aminidase) proteins. Knockdown 
of Ogt proteins is also shown to decrease in transcription and RNAPII 
occupancy over B-cell promoters. The cycling of O-GlcNAc levels in higher 
eukaryotes is though to be important for specific gene transcription (Comer 
and Hart 2001; Ranuncolo et al. 2012). 
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The Rpb1-CTD is a target for ubiquitination and this modification is catalysed 
by protein Wwp2 (E3 ubiquitin ligase) in mouse stem cells (Li et al. 2007b). 
The lysine residues in the non-consensus repeats present in distal part of 
CTD are primary targets. Ubiquitination is known to occur at non-CTD 
residues and is believed to alter the subunit composition and complex 
assembly of RNAPII (Daulny et al. 2008). 
 
Arginine methylation has also been more recently reported on the Rpb1-CTD 
on the single non-consensus Arginine residue at the proximal part in the non-
consensus heptad repeat (Sims et al. 2011). Arginine methylation at repeat 31 
(YSPSSPR) is catalysed by Carm1 protein (co-activator-associated arginine 
methylation) and this modification is implicated in inhibition of general 
expression of snRNA and snoRNAs (Chapman et al. 2008; Sims et al. 2011).  
 
The CTD heptad repeat can be modified at all residues (phosphorylation, 
glycosylation, methylation, ubiquitination and isomerisation) leading to a 
combinatorial possibility of multiple CTD states. In addition, there are 52 
repeats of the heptad in the mammalian CTD that further increases the 
permutation of combinations. New modifications and tandem combinations of 
modifications are increasingly being studied on the CTD that can further 
elucidate the functionality and role of the CTD code. 
1.3. Active transcription cycle and CTD modifications 
The transcription cycle at active protein-coding genes consists of recruitment 
of hypo-phosphorylated RNAPII onto the gene promoter, with the RNAPII 
undergoing transcription initiation, transition to elongation, elongation, 
termination and recycling, to produce a stable, mature mRNA that is exported 
to sites for translation and protein output of the encoded DNA message. The 
distinct phases of transcription are regulated, demarcated by specific 
modification on the Rpb1-CTD and further dynamic interactions with 
activators, repressor, chromatin remodellers, RNA processing machinery and 
co-transcriptional processing factors. The tight regulation of transcription and 
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its components keeps gene expression in control, allowing appropriate 
responses either to gene specific expression levels or global overhaul during 
differentiation or in response to environmental cues. 
1.3.1. Initiation (PIC assembly and disassembly) 
Transcription initiation is a complex, multistep process that involves the 
recruitment of hypo-phosphorylated RNA polymerase to gene promoters and 
accessibility to DNA around the transcription start site (TSS). Initiation is 
thought to be a rate-limiting step in the transcriptional process (Wade and 
Struhl 2008). RNAPII and basal transcription factors recognize and assemble 
on the promoters. The pre-initiation complex, corresponding to a minimal set 
of factors required for initiation, includes RNAPII, basal transcription factors 
(TFIIB, TFIID, TBP, TFIIE, TFIIH), and formation of the PIC requires dynamic 
interactions between RNAPII and basal factors to increase binding affinity to 
promoters and occupancy (Butler and Kadonaga 2002). Other factors include 
the Mediator complex, DNA binding co-activators, nucleosome remodelers 
and chromatin modifiers (Li et al. 2007a; Nechaev and Adelman 2011). The 
exact mechanism of Transcription Start Site (TSS) selection is thought to be 
specific to organismal diversity and chromatin architecture. Factors important 
for selection include positioning of RNAPII and GTF’s to sequence specific 
factors, the presence of distinct sequence elements including a TATA box, 
Initiator, or Downstream Promoter Element (DPE), TFIIB recognition element 
and importantly CpG islands, amongst other genetic features. 
 
Following PIC initiation, assembly and nucleosome repositioning, DNA 
unwinds and RNAPII initiates transcription. Promoter clearance and transition 
into elongation requires S5p on Rpb1-CTD by Cdk7 subunit of TFIIH and is 
also facilitated by promoter-proximal modified histones and other co-factors. 
Instability of the RNAPII complex during the early stages of transcription leads 
to abortive transcription. Following promoter escape and synthesis of an 
nascent transcript (~20 nucleotides), S5p recruits the capping enzyme and 
stabilises RNA by addition of the 7-methyl-guanosine cap. S5p also 
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coordinates and interacts with chromatin remodellers including Set family 
proteins. During the initial transcription steps, promoter proximal pausing has 
been demonstrated by stalling of transcriptionally engaged RNAPII (10-50 
nucleotides) near the TSS by negative elongation factors. 
 
Figure 1.2 Transcription cycle at active genes and factors that interact with 
RNAPII during transcription. Recruitment of RNAPII at promoters, S5p and 
subsequently S7p on Rpb1-CTD associates with transcriptional initiation. S2p 
transitions RNAPII to elongation further interacting with range of protein cohorts to 
mature and stabilise RNAPII. Termination prepares RNAPII for next round of 
transcription. During the process of transcription, Rpb1-CTD interacts with range of 
chromatin remodellers, histone modifiers and components of transcription machinery 
as highlighted (Adapted from (Zhang et al. 2012b). 
1.3.2. Elongation 
Phosphorylation of S7p is thought as a transition from initiation to productive 
elongation and occupancy of S7p mirrors S5p. S7p precedes S2p for 
productive elongation and is important for transcription and 3′-end processing 
of snRNA genes (Komarnitsky et al. 2000). Although the exact function of S7p 
is still unclear, modification by Cdk7, enrichment at promoters and de-
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places initial Ser2-P marks, which facilitate recruitment of Ctk1 kinase, and continues to replenish Ser7-P marks during elongation.
Ctk1 is the primary Ser2 kinase, and its phosphorylation recruits splicing machinery (SP) through Prp40, as well as Set2 histone
methyltransferase, which places di- and trimethyl marks on histone H3K36. Cleavage and polyadenylation (PA) machinery are recruited
through many factors associating with the CTD. One of the factors, Pcf11, binds cooperatively to Ser2-P with Rtt103. The exonuclease
complex (Exo) is also recruited through interaction between CTD and Rtt103 and through cooperative interaction between Rtt103 and
Pcf11. Finally, the hyp phosphorylated CTD is r generated through three CTD phosphatases. Ser2-P is emoved by the phosphatase Fcp1,
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phosphorylation, Pol II is released with the assistance of a mechanism involving Pcf11 and can begin another cycle of transcription.
modifications it can accommodate. Tyrosine, threonine, and
three serines can all be phosphorylated, the threonine and
serine can be glycosylated, and the prolines can undergo
isomerization (Figure 1(c)) [27, 37, 38]. In humans, CTD
repeats further away from core Pol II bear noncanonical
repeats that can be methylated [39]. Taken together, at least
1059 unique modification patterns can occur on the CTD.
The combinatorial nature of these mo ifications, which is
reminiscent of the histone code, led to the hypothesis of
a CTD code, where the patterns of modifications are read
by the transcriptional machinery and these patterns dictate
the association or disassociation of complexes [40, 41]. To
date, much effort has beenmade towards characterizing these
modifications and understanding the interactions between
the CTD and components of various protein machines that
play a role in RNA biogenesis. Our current knowledge of the
integration of these events by Pol II CTD is summarized in
Figure 2, and the known yeast CTD-interacting factors are
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phosphorylation by S5p phosphatase (Ssu72) suggests a general and 
important function in gene expression (Ghazy et al. 2009; Zhang et al. 2012a). 
 
Transition into productive elongation is triggered by recruitment of the P-TEFb 
kinase (Cdk9) that phosphorylates the S2 residue on Rpb1-CTD and relieves 
the effect of negative elongation factors (including DSIF and NELF). S2p 
mediates interactions with set of diverse RNAPII-associated chromatin factors 
that favour progressive elongation by facilitating open chromatin architecture 
and RNA processing (Nechaev and Adelman 2011; Hsin and Manley 2012). 
S2p provides a platform for assembly of complexes that travel along with the 
RNAPII towards the end of the gene. These factors include splicing factors, 
RNA processing and chromatin remodellers (Phatnani and Greenleaf 2006). 
S2p levels increase through the gene body with lower S5p (than promoters) 
and once elongating, RNAPII is remarkably stable and transcribes kilobases 
without dissociation from the DNA template. 
1.3.3. Termination and recycling of RNAPII 
Transcription termination requires release of the RNA transcript from 
transcription complexes, canonical cleavage and processing by 
polyadenylation machinery to generate a nuclease-protective poly-A tail 
(Richard and Manley 2009). The downstream transcripts produced by RNAPII 
on DNA are chopped off by exonculease digestion and destabilisation of 
RNAPII is mediated by a range of chromatin factors and additional factors 
(CTD phosphatases) that directly associate with CTD and alter its 
conformation (Nechaev and Adelman 2011; Zhang et al. 2012b). Appropriate 
termination is essential for maturation of the RNA molecule. In addition, 
termination allows recycling of RNAPII to allow multiple rounds of transcription 
in rapid succession, thereby facilitating subsequent rounds of productive 
transcription (West et al. 2008). 
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Figure 1.3 Transcription and coupling of co-transcriptional processes along 
with Rpb1-CTD modifications. (A) Initiation of transcription is coordinated with S5p, 
which further recruits capping machinery and associated histone and chromatin 
modifiers. RNAPII-S2p (S5p, S7p and S2p) is hallmark of transcription elongation 
that along with interaction with histone modifiers, also co-ordinates recruitment of co-
transcriptional machinery, including splicing and polyadenylation machinery that 
processes the RNA to make a stable transcript. Termination requires the action of 
phosphatases on Rpb1-CTD to recycle and prepare hypo-phosphorylated RNAPII for 
the next round of transcription. 
1.3.4. RNA polymerase II, protein interactions and stem cell specific co-
factors 
RNAPII and modifications to the Rpb1-CTD transcribe the genetic information 
into an mRNA message. The Rpb1-CTD acts as a platform whereby 
chromatin factors including remodellers, RNA processing and co-
transcriptional machinery interact and regulate transcription. Dynamic 
modifications to the CTD transition RNAPII to different stages of transcription 
cycle along with recruitment of appropriate factors (Buratowski 2009). 
 
During initiation, S5p associates with histone methyltransferases (Set1) 
leading to open chromatin confirmation marked by H3K4me3. In addition S5p 
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recruits capping enzyme to modify the 5’ end of nascent RNAs (Fabrega et al. 
2003). S5p physically associates with mRNA and capping enzyme to add a 
protective m7G (7-methyl guanosine) cap to the nascent RNA, while 
disrupting interactions with factors involved in formation of pre-initiation 
complex (mediators, basal transcription factors, etc.) (Proudfoot et al. 2002). 
S7p and S2p hallmarks of elongating RNAPII occur post-initiation (S5p) 
signalling in the transition to active elongation (Li et al. 2005). S7p and S2p 
integrate elongation with chromatin remodelling through the recruitment of 
Set2 (and H3K36me3) marking open chromatin structure compatible with 
elongation in gene bodies (Keogh et al. 2005). Transcription elongation also 
couples RNA synthesis with co-transcriptional RNA processing, splicing and 
polyadenylation factors (Kizer et al. 2005; Walsh et al. 2010). The 
polyadenylation factors and the termination factors preferentially associate 
with S2p and prepare RNA for maturation and protection while recycling 
RNAPII for next round of transcription.  
 
Our knowledge of transcriptional process and components involved stems 
mostly from seminal work done in yeast. Quite a few yeast protein homologs 
exist in mammalian cells. However, the organismal complexity in mammals 
(e.g. 52 heptad repeats in the CTD including many non-canonical amino acids 
target for additional modifications) introduces overlapping function for 
homolog proteins and in addition often similar processes between yeast and 
mammalian are regulated by different cascades of protein cohorts. Stem cells 
additionally have specific sets of activators and co-activators that functionally 
interplay to maintain stem cell state (Fong et al. 2012). Remarkably, in stem 
cells a limited number of master transcription factors (Oct4, Sox2 and Nanog) 
define a stem cell-specific transcriptional signature by recruitment of specific 
factors including histone modifiers (e.g. p300/CBP, WDR5/Trithorax complex) 
and chromatin remodellers (esBAF) to ensure active chromatin architecture 
and RNAPII access (Ho et al. 2009; Ang et al. 2011; Fong et al. 2011). 
Additionally stem-cell specific transcriptional programs are mediated by 
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interactions with Mediator, TAFs/TFIID and the nucleotide excision repair 
(NER) complex (Fong et al. 2012).  
 
TBP-associated factors (TAFs) are transcriptional co-activators that along with 
GTF’s recognize promoters, anchor TFIID to nucleosomes leading to 
formation of a PIC (Pre-initiation complex). TAFs are known to have many 
paralogs, TBP-associated factors and importantly tissue specific expression. 
In ES cells, TAFs are highly expressed and down regulated in terminally 
differentiated cells (Deato and Tjian 2008; Goodrich and Tjian 2010). 
Genome-wide studies and proteomic studies have identified TAFs and TBP 
as important regulators of Oct4 in stem cells (Kagey et al. 2010; Ding et al. 
2012). In addition, combinatorial assembly of cofactors (TAFs/TFIID, 
XPC/SCC, OCT4, SOX2) can led to transcriptional specificity in stem cells.  
TAFs are also important for pluripotency and Taf3 has been shown to mediate 
novel long-distance enhancer–promoter DNA interaction (with cohesion and 
mediator) in mouse ES cells (Liu et al. 2011). 
 
The Mediator complex has recently been shown to interact with a wide array 
of transcriptional activators and RNAPII and coordinate stem cell specific 
functions (Kagey et al. 2010). Mediator complex functions as a docking site 
for RNAPII and TFIIH and facilitates promoter escape and transition to 
transcription elongation. Mediator in stem cells is required for proper 
expression of Oct4 and interactions with the cohesin complex stabilizes long-
distance enhancer–promoter DNA interactions specific for ES cell genes. In 
stem cells, Mediator also functions as critical cofactor in a cascade of 
signalling pathways required for ES cellular maintenance and homeostasis 
(including Wnt signalling, BMP and TGFβ pathway) (Morris et al. 2008; 
Varelas et al. 2008). Other stem cell specific factors including chromatin 
remodellers (Chd1) (Gaspar-Maia et al. 2009), histone acetyltransferase 
(p300) (Black et al. 2006) and elongation factor (Paf1) (Ding et al. 2009) also 
play fundamental roles in coordinating with master regulators and regulating 
transcription. 
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1.4. The Polycomb group of proteins and silencing via chromatin 
modifications 
The Polycomb Group (PcG) gene family is an evolutionarily conserved family 
of proteins, originally discovered in D. melanogaster as repressors 
of Homeotic genes that establish body plan and segmentation. Polycomb 
proteins are classified into two distinct multi-protein complexes names PRC1 
(Polycomb repressive complex 1) and PRC2 (Polycomb repressive complex 
2). PRC2 is involved in the initiation of silencing and is composed of three 
main subunits (Eed, Suz12 and Ezh2) containing histone de-acetylase and 
histone-methyltransferase activities. Ezh2 subunit can methylate histone 
H3K9me and H3K27me3, that mark silenced chromatin (also histone H1 
lysine 26)(Cao et al. 2002; Valk-Lingbeek et al. 2004). PRC2 deletion is 
embryonic lethal and mutation in the catalytic domain has implications in 
development, pluripotency and differentiation. PRC1 is implicated in stable 
maintenance of gene repression, recognizes the PRC2-catalysed H3K27me3 
and via its chromodomain catalyses H2Aub1. PRC1 complexes are diversified 
with the core complex being composed of Cbx proteins (Polycomb homolog), 
Ring1b, Ring1a while the other components inter-changeably form multiple 
PRC1 complexes. Both PRC2 and PRC1 interact with histone 
methyltransferases, histones and counteract SWI/SNF-chromatin-remodelling 
complexes (Breiling et al. 1999; Valk-Lingbeek et al. 2004).  
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Figure 1.4 Polycomb proteins, their catalysed modifications and reversibility of 
Polycomb modifications. (a) Polycomb repressive complexes (PRC2, PRC1) 
catalyse repressive histone modifications (H3K27me3, H2Aub and H3K4me3) 
whereas Trithorax complex is associated with active histone marks (H3K4me3). (b) 
Both the active and repressive histone modifications are reversible by action of 
specific demethylases, de-ubiquitinating enzymes and ubiquitin-specific proteases 
(from (Lund and van Lohuizen 2004).  
 
Table 1.2 Polycomb repressive complex proteins and their mouse 
counterparts (from (Lund and van Lohuizen 2004). 
Drosophila proteins Mouse proteins 
PRC2/Initiation complex 
Esc (Extra sex combs) Eed 
E(z) (Enhancer of Zeste) Ezh1/Enx2 
 Ezh2/Enx1 Su(z)12 (Suppressor of Zeste 12) Suz12 
PRC1/Maintenance complex 
Pc (Polycomb) Cbx2/M33 
 Cbx4/Mpc2 Ph (Polyhomeotic) Edr1/Mph1/Rae28 
dRING (Really Interesting New Gene) Ring1/Ring1a 
 Rnf2/Ring1b Psc (Posterior sex combs) Bmi1 
 Rnf110/Zfp144/Mel-18 
 Znf134/Mblr 
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Pho (Pleiohomeotic) Yy1 
Scm (Sex combs on midleg) Scmh1 
 Scmh2 
1.4.1. Polycomb proteins and stem cells 
Stem cells possess the unique capacity of self-renewal and the ability to 
differentiate into all lineages. Polycomb proteins have essential roles in 
embryonic development and consistent with this, loss of Polycomb proteins 
has implications for pluripotency, differentiation potential and even viability 
(O'Carroll et al. 2001; Valk-Lingbeek et al. 2004). Knockout of Polycomb 
proteins in ES cells causes de-repression of important developmental 
regulator genes and subsequent ES cell differentiation (Azuara et al. 2006; 
Stock et al. 2007b; Brookes et al. 2012). 
1.4.2. Polycomb proteins and transcription regulation 
The association of Polycomb proteins together with RNAPII, TFs and other 
chromatin proteins suggests a complex mechanism of PRC regulation along 
with transcriptional machinery downstream of transcription initiation (Brookes 
and Pombo 2009a). 
 
Polycomb repression in D. melanogaster is mediated by short sequence 
motifs called PREs (Polycomb response elements). The PREs act as 
sequence signals for binding of Polycomb proteins and their subsequent 
repression. In D. melanogaster, insertion of a PRE within an active gene leads 
to onset of transcription by RNAPII but PREs prevent appropriate expression 
(Dellino et al. 2004; Schwartz et al. 2004). In mES cells, RNAPII-S5p 
complexes bind at the promoters of PRC-repressed genes and transition into 
coding regions. However, in the absence of S2p (Stock et al. 2007b; Brookes 
et al. 2012) loss of PRC1 components results in de-repression at PRC-
repressed genes, suggesting the mechanistic link between PRC1 and Rpb1-
CTD and not with elongation complexes (Brookes and Pombo 2009a). PREs 
or PRE-like mechanisms have not yet been identified in mES cells,  
suggesting a more complex recruitment and dynamic interplay for 
transcriptional repression. A combination of several TFs, including master 
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regulators (Oct4, Nanog, Sox2), CTCF, E2F1 and Myc are known to associate 
with Polycomb proteins in mES cells. In addition, there is growing evidence 
that short and long ncRNAs mediate Polycomb recruitment to target sites. 
1.4.3. Bivalency and poised genes in mES cells 
In mES cells, important developmental regulator genes are bound by 
Polycomb proteins and harbour bivalent chromatin modifications that are 
thought to keep these genes poised for future activation (Azuara et al. 2006; 
Bernstein et al. 2006; Mikkelsen et al. 2007). The chromatin at PRC-
repressed genes contains Polycomb-mediated H3K27me3, H2Aub1 along 
with active modification H3K4me3 (Brookes and Pombo 2009a). These 
bivalent domains have been identified in human ES cells, mES cells and also 
in differentiated cells, albeit to a much lower extent, that as in differentiated 
cells they resolve into monovalent configurations (Mikkelsen et al. 2007; Pan 
et al. 2007). The PRC-repressed genes are enriched for transcription factors 
that are critical for differentiation and development, and the bivalent chromatin 
configuration i.e. repressive histone modifications silence their expression in 
mES cells for pluripotent characteristics while the active chromatin marks 
allow for later activation (Brookes and Pombo 2009a). 
 
Both PRC2 and PRC1 components occupy PRC-repressed genes along with 
their respective histone modifications H3K27me3 and H2Aub1 along with 
cohorts of transcription factors and chromatin co-factors (Stock et al. 2007b). 
Despite PRC-mediated repression, RNAPII is detected at promoters and 
coding regions of PRC-repressed genes in an unusual conformation 
incompatible with gene expression (Stock et al. 2007b). At these genes, 
RNAPII-S5p (initiating) is detected at promoters and coding regions in the 
absence of S7p or S2p (elongation). In addition, low level transcripts are 
identified at these genes. Interestingly, removal of Polycomb protein Ring1b 
cause de-repression of these genes although without characteristic 
transcription elongation (mediated by RNAPII-S2p), suggesting a dynamic 
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interplay between Rpb1-CTD and Polycomb proteins (Stock et al. 2007b; 
Brookes et al. 2012).  
1.4.4. Transcription cycle at Polycomb repressed genes and CTD 
modifications 
The dynamics of gene expression regulation at PRC-repressed genes is quite 
complex. At PRC-repressed genes, Polycomb proteins, their histone 
modifications, active histone modifications and unusual RNAPII conformation 
mark and regulate their chromatin environment. In stem cells, this regulation 
is further kept in check by important stem cell master regulator transcription 
factors (Oct4, Sox2 and Nanog) that regulate the gene expression maintaining 
pluripotency and the capacity to self-renew. 
 
 
Figure 1.5 Transcription cycle at PRC-repressed genes and chromatin 
assembly. (A) RNAPII is present in an unusual state at PRC-repressed genes 
marked by only S5p and present at promoter and coding regions of genes. (B) 
Polycomb proteins mark repressive histone modifications and the presence of 
H3K4me3 (active mark) mediates a bivalent chromatin architecture and novel 
RNAPII binding pattern at these genes. No mRNA is produced at PRC-repressed 
genes,  highlighting the absence of S2p and co-transcriptional processing machinery 
(adapted from (Brookes and Pombo 2009b). 
 
Genome wide analysis by ChIP-Sequencing (ChIP-Seq) from our group has 
unravelled that 30% of Refseq genes constitute PRC-repressed genes. The 
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characteristic hallmark of PRC-repressed genes is an unusual RNAPII 
(S5p+S7p-S2p-) and histone modifications (H3K4me3, H3K27me3, H2Aub). 
Analysis by single ChIP and sequential-ChIP confirms the co-existence of 
both RNAPII (S5p+S7p-S2p-) and Polycomb proteins (Ezh2 and Ring1b) at 
these genes. RNAPII-S5p at these genes extends from the promoters to the 
coding region of the genes without any S7p or S2p or mRNA production, 
consistent with impaired elongation and lack of association with the RNA 
processing machinery.  Conditional knockout of the Polycomb protein Ring1b 
leads to rapid de-repression without characteristic S2p elongation further 
highlighting the role of Rpb1-CTD in the mechanistic regulation at these 
genes. 
 
From the genome-wide analysis in mES cells, broadly three groups of genes 
were observed (and sub-groups). The first group of genes are actively 
transcribing genes that contained characteristic active RNAPII configuration 
(S5p+S7p+S2p+), without any repressive histone modification or Polycomb 
occupancy. The next group of genes includes Polycomb-repressed genes that 
contained RNAPII (S5p+S7p-S2p-), Polycomb proteins (Ring1b and Ezh2) and 
repressive histone modifications (H3K27me3 and H2Aub1) (Brookes et al. 
2012). PRC-repressed genes were further classified based on levels of 
occupancy of RNAPII and Polycomb proteins and 4 broad sub-classes were 
identified in a gradient range of Polycomb regulation i.e. PRC-active, PRC-
intermediate, PRC-repressed and PRC-only. The last group of genes consist 
of inactive genes that do not harbour either RNAPII or Polycomb proteins 
(Brookes et al. 2012). Genome-wide classification of PRC-repressed genes 
has revealed several important biological processes these genes encode for, 
inlcuding important developmental regulators genes, metabolic proteins 
(Pyruvate metabolism, TCA cycle, Glycolysis, Notch signalling etc.), signalling 
pathways (TGFβ, MAPK, Wnt, p53 signalling pathways) (Brookes et al. 2012).  
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1.5. Proteomics and Mass spectrometry 
The global analysis of proteins, which are the key functional entities in the 
cell, arguably forms the principal level of information required to understand 
how cells function; such analysis is referred to as proteomics (Altelaar et al. 
2013). The different disciplines that contribute to proteomics include cell 
imaging (Light and electron microscopy), Microarray, ChIP experiments, and 
genetic readout experiments, as exemplified by the yeast two-hybrid assay 
(Aebersold and Mann 2003).  
 
In recent years, proteomics technologies particularly mass spectrometry (MS)-
based protein identification has matured immensely and has been applied to 
gain significant biological insights. Various MS-based proteomics approaches 
have been developed and applied to various biological systems including 
label-free protein quantification, label-based protein quantification, proteome 
expression profiling, characterization of proteomic repertoires, comparative 
gene expression profiling, absolute protein quantification and characterisation 
of dynamic and spatial protein distribution (Ong and Mann 2005; Altelaar et al. 
2013). More recently several clinical applications have yielded significant 
insights and these include integrative omics profiling to identifu molecular 
causes of disease, identification of clinical biomarkers, understanding cellular 
heterogeneity and personalized cancer therapies (Zhou et al. 2012; Altelaar et 
al. 2013).  
 
Stable isotope labelling of amino acids in cell culture (SILAC) offers a simple 
and practical approach to perform quantitative proteomics (Ong et al. 2002). 
SILAC labelling methods have been further developed and applied to 
generate entire fly and mouse (Sury et al. 2010; Zanivan et al. 2012). 
Additionally SILAC approaches have also been applied to distinguish 
proteomic differences between control and disease samples (Mann 2006; 
Sury et al. 2010; Zanivan et al. 2012).  
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The dramatic and ongoing improvements in MS technologies have 
accelerated the application of MS-based proteomics to detective sensitively 
and robustly proteins, their abundance and dynamic regulatory network in 
different biological applications. The field of proteomics is geared towards 
unravelling novel proteins interactions, structural dynamics, coupling imaging 
with MS (Imaging MS), whole proteome identifications and genome-based 
proteome (Proteo-genomics). Recent advancements in single cell proteomics 
have further highlighted the potential of MS based approaches in developing 
our understanding of biological processes.  
1.6. Research aims and objectives 
Understanding the regulation of RNAPII and Polycomb interplay in stem cells 
provides significant insights into stem cell pluripotency, dynamic chromatin 
architecture and gene regulation in mES cells and during lineage 
specification. These aspects are critical to understand development and 
developmental regulation of an organism. To understand the dynamic 
interplay and dissect the components involved, I aimed to investigate the 
RNAPII-Polycomb interplay in mES cells from a proteomic point of view. I 
developed an unbiased method called ‘Proteome-ChIP’ (pChIP) that unravels 
the chromatin bound proteome. To identify the chromatin landscape 
associated with RNAPII, I applied pChIP to qualitative and quantitatively 
dissect RNAPII modifications and highlight their proteome composition. 
Towards understanding the complex RNAPII regulation in mES cells and 
identifying the plethora of RNAPII modifications and their mechanistic 
processes, I applied a Systems Biology approach to comprehensively dissect 
RNAPII proteome and unravel protein associations and their dependencies on 
RNAPII modifications (S5p, S7p and S2p). The analysis also serves to 
provide an invaluable resource of RNAPII modifications and respective protein 
dependencies. 
 
Further extending our analysis and challenging the current technologies, I also 
aimed to perform pChIP on lower complexity samples (Native-ChIP and 
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Gradient-ChIP) to unravel the chromatin landscape. The work in this thesis 
focuses on characterisation of RNAPII-bound chromatin proteome in mES 
cells and unravelling of novel RNAPII processes specific for ES cells and with 
implications for stem cell biology. 
1.7. Thesis outline 
The thesis starts with literature review (Chapter 1) of mechanism of epigenetic 
modifications and gene regulation on chromatin, particularly focusing on 
RNAPII regulation, transcriptional regulation and RNAPII-Polycomb interplay 
in stem cells.  Chapter 2 describes the briefly the experimental methods and 
approaches used for this thesis. Results are described in Chapter 3 to 8. In 
Chapter 3, I highlight the mES cells chromatin complexity, optimise and 
develop the pChIP method along with RNAPII-pChIP as proof of principle. In 
Chapter 4, I optimise and extend pChIP to quantitatively explore the RNAPII 
proteome using SILAC methodology. Chapter 5 describes the comprehensive 
pChIP experimental setup and using a simple classification to unravel the 
chromatin landscape and dependencies on RNAPII modifications. I also 
uncover and discuss novel S5p only processes previously not identified. In 
Chapter 6, I employ a Systems Biology approach (in collaboration) to dissect 
and unravel patterns within the pChIP dataset and uncover novel associations 
not previously identified by conventional approaches. Chapter 7 includes 
bioinformatic comparisons with published datasets for mRNA-bound proteome 
and RNAPII interactome in mitosis. Finally, in Chapter 8, I extend RNAPII-
pChIP to native chromatin and perform gradient fractionation to obtain purified 
crosslinked chromatin sample for RNAPII-pChIP. Lastly and importantly, I 
discuss the results and their implication with future research directions in 
Chapter 9. 
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2. Materials and Methods 
2.1. Murine embryonic stem cell culture 
2.1.1. Murine ES-OS25 cell culture 
Mouse ES-OS25 cells (kindly donated by A. Smith) were grown on 0.1% 
gelatin-coated surfaces in GMEM-BHK21 supplemented with 10% fetal calf 
serum (FCS), 2 mM L-glutamine, 1% MEM non-essential amino acids 
(NEAA), 1 mM sodium pyruvate, 50 μM 2-mercaptoethanol, 1000 U/ml of 
human recombinant leukaemia inhibitory factor (LIF; Chemicon, Millipore, 
Chandler’s Ford, UK) and 0.1 mg/ml Hygromycin (Roche) as described 
previously (Niwa et al. 2000; Billon et al. 2002). 
2.1.2. Murine ES-OS25 SILAC cell culture 
Mouse ES-OS25 cells were grown for a minimum of 4 passages before SILAC 
labelling. SILAC cells were grown on 0.1% gelatin-coated surface with SILAC-
DMEM (without lysine and arginine amino acids) supplemented with 15% 
knockout serum replacement (KOSR), 2 mM L-glutamine, 1% MEM non-
essential amino acids (NEAA), 1 mM sodium pyruvate, 50 μM 2-
mercaptoethanol, 1000 U/ml of human recombinant leukaemia inhibitory 
factor (LIF) and 0.1 mg/ml Hygromycin (Roche). For SILAC-light cells, L-
lysine-HCl ((12C6 H14 14N2 O2); 0.8mM) and L-arginine-HCl (12C6 H1414N4  O2; 
0.4mM) were added to media. For SILAC-heavy cells, L-lysine-HCl 
(13C6 H14 15N2  O2; 0.798mM) and L-arginine-HCl (13C6 H14 15N4 O2; 0.398mM) 
were added to media. 
2.2. DNA-Chromatin immunoprecipitation 
Antibodies used for chromatin immunoprecipitation (ChIP), including control 
and bridging antibodies, are presented in Table 2.1. Antibodies towards 
different epitopes of RPB1 are schematically represented in Fig. 2.1. 
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Figure 2.1 RPB1 antibodies recognising specific phospho-epitopes. H224 binds 
outside of the RPB1 CTD and so recognises both hypo- and hyper-phosphorylated 
RPB1. Clone 4H8 recognises phosphorylated serine residues (position 5; S5p; blue). 
Clones H5, 4E12 and 3D12 are used for detection of S2p (red) and S7p (green) 
respectively. 8WG16 (purple) recognises un-phosphorylated S2 residues.  
2.2.1. Fixed chromatin preparation 
2.2.2. Fixed chromatin preparation (Formaldehyde crosslinked) 
Fixed chromatin was prepared as described previously (Stock et al. 2007a). 
Briefly, cells were treated with 1% formaldehyde (37°C, 10 min) and the 
reaction was stopped by addition of glycine to a final concentration of 0.125 
M. Cells were washed in ice-cold PBS, before “swelling” buffer (25 mM 
HEPES pH 7.9, 1.5 mM MgCl2, 10 mM KCl and 0.1% NP40) was added to 
lyse the cells (4°C, 10 min). Cells were scraped from flasks, and nuclei 
isolated by Dounce homogenization (60 strokes, “Tight” pestle) and 
centrifugation. After re-suspension in “sonication” buffer (50 mM HEPES pH 
7.9, 140 mM NaCl, 1 mM EDTA, 1% Triton X100, 0.1% Na-deoxycholate and 
0.1% SDS), nuclei were sonicated to produce DNA fragments with a average 
length of <1.6 kb (Stock et al. 2007a) using a Diagenode Bioruptor (Liege, 
Belgium; full power; 1h: 30s ‘on’, 30s ‘off’; 4°C) or using a Diagenode 
Bioruptor-Plus (full power; 30 cycles: 30s ‘on’, 30s ‘off’; 4°C). The resulting 
material was centrifuged twice (4°C, 10 min) at 14,000 rpm to remove 
insoluble material. Swelling and sonication buffers were supplemented with 
phosphatase inhibitors 5 mM NaF, 2 mM Na3VO4, 1 mM PMSF, and protease 
inhibitor cocktail (Roche, Burgess Hill, UK).  
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“Chromatin concentration” was estimated by measuring absorbance (280 nm) 
of alkaline-lysed, crosslinked chromatin, and converting into arbitrary 
chromatin units using the conversion 50 mg/ml for 1 absorbance unit. 
2.2.3. Fixed chromatin preparation (Double crosslinked – EGS and 
Formaldehyde) 
Fixed chromatin was prepared as described previously (Stock et al. 2007a). 
Briefly, cells were treated with 1.5mM EGS (Ethylene glycolbis [succinimidyl 
succinate] for 37°C, 10 min) and subsequently with 1% formaldehyde (37°C, 
10 min) and the reaction was stopped by addition of glycine to a final 
concentration of 0.125 M. Rest of the protocol was same as that 
formaldehyde crosslinked ChIP.  
2.2.4. Native chromatin preparation 
Preparation of unfixed chromatin was carried out as described previously 
(O'Neill and Turner 2003; Szutorisz et al. 2005) with some modifications, and 
used for histone modification and RNAPII modification ChIP. Cells were 
washed in ice-cold PBS and incubated in 0.5% NP40 in 1X TBS (0.01 M Tris-
HCl pH 7.4, 3 mM CaCl2, 2 mM MgCl2) for 10 min. Cells were scraped and 
incubated on ice (50 min) to complete cell lysis. Nuclei were extruded by 
Dounce homogenization (60 strokes, “Tight” pestle) and re-suspended in 25% 
sucrose in 1X TBS. 50% sucrose in 1X TBS was used to underlie this 
suspension. The nuclear pellet was washed once in 25% sucrose in 1X TBS 
and then re-suspended in “digestion” buffer (50 mM Tris-HCl pH 7.4, 1 mM 
CaCl2, 4 mM MgCl2, 0.32 M sucrose) to a concentration of 0.5 mg DNA/ml 
(determined by measuring absorbance of alkaline-lysed chromatin). 
 
Chromatin was digested with 2U/ml micrococcal nuclease (MN, Sigma) to 
produce fragments containing mainly mono- and di-nucleosomes (37°C, 10 
min; for optimisation of MN digestion see Fig. 5.9). Digestion was stopped by 
addition of 5 mM EDTA on ice. The first supernatant (S1) was recovered, and 
the pellet re-suspended in “lysis” buffer (1 mM Tris-HCl pH 7.4, 0.2 mM 
EDTA). After nuclear lysis was completed (30 min on ice and overnight at -
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20°C) a second supernatant (S2) was collected. After fragment size analysis, 
supernatants (S1 and S2) were combined. TBS, digestion and lysis buffers 
were supplemented with 5 mM NaF, 2 mM Na3VO4, 1 mM PMSF, and 
protease inhibitor cocktail (Roche, Burgess Hill, UK). 
 
“Chromatin concentration” was obtained by measuring absorbance (280 nm) 
of alkaline-lysed, native chromatin, and converting into arbitrary chromatin 
units using the conversion 50 mg/ml for 1 absorbance unit. 
2.2.5. Fixed DNA-ChIP with cesium chloride gradient (gradient-ChIP) 
Fixed chromatin (formaldehyde crosslinked) was prepared as described 
(Section 2.2.1.1). Chromatin was re-suspended in cesium chloride solution 
(CsCl2; Final concentration- 567.8mg/ml) and ultra-centrifuged (Sw55Ti, 
Beckmann coulter, 40,000 rpm, 72 hrs, 4°C). After gradient separation, 10-11 
fractions were collected (using low flow rate) and excess salt removed by 
dialysis with sonication buffer. Fractions 1-4 were pooled together to form 
‘DNA-only’ fraction, fraction 5-8 were pooled to form ‘nucleo-histone’ fraction 
and fraction 9-10 were pooled to form ‘protein-only’ fractions.  
 
DNA concentration was measured from the 3 fractions (DNA-only fraction, 
nucleo-histone fraction and protein-only) as described (Section 2.2.7) and 
corresponding chromatin concentration was used for pChIP. 
2.2.6. Confirmation of fragment size of native or fixed chromatin 
To confirm appropriate shearing or enzymatic fragmentation had occurred, 
DNA was purified from chromatin and subjected to Agarose electrophoreses. 
Fixed chromatin first had aldehyde cross-links reversed by adding NaCl and 
RNase A to final concentrations of 160 mM and 20 μg/ml, respectively, and 
incubating at 65°C overnight. With all samples, the EDTA concentration was 
adjusted to 5 mM, and then 200 μg/ml proteinase K (Roche) was added 
(45°C, 2h). DNA was recovered by phenol-chloroform extraction and ethanol 
precipitation, and re-suspended in TE. DNA was separated on a 1% Agarose 
gel to check fragmentation efficiency. 
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2.2.7. Immunoprecipitation with magnetic beads 
For mouse IgG and IgG antibodies, protein-G-magnetic beads (Active Motif) 
were incubated with rabbit anti-mouse (IgG+IgM) or anti-IgM bridging 
antibodies, respectively (Jackson Immunoresearch; 10 μg per 50 μl beads) for 
1h (4ºC) and washed with sonication buffer. For rabbit antibodies, magnetic 
beads were just washed with sonication buffer. Fixed (700 μg) or native 
chromatin (250 μg) was immunoprecipitated (4ºC, overnight) with 10-50 μg 
antibody and 50 μl beads (with/without bridging antibody). 
2.2.8. ChIP washes and elution’s 
For Protein A/G immunoprecipitations, beads were washed (1x) with 
sonication buffer, (1x) sonication buffer containing 500 mM NaCl, (1x) 20 mM 
Tris pH 8.0, 1 mM EDTA, 250 mM LiCl, 0.5% NP40 and 0.5% Na 
deoxycholate, and (2x) TE buffer (1 mM EDTA, 10 mM Tris HCl pH 8.0). 
 
After immunoprecipitations using IgM antibodies, beads were washed (2x) 
with sonication buffer, (1x) 2 mM Tris pH 8.0, 0.02 mM EDTA, 50 mM LiCl, 
0.1% NP40 and 0.1% Na-deoxycholate; and (1x) TE buffer. Immune 
complexes were eluted from beads (65°C, 5 min; and room temperature, 15 
min) with 50 mM Tris pH 8.0, 1 mM EDTA and 1% SDS. The elution was 
repeated and eluates pooled. 
2.2.9. DNA purification, quantification and analysis 
For fixed chromatin samples, reverse cross-linking was carried out (16h, 
65°C) with addition of NaCl and RNase A to final concentrations 160 mM and 
20 µg/ml, respectively. Native and fixed samples had EDTA increased to a 
final concentration of 5 mM and samples were incubated with 200 µg/ml 
proteinase K (50°C, 2h). DNA was recovered by phenol-chloroform extraction 
and ethanol precipitation. The final DNA concentration was determined by 
PicoGreen fluorimetry (Molecular Probes, Invitrogen) and samples were 
diluted to the same concentration (0.2 ng/µl). The same amount (0.5 ng) of 
immunoprecipitated and input DNA were analysed by quantitative real-time 
PCR (RT-PCR). Amplifications (40 cycles) were performed using SensiMix 
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NoRef (Quantace, London, UK) with DNA Engine Opticon 1/2 RT-PCR 
system (BioRad, Hemel Hempstead, Hertfordshire, UK). 
 
IP or control “cycle over threshold” (Ct) values from the quantitative PCR (IP) 
were subtracted from the input Ct values (Input Ct). This figure was converted 
into the fold enrichment by 2(input Ct – IP). Histone modifications levels were 
normalized to levels of the core histone in some situations. 
2.3. Protein-chromatin immunoprecipitation 
2.3.1. Fixed pChIP, reverse crosslinking and protein elution 
Fixed chromatin was prepared as described (Section 2.2.1.1) and gradient 
fractions were obtained as described (Section 2.2.3). pChIP’s were set up 
using magnetic beads and bridging antibody (Section 2.2.5). ChIP washes 
were performed as normal (Section 2.2.6). After the final wash in TE buffer, 
fixed immunoprecipitated chromatin complexes were treated with Benzonase 
(25 units) in 30μl DNase buffer at 37°C, 30 min; Merck) to chop DNA 
fragments and to allow efficient elution of proteins. Proteins were reverse 
crosslinking and eluted from the beads twice (first at 60°C, O/N min; and 
second time at 95°C, 15 min) using 30 μl of custom Laemmli buffer (130 mM 
Tris-HCl pH 6.8, 20% glycerol, 200mM DTT, 0.02% bromophenol blue, and 
4% SDS) per pChIP elution, giving a final eluate volume of 60 μl. 
 
Unlike DNA, the proteins in the samples cannot be amplified by a PCR and it 
is very important to elute as much as possible from beads and also to make 
sure that no remaining beads are present in sample. Any bead contaminants 
will clog the SDS-PAGE gel, not allowing the proper separation of proteins. 
We recommend spinning the eluted 60μl samples twice after elution, 
recovering a cleared supernatant to completely remove any traces of beads, 
which is then frozen. As repeat freeze-thaw cycles can degrade the proteins 
in buffer, we recommend running the SDS-PAGE on the same day as protein 
elution.  
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Specificity of pChIP is also critical and we recommend comparison with No 
antibody control and a non-specific antibody (we use mouse anti-Digoxigenin) 
to filter non-specific binders from common contaminants. Robustness and 
specific enrichment of pChIP should be measured by running the input 
chromatin sample along with pChIP in Mass Spectrometry (MS).  
2.3.2. Native pChIP, reverse crosslinking and protein elution 
Native chromatin was prepared as described (Section 2.2.2) and the pChIP’s 
were set up using magnetic beads and bridging antibody (Section 2.2.5). ChIP 
washes were performed as normal (Section 2.2.6). After the final wash in TE 
buffer, native immunoprecipitated chromatin complexes were reverse 
crosslinked and eluted from the beads twice (95°C, 10 min), using 60 μl of 
custom Laemmli buffer (130 mM Tris pH 6.8, 20% glycerol, 200mM DTT, 
0.02% bromophenol blue, and 4% SDS) per pChIP elution. 
 
Native protein complexes are more susceptible to degradation, so we 
recommend to use the samples straightaway and avoid long-term storage. As 
with fixed pChIP, care should be taken to remove any bead contamination in 
sample. 
2.3.3. Fixed pChIP with cesium chloride gradient (modified pChIP) 
Fixed chromatin was prepared as described (Section 2.2.2) and the pChIP’s 
were set up using magnetic beads and bridging antibody (Section 2.2.5). ChIP 
washes were performed as normal (Section 2.2.6). After the final wash in TE 
buffer, native immunoprecipitated chromatin complexes were reverse 
crosslinking and eluted from the beads twice (95°C, 10 min), using 60 μl of 
custom Laemmli buffer (130 mM Tris pH 6.8, 20% Glycerol, 200mM DTT, 
0.02% bromophenol blue, and 4% SDS) per pChIP elution. 
 
Native protein complexes are more susceptible to degradation and we 
recommend using the samples straightaway and avoid long-term storage. As 
with fixed pChIP, care should be taken to remove any bead contamination in 
sample. 
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2.4. Western analysis 
Antibodies used for western analysis, including loading control antibodies, are 
presented in Table 2.2. Antibodies towards different epitopes of RPB1 are 
schematically represented in Fig. 2.1. 
2.4.1. RNAPII western analysis 
Whole cell extracts for RNAPII westerns were prepared by lysing cells in ice-
cold “lysis” buffer (Daniel and Carling 2002), scrapping, and shearing DNA by 
passage through a 25G needle. Total protein concentration was determined 
by Bradford assay. Cell lysates (0.5 µg total protein for 4H8 antibody, 10 µg 
for 4E12, 3E8 and Y1P antibodies, 5 µg for all other RNAPII antibodies) were 
resolved on 7.5% Tris-HCl or 3-8% Tris-acetate SDS-PAGE gels. Chromatin 
and pChIP samples for RNAPII westerns were resolved in a 10% Tris-HCl or 
3-8% Tris-acetate SDS-PAGE gels. 
 
Membranes were blocked (1h), incubated (2h) with primary antibody, washed, 
and incubated (1h) with HRP-conjugated secondary antibodies, all in blocking 
buffer (10 mM Tris-HCl pH 8.0, 150 mM NaCl, 0.1% Tween-20,; 5% non-fat 
dry milk). Membranes were washed (30 min) in blocking buffer without milk 
and briefly in 0.1% Tween-20 in PBS. HRP-conjugated antibodies were 
detected with ECL western blotting detection reagents (Amersham), according 
to the manufacturer’s instructions.  
2.4.2. Alkaline phosphatase treatment 
To dephosphorylate RPB1 after electrophoresis and transfer, membranes 
were incubated (37°C, 1h) in 0.1 U/µl alkaline phosphatase (AP) in NEB buffer 
3 (New England Biolabs, Hitchin, UK) prior to blocking. 
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Figure 2.2 Alkaline phosphatase treatment de-phosphorylates Rpb1. Alkaline 
phosphatase (AP) removes phosphates from S5 (blue), S2 (pink) and S7 (green) 
residues, and allows reactivity with 8WG16 (purple). Antibody against Rpb1 N-
terminal (H224) is not affected by AP treatment. 
2.4.3. Polycomb, histone and other western analysis 
Nuclear and histone extracts were prepared as described previously 
(Kuzmichev et al. 2002; de Napoles et al. 2004). Nuclear extracts (20 µg) or 
histone extracts (5 µg) were loaded on 10-15% gradient SDS-PAGE gels. 
2.5. Imaging 
2.5.1. Whole cell immunofluorescence for S5p and Nanog 
Immunofluorescence was carried out essentially as described previously (Xie 
et al. 2006). Cells were cultured on sterile coverslips (No. 1.5, Agar Scientific) 
to achieve ~70% confluence on the day of fixation. Coverslips were fixed in 
4% PFA, 125 mM HEPES, 0.1% Triton X100 (4°C, 10 min) and in 8% PFA in 
125 mM HEPES (4°C, 30 min; (Guillot et al. 2004). Cells were permeabilized 
in 0.5% Triton X100 in PBS (60 min), and then incubated with 20 mM glycine 
in PBS (30 min). Cells were blocked (1h), incubated with respective antibodies 
(3h), washed (1.5h), incubated (1h) with FITC-conjugated donkey anti-mouse 
Ig (1:100; Jackson Immunoresearch Laboratories), and washed (4°C, 
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overnight); all in PBS+ (PBS supplemented with 0.1% casein, 1% BSA, 0.2% 
fish skin gelatin, pH 7.8). Coverslips were washed in 0.1% Tween-20 in PBS, 
incubated with TOTO-3 in 0.1% Tween-20 in PBS (1:500, 15 min), and 
washed in 0.1% Tween-20 in PBS and then PBS, before coverslips were 
mounted in VectaShield (Vector Labs), immediately before imaging. 
2.5.2. Microscopy 
Images were collected sequentially on a Leica SP2 confocal laser-scanning 
microscope (100x objective; NA 1.3) using Green Argon (488 nm) and Far 
Red (633 nm) lasers and pinhole equivalent to 1 Airy disk. For comparison of 
different treatments, images were collected on the same day using the same 
settings, and without saturation of the intensity signal. Images were 
transferred to Adobe Photoshop and contrast stretched with the same settings 
for all conditions. 
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Table 2.1 Antibodies used for ChIP analysis 
Antibody against 
Clone 
Raised in (isotype) 
Volum
e used in ChIP 
(per IP) M
agnetic beads 
Origin 
RNAPII 
RNAPII S2p 
H5 (M
M
S-129R) 
M
ouse (IgM
) 
20 µl 
Covance, Princeton, NJ 
RNAPII S5p 
CTD4H8 (M
M
S-128P) 
M
ouse (IgG) 
10 µl (25 µg) 
Covance 
RNAPII S7p 
4E12 
Rat (IgG, hybridom
a) 
100 µl 
Kind gift from
 Dirk Eick 
Non-phosphorylated S2 
CTD residues 
8W
G16 (M
M
S-126R) 
M
ouse (IgG) 
10 µl (25 µg) 
Covance 
RPB1 N-term
inus (am
ino 
acids 1-224) 
H224  (sc-9001x) 
Rabbit (IgG) 
- 
Santa Cruz 
Biotechnology, Santa 
Cruz, CA 
Histones and m
odifications 
H2Aub1 
E6C5 (05-678) 
M
ouse (IgM
) 
50 µl 
Upstate/M
illipore 
H3K4m
e3 
16H10 
M
ouse (IgG) 
10 μg purified 
Kind gift from
 Hiroshi 
Kim
ura 
H3K27m
e3 
07-449 
Rabbit (IgG) 
50 µl 
Upstate/M
illipore 
H3K36m
e3 
13C9 
M
ouse (IgG, hybridom
a) 
20 µl 
Kind gift from
 Hiroshi 
Kim
ura 
H2A 
07-146 (acidic patch) 
Rabbit 
- 
Upstate/M
illipore 
H3 
ab1791 
Rabbit 
- 
Abcam
 Ltd, Cam
bridge, 
UK 
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Polycom
b com
ponents 
 
 
 
 
Ring1B 
A-20 
M
ouse (IgG, hybridom
a) 
50 μl 
Kind gift from
 Haruhiko 
Koseki 
Ezh2 
pAb-039-050 
Rabbit (IgG) 
5 µl (5 µg) 
Diagenode, Liège, 
Belgium
 
Controls 
 
 
 
 
Digoxigenin 
M
ouse (IgG) 
10 µl (13 µg) 
10 µl (13 µg) 
Jackson 
Im
m
unoResearch 
Technologies, W
est 
Grove, PA 
Anti-m
ouse IgM
 (μ chain) 
Rabbit 
10 μl 
- 
M
P Biochem
icals, Irvine, 
CA 
Bridging antibodies 
 
 
 
 
Anti-M
ouse IgM
, μ Chain 
Specific 
Rabbit 
- 
10 µg per 50 μl beads 
Jackson 
Im
m
unoResearch 
Technologies 
Anti-M
ouse IgG+IgM
 
(H+L) 
Rabbit 
- 
10 µg per 50 μl beads 
Jackson 
Im
m
unoResearch 
Technologies 
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Table 2.2 Antibodies used for W
estern analysis. 
Antibody against 
Clone 
Raised in (isotype) 
W
orking dilution 
Origin 
RNAPII 
 
 
 
 
RNAPII S2P 
H5 (M
M
S-129R) 
M
ouse (IgM
) 
1:500 
Covance, Princeton, NJ 
RNAPII S5P 
CTD4H8 (M
M
S-128P) 
M
ouse (IgG) 
1:200,000 
Covance 
RNAPII S7P 
4E12 
Rat (IgG, hybridom
a) 
1:50 
Kind gift from
 Dirk Eick 
Non-phosphorylated S2 
CTD residues 
8W
G16 (M
M
S-126R) 
M
ouse (IgG) 
1:200 
Covance 
RPB1 N-term
inus (am
ino 
acids 1-224) 
H224  (sc-9001x) 
Rabbit (IgG) 
1:200 
Santa Cruz 
Biotechnology, Santa 
Cruz, CA 
Polycom
b com
ponents 
 
 
 
 
Ring1B 
A-20 
M
ouse (IgG, hybridom
a) 
1:500 
Kind gift from
 Haruhiko 
Koseki 
Ezh2 
pAb-039-050 
Rabbit (IgG) 
1:1000 
Diagenode, Liège, 
Belgium
 
Pluripotency m
arkers 
 
 
 
 
Pou5f1 
Sc-8628 
Goat (IgG) 
1:1000 
Santa Cruz 
Biotechnology, Santa 
Cruz, CA 
Sox2 
Ab 158630 
Rabbit (IgG) 
1:2000 
Abcam
 Ltd, Cam
bridge, 
UK 
Nanog 
Ab 80892 
Rabbit (IgG) 
1:300 
Abcam
 Ltd, Cam
bridge, 
UK 
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Table 2.3 ChIP primers 
 
Active genes 
b-actin promoter F GCAGGCCTAGTAACCGAGACA 
b-actin promoter R AGTTTTGGCGATGGGTGCT 
b-actin coding F TCCTGGCCTCACTGTCCAC 
b-actin coding R GTCCGCCTAGAAGCACTTGC 
Oct4 promoter F GGCTCTCCAGAGGATGGCTGAG 
Oct4 promoter R TCGGATGCCCCATCGCA 
Oct4 coding F CCTGCAGAAGGAGCTAGAACA 
Oct4 coding R TGTGGAGAAGCAGCTCCTAAG 
Sox2 promoter F CCATCCACCCTTATGTATCCAAG 
Sox2 promoter R CGAAGGAAGTGGGTAAACAGCAC 
Sox2 coding F GGAGCAACGGCAGCTA  
Sox2 coding R GTAGCGGTGCATCGGT  
Polr2a gene primers 
Rpb1 (-1kb) F CCGTAAAGCTATTAGAGCACAGG 
Rpb1 (-1kb) R ATGCATAAGGCAGGCAAGAT 
Rpb1 (-0.5kb) F GTAACCTCTGCCGTTCAGGA 
Rpb1 (-0.5kb) R TTTCTCCCTTTCCGGAGATT 
Rpb1 1 F CAGGCTTTTTGTAGCGAGGT 
Rpb1 1 R GACTCAGGACTCCGAACTGC 
Rpb1 2 F TGGGTCAGTGATGCTGATGT 
Rpb1 2 R CTGGGGATCCACTTCCTGTA 
Rpb1 3 F CAGAGGGCTCTTTGAATTGG 
Rpb1 3 R GCATCAGATCCCCTTCATGT 
Rpb1 4 F CCAAGTTCAACCAAGCCATT 
Rpb1 4 R TCTTAACCGCTGAGCCATCT 
Rpb1 5 F TCCCAACTATACCCCGACAT 
Rpb1 5 R TGGTGAGCTTGGTGTGTAGG 
Rpb1 6 F TCTCCCACTTCTCCTGGCTA 
Rpb1 6 R CCGAGGTTGTCTGACCCTAA 
Rpb1 (+0.6kb) F TGCCCTTTTCTGGAGTGTCT 
Rpb1 (+0.6kb) R GCCAGGACTACACAGGCATT 
Rpb1 (+2kb) F GAGGGGCAGACACTACCAAA 
Rpb1 (+2kb) R AAAAGGCCAAAGGCAAAGAT 
Rpb1 (+5kb) F AATGCACAAACCCACACTCA 
Rpb1 (+5kb) R CGCTGAGTGCATTCTTGGTA 
PRC-repressed genes 
Math1 promoter F CCTTCTTTGACTGGGCAGAC 
Math1 promoter R ACTCGGAGATCGCACACC 
Math1 coding F CCAGTTGCCATTGCTTTAT 
Math1 coding R AGGATACTAGATTTGCAACATTCTT 
Msx1 promoter F ACAGAAAGAAATAGCACAGACCATAAGA 
Chapter 2  Materials and methods 
 68 
Msx1 promoter R TTCTACCAAGTTCCAGAGGGACTTT 
Msx1 coding F AGATGGCCGCGAAAC 
Msx1 coding R CCAGAGGCACTGTAGAGTGA 
HoxA7 promoter F GAGAGGTGGGCAAAGAGTGG 
HoxA7 promoter R CCGACAACCTCATACCTATTCCTG 
HoxA7 coding F CTGGACCTTGATGCTTCTAACT 
HoxA7 coding R AGCCAGAGAAAGAGGGATTCTA  
Gata4 promoter (-0.5 kb) * F AAGAGCGCTTGCGTCTCTA 
Gata4 promoter (-0.5 kb) * R TTGCTAGCCTCAGATCTACGG 
Gata4 coding (A) * F TTGCACATTAACACCACACGTATA 
Gata4 coding (A) * R CCACCATTCAATTTTTAAGTCAAGTA 
Silent genes 
Gata1 promoter F AGAGGAGGGAGAAGGTGAGTG 
Gata1 promoter R AGCCACCTTAGTGGTATGACG 
Gata1 coding F TGGATTTTCCTGGTCTAGGG 
Gata1 coding R GTAGGCCTCAGCTTCTCTGTAGTA 
Myf5 promoter F GGAGATCCGTGCGTTAAGAATCC 
Myf5 promoter R CGGTAGCAAGACATTAAAGTTCCGTA  
Myf5 coding F GATTGCTTGTCCAGCATTGT 
Myf5 coding R AGTGATCATCGGGAGAGAGTT 
Sequences are reported in 5’ to 3’ orientation. (*) Indicates primers with two 
designations for their use, in promoter and coding region analyses and in the 
detailed mapping of single genes. 
 
Table 2.4 Expression primers used to detect spliced transcripts.  
House-keeping genes 
b-actin F TCTTTGCAGCTCCTTCGTTG 
b-actin R ACGATGGAGGGGAATACAGC 
UBC F AGGAGGCTGATGAAGGAGCTTGA 
UBC R TGGTTTGAATGGATACTCTGCTGGA 
G6PD (5) CGACAGTTGATTGGAGCTCTG 
G6PD (3) AGCCACATGAATGCCCTGCAC 
Pluripotency genes 
Oct4 F  ACCTCAGGTTGGACTGGGCCTA 
Oct4 R GCCTCGAAGCGACAGATGGT 
Nanog F AATTCTGGGAACGCCTCAT 
Nanog R TTGTTTGGGACTGGTAGAAGAATC 
Sox2 F CATGTGAGGGCTGGACTGCG 
Sox2 R GCTGTCGTTTCGCTGCGG 
PRC-repressed genes 
Math1 F GGAGAAGCTTCGTTGCACGC 
Math1 R GGGACATCGCACTGCAATGG 
Nkx2.2 F TGTGCAGAGCCTGCCCCTTAA 
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Nkx2.2 R GCCCTGGGTCTCCTTGTCAT 
Msx1 F GCCTCTCGGCCATTTCTCAG 
Msx1 R CGGTTGGTCTTGTGCTTGCG 
Nkx2.9 F GGCCACCTCTGGACGCCTCG 
Nkx2.9 R GCCAGCTGCGACGAGTCTGC 
Mash1 F TGGAGACGCTGCGCTCGGC 
Mash1 R CGTTGCTTCAATGGAGGCAAATG 
Cdx2 F CAGCCGCCGCCACAACCTTCCC  
Cdx2 R TGGCTCAGCCTGGGATTGCT 
HoxA7 F  AAGCCAGTTTCCGCATCTACC  
HoxA7 R GTAGCGGTTGAAATGGAATTCC 
Flk1 F AGGGGAACTGAAGACAGGCTA 
Flk1 R GATGCTCCAAGGTCAGGAAGT 
Gata4 F GAGGCTCAGCCGCAGTTGCAG 
Gata4 R CGGCTAAAGAAGCCTAGTCCTTGCTT 
HoxB1 F AGGAATCGCCTTGCTCG 
HoxB1 R GTGAAGTTTGTGCGGAGACC 
HoxD1 F GCCCACAGCACTTTCGA 
HoxD1 R CTGAAATTTGTGCGGATGG 
HoxD13 F GTGTACTGTGCCAAGGATCA 
HoxD13 R TGTCCGGCTGGTTTAAAG 
Silent genes 
Gata1 F GTCCTCACCATCAGATTCCACAG 
Gata1 R AGTGGATACACCTGAAAGACTGGG 
Myf5 F  GGAGATCCTCAGGAATGCCATCCGC 
Myf5 R   GACGTGATCCGATCCACAATGCTGG 
Sequences are reported in 5’ to 3’ orientation. 
Chapter 3  Proteome-ChIP (pChIP) as a tool to dissect the 
chromatin bound proteome (Optimising pChIP)  
 
 70 
3. Proteome ChIP (pChIP) as a tool to dissect chromatin-
bound proteome (Optimizing pChIP method) 
3.1. Research motivation 
Chromatin proteins provide a scaffold for DNA packaging and basis for 
epigenetic regulation and gene expression. With the advent of chromatin 
proteomics and methods, the field is increasingly identifying large cohorts of 
proteins and capturing novel biological interactions that would not be possible 
with conventional methods.  
 
My aim in this project was to investigate the composition of proteome of 
RNAPII-bound chromatin bound proteome and further dissect the proteome 
dependencies to specific RNAPII modifications. Therefore first I aimed to 
understand diversity of proteins obtained from different chromatin 
preparations using mass spectrometry in mES cells.  My aim was to develop 
an unbiased method called ‘Proteome-ChIP’ that parallels DNA-ChIP and 
captures the cohorts of interactions occurring on chromatin along with protein 
of interest (i.e. RNAPII) in mES cells. Moreover to perform pChIP on distinct 
RNAPII modifications (RNAPII-S5p and RNAPII-S7p) to capture their 
chromatin bound proteome thereby identifying novel proteins and also 
uncovering known associations. 
 
All of the MS experiments were carried out in collaboration with Dr. Bram 
Snijders at Proteomics facility at MRC-CSC, who helped with sample pre-
processing for MS and performed all MS run time operations and 
quantification of MS spectra. Dr. Hiroshi Kimura (Osaka University, Japan) 
shared initial conditions and advice for protein extraction after ChIP. 
3.2. Stem cells and regulation of gene expression 
Embryonic stem (ES) cells are derived from the inner cell mass (ICM) cells of 
the blastocyst stage of early embryo. ES cells retain the ability to differentiate 
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into somatic lineages of all three germs layer, a characteristic referred to as 
pluripotency. ES cells can also grow indefinitely in culture under appropriate 
conditions (self renewing), thereby making them invaluable model system to 
study early development and potential for therapeutic possibilities (Jaenisch 
and Young 2008). The gene expression in ES cells is quite dynamic and well 
regulated by specific Transcription factors (TFs), chromatin modifiers and 
regulatory modules that interact on chromatin and cascade a range of 
downstream processes essential not only for pluripotency and self-renewal 
but also for normal function of cellular processes.  
 
The ES cell chromatin is tightly and dynamically regulated owing to 
architectural proteins that contribute to genome plasticity (Meshorer et al. 
2006; Melcer and Meshorer 2010). The ES cell chromatin provides the 
platform for TFs and master regulators (e.g. Oct4, Sox2, Nanog etc.) to 
interact and direct chromatin states whereby cohorts of interactions regulated 
gene expression.  The ES cell chromatin is thought to be transcriptionally 
hyperactive and central to this RNA polymerase II (RNAPII) the proteins that 
transcribes through on chromatin leading to production of stable and mature 
mRNA as well as many structural and non-coding RNAs(Efroni et al. 2008; 
Young 2011). 
3.3. RNAPII transcription in mES cells. 
In mES cells, we have shown that RNAPII not only binds and transcribes 
active genes defined by open chromatin architecture, but is also known to 
associate with PRC-repressed genes (Polycomb repressed genes) 
characterised by bivalent chromatin modifications (both open and closed 
chromatin marks) and unusual RNAPII variant (Stock et al. 2007b; Brookes et 
al. 2012). At active genes, RNAPII undergoes dynamic and sequential 
phosphorylation on its carboxy-terminal domain (CTD) at serine’s on position 
5,7 and 2 respectively which correlate with transcription initiation, transition to 
elongation and transcription elongation respectively. The successful round of 
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transcription additionally involves de-phosphorylation, recycling and unloading 
of RNAPII from chromatin for next round of transcription cycle (Brookes and 
Pombo 2009b).  
 
Remarkably at PRC-repressed genes, RNAPII initiates transcription i.e. S5p 
and transcribes across coding regions in the absence of S7p or S2p but 
without expression or production of stable mRNA. The PRC-repressed genes 
constitute almost 25% of the Refseq genes and encode important 
developmental regulator genes that are activated upon early steps of lineage 
specification (Brookes et al. 2012). Therefore the need to explore the 
chromatin bound RNAPII-proteome in mES cells became apparent as a 
means of identify additional activities associated with RNAPII-S5p at PRC-
target genes. 
3.4. Results 
3.4.1. Proteome complexity is reflected by different chromatin 
preparations. 
To understand the complexity of proteins that can be extracted from different 
chromatin preparations, I started by preparing three different types of 
chromatin and comparing their pattern of DNA enrichment and proteome 
composition. Native chromatin is prepared by micrococcal nuclease digestion 
of cell nuclei and captures resolution at level of mono-, di- and tri-
nucleosomes (O'Neill and Turner 2003). It is primarily used for analysis of 
histones and their post translationally modified isoforms. Fixed chromatin (or 
Fixed nuclear preparation) is prepared by formaldehyde crosslinking of cells, 
prior to nuclear isolation, to preserve DNA-protein and protein-protein 
interactions (within 2Å spacer arm) and is mainly used for capture 
transcription factor (TF) binding across the genome. Fixed chromatin is 
essentially a formaldehyde-crosslinked total nuclear extract that preserves 
DNA-protein, protein-protein and RNA-protein interactions (within the spacer 
arm distance). Double-crosslinked chromatin is an adaptation of fixed 
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chromatin wherein two crosslinking agents (formaldehyde and EGS) are used 
in tandem to capture direct and indirect DNA-associated protein interactions 
(Zeng et al. 2006).  
 
After DNA extraction from the three chromatin preparations and 
electrophoresis on an Agarose gel (Fig. 3.1), I observed that native chromatin 
mostly consisted of mono-nucleosome fragments and to some extent di- and 
tri-nucleosomes (fragment size range 145 - 300 bp). Fixed and double-
crosslinked chromatin produced DNA fragments of typical size range 0.25-
1.2kb. 
 
Figure 3.1 Diversity of DNA fragments in different chromatin preparations 
separated by Agarose gel electrophoresis. DNA from native chromatin, fixed 
chromatin and double-crosslinked chromatin was extracted and separated by 
electrophoresis on 1.2% Agarose gel. DNA extraction was performed as described 
(section 2.2.9). The DNA fragment range from native chromatin reflects the size 
distribution of mono- and di-nucleosomes, while the fixed and double-crosslinked 
chromatin show a range of 300bp-1.2kb.  
 
Before investigating the proteome composition in different chromatin 
preparations, I first optimised conditions for reverse-crosslinking of proteins 
from fixed chromatin thereby facilitating the reduction and denaturation of 
proteins. Unlike DNA detection by PCR, proteins cannot be amplified, so the 
efficiency of extraction and the protein yield are crucial for successful protein 
identification and quantification. I optimised reverse crosslinking (RCL) 
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conditions by treating fixed chromatin samples under a range of conditions 
with varying temperature and time (Fig. 3.2).  
 
Figure 3.2 Reverse crosslinking conditions to extract proteins from fixed 
chromatin. Fixed chromatin was re-suspended in custom Laemmli buffer and 
subjected to range of conditions (with varying temperature and time) to effectively 
reverse crosslink and elute proteins. (A) Coomassie stained gel with whole cell 
extract proteins and chromatin proteins under different RCL conditions. Minor effects 
are noticed at the level of total protein analyses, although it is noticeable that longer 
incubations at 100°C give less definition in the protein banding pattern (B, C and D) 
Western blotting of proteins (Ezh2, RNAPII-S5p and Ring1b) from whole-cell-extract 
and fixed chromatin preparations reverse crosslinked under a range of conditions. 
Different proteins have different sensitivity to the RCL condition. I chose condition 8 
(60°C o/n and 100°C for 10min) for further experiments. 
 
After Coomassie staining of chromatin proteins, I observed that most of the 
RCL conditions gave a similar pattern of distribution of proteins. However, 
proteins seemed to degrade when exposed to longer incubation and at higher 
temperature (Fig. 3.2A, lanes 5, 6, 10 and 11). Probing for specific proteins by 
western blotting, it was apparent that the different RCL conditions had slightly 
different effects on proteins. For example, Ezh2 protein was best extracted in 
lanes 4 and 7 (Fig. 3.2B; lanes 2 and 3 show a doublet not present in whole 
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cell extract, consistent with insufficient RCL). RNAPII-S5p was extracted 
optimally in lanes 7 and 8 (Fig. 3.2C). We decided to fix our RCL conditions 
(60°C o/n and 100°C for 10min; lane 8) keeping in mind that specific proteins 
might have a different optimal RCL condition. 
 
Next, I compared the proteome composition of the three different chromatin 
preparations (native, fixed and double-crosslinked) by Coomassie staining of 
chromatin extracts after separation by SDS-PAGE (Fig. 3.3). As expected, I 
observed that native chromatin is enriched particularly for histones, but 
interestingly a number of proteins are also detected in the larger size range of 
25 to 250 kDa). As anticipated, fixed chromatin is highly enriched for a range 
of proteins of different molecular weights, including core histones. Detection of 
proteins on the stacking portion of the gel suggests incomplete reverse-
crosslinking of proteins. Double crosslinked chromatin gave rise to the most 
intense Coomassie staining, representing the most diverse range of proteins 
with most detectable enrichment. As with fixed chromatin, stacking was 
observed with double-crosslinked chromatin. 
 
Figure 3.3 Diversity of proteins present in different chromatin preparations 
visualised by Coomassie staining. Native proteins were reduced and denatured by 
adding custom prepared Laemmli buffer (Section 2.4.1, 1:1 ratio by volume). Fixed 
and double-crosslinked chromatins were first reverse crosslinked (60°C o/n and 
100°C 10min) and eluted in custom Laemmli buffer (1:1 by volume). 
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To explore the specific enrichment or depletion of proteins between native and 
fixed chromatin and their function, I analysed the proteins from native and 
fixed chromatin by mass spectrometry (MS) and performed Gene Ontology 
(GO) analyses to ask which protein groups were shared and/or selectively 
enriched and their biological function (Fig. 3.4). MS analyses robustly 
identified 1320 and 2455 proteins in native and fixed chromatin, respectively, 
with ~1000 proteins overlapping between the two datasets. Nucleosomes 
(histones) and chromatin components were enriched and shared in both 
datasets. I performed GO analysis to identify biological processes shared 
between the datasets and also enriched in one preparation over another. 
Shared proteins were enriched for GO terms ‘nucleosome assembly’, ‘RNA 
splicing’, ‘mRNA processing’ and ‘translation’ (p-values <2x10-6). We 
expected histones to be shared between the two chromatin methods, however 
enrichment of mRNA processing and RNA splicing terms along with histone 
terms suggest that we may also enrich for chromatin proteins involved in 
active transcription. Interestingly, proteins enriched only in native conditions 
(344 proteins) are involved in processes including G-protein signalling, 
blastocyst formation and positive regulation of transcription and include 
proteins fundamental for stem cell pluripotency and self renewal (Oct4, Sox2, 
Dppa2 and Dppa4). Fixed chromatin represents essentially a total nuclear 
extract, and it is perhaps not surprising that a larger number of proteins is 
identified enriched only in fixed chromatin (1322 proteins) which are involved 
in diverse biological processes including signalling, transport and proteolysis. 
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Figure 3.4 Comparing the proteome composition of native chromatin and fixed 
chromatin. MS identified 1320 proteins from native chromatin (signal intensity > 
20,000) and 2455 proteins from fixed chromatin (mascot score > 50). Significant 
overlap (976 proteins) was observed between the datasets. Gene ontology (GO) for 
biological processes (BP) was performed for proteins common in both preparation 
and proteins identified only specific chromatin preparations (p-value < 10-4). 
 
In summary, the comparisons between native, fixed and crosslinked 
chromatin show the expected increase in protein complexity (Fig. 3.4) 
whereas comparisons of different RCL conditions demonstrate that it is 
possible to successfully extract proteins for MS analyse from crosslinked 
chromatin (Fig. 3.2). Formaldehyde crosslinked (fixed) chromatin was chosen 
as a starting material for further analyses by proteome-ChIP (pChIP), to 
identify the cohorts of proteins that co-associate with RNAPII bound to 
chromatin. First, our laboratory has developed a DNA-ChIP protocol optimised 
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to detect the chromatin occupancy of RNAPII modifications using fixed 
chromatin. Second, many proteins are lost in native chromatin preparations. 
Third, formaldehyde crosslinks can capture robust and transient interactions 
within 2Å spacer arm. Fourth, we could demonstrate the feasibility of 
detecting proteins by MS from formaldehyde-crosslinked chromatin, after 
optimising the RCL conditions.  
 
To check the specificity and robustness of our detection of chromatin proteins 
from crosslinked chromatin, I decided to compare our MS dataset from fixed 
chromatin from mES-OS25 cells, with published datasets for fractionated 
nucleoplasmic, cytoplasmic and chromatin proteins from a different mES cell 
line (Graumann et al. 2008) (Fig. 3.5). We observe a 60% overlap (1331 
proteins out of 2191 proteins) with published chromatin fraction proteins. In 
addition, our fixed chromatin dataset contains very few cytoplasmic (158 
proteins) and nucleoplasmic proteins (198 proteins). The high specificity and 
depth of our chromatin MS dataset is highlighted by the fact that 22% (496 
proteins) of our chromatin proteins were not detected by the previous study. 
Moreover, we enrich for important chromatin remodellers (Nanog, Bap18, 
Carm1, Setd3, CCR4-NOT complex), metabolic proteins (Arglu1, Prmt3, Hk3) 
and transcription associated proteins (mediator subunits, integrator subunits, 
RNAPII phosphatases, RNA binding proteins and splicing factors). 
 
 
Chapter 3  Proteome-ChIP (pChIP) as a tool to dissect the 
chromatin bound proteome (Optimising pChIP)  
 
 79 
 
Figure 3.5 Specificity of our fixed chromatin in comparison with different 
cellular fractions. MS robustly identified 2191 proteins from our fixed chromatin 
from mES-OS25 cells. Proteins from published MS analysis of mES cells (Graumann 
et al. 2008) identified 3152, 2651 and 2564 proteins from native cytoplasmic, 
nucleoplasmic and chromatin fractions respectively.  
 
Taken together, these analyses of total chromatin suggest the feasibility of 
analysing the proteome of fixed chromatin. In the next sections, I combine the 
protein extraction steps optimised here with protein extraction from chromatin 
immunoprecipitated with different RNAPII antibodies using an optimised ChIP 
protocol (Stock et al. 2007b). 
3.4.2. DNA-ChIP using RNAPII antibodies. 
Before optimising conditions for identifying the proteome of chromatin by 
pChIP using RNAPII antibodies, I started by reproducing previous DNA-ChIP 
analysis of RNAPII occupancy across a panel of genes in mES cells (Stock et 
al. 2007b; Brookes et al. 2012). I used three highly specific and well-
characterised antibodies directed against phosphorylation on S5, S2 and S7 
residues on the RNAPII CTD, which reflect distinct stages of the transcription 
cycle. RNAPII-S5p marks transcriptional initiation and is found highly enriched 
at promoter of actively transcribed genes and also at Polycomb repressed 
genes. RNAPII-S7p transitions RNAPII from transcription initiation to 
transcription elongation and is enriched at promoters of actively transcribed 
genes. RNAPII-S2p occurs downstream of initiation, marks transcriptional 
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elongation and is associated with coding regions of actively transcribed 
genes.  
 
Consistent with the published data (Stock et al. 2007b; Brookes et al. 2012) in 
my DNA-ChIP results (Fig. 3.6), RNAPII-S5p was found enriched at promoters 
and coding (+2kb downstream of TSS) regions of active and PRC-repressed 
genes. RNAPII-S7p was enriched at promoters and coding regions of active 
genes consistent with role in active transcription. RNAPII-S2p is enriched only 
at the active genes, with enrichment at coding regions much higher than at 
promoters. Mock ChIP (control immunoprecipitation using an antibody against 
plan steroid, Digoxigenin) demonstrates the specificity of our ChIP protocol, 
with no detectable DNA enrichment compared to ChIP with RNAPII-S5p, -S7p 
or -S2p antibodies. 
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Figure 3.6 Occupancy of different RNAPII modifications across a panel of 
active, PRC-repressed and silent genes in mES cells. Occupancy of RNAPII-S5p 
(light and dark blue), -S7p (light and dark green) and -S2p (light and dark red) as 
measured by DNA-ChIP and qRT-PCR at promoters (P, light) and coding (C, dark) 
regions of panel of two active, four PRC-repressed and two inactive genes. Light and 
dark grey bars represent background enrichment levels as measured by control 
immunoprecipitation (Mock). Enrichment is expressed relative to input DNA using 
total amount of DNA in qRT-PCR. Mean and standard deviation are representative of 
3 independent biological replicates (2 replicates for S2p). 
 
To further demonstrate the quality of the ChIP experiments, I also measured 
the chromatin occupancy of S5p, S7p and S2p across a single gene locus, the 
polr2a gene, spanning ~28kb. I observed RNAPII-S5p highly enriched at 
promoter and present throughout coding regions (Fig. 3.7). RNAPII-S7p is 
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highly enriched at promoters and RNAPII-S2p enrichment occurs 
predominantly downstream of promoters and towards end of gene.  
 
Figure 3.7 Occupancy of RNAPII modifications across a single gene locus in 
mES cells. Occupancy of RNAPII-S5p (blue), -S7p (green) and -S2p (dark red) as 
measured by DNA-ChIP and qRT-PCR across a single gene locus (Polr2a – 28kb) 
spanned by 12 spatially positioned primers (primers kindly designed by I. de Castro; 
our lab). Grey bars represent background enrichment levels as measured by control 
immunoprecipitation (Mock). Enrichment is expressed relative to input DNA using 
total amount of DNA in qRT-PCR. Mean and standard deviation are representative of 
3 independent biological replicates.  
 
These analyses show that the DNA-ChIP detects specific RNAPII 
modifications at the appropriate locations, and with good and reproducible 
yields comparable with previous analyses in the laboratory (Stock et al. 
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2007b). In the next section, I combine the ChIP procedure with the RCL 
extraction of proteins and MS analyses, towards identifying the proteome 
associated with RNAPII complexes bound to chromatin in ES cells. 
3.4.3. Proteome-ChIP (pChIP): Overview and optimization 
With an aim to identify the RNAPII-bound chromatin proteome, I first 
developed and optimised the pChIP protocol to effectively enrich and extract 
proteins that bind to RNAPII on chromatin. With pChIP, we aim to capture the 
protein complexes that are associated with chromatin at the same time as 
RNAPII, i.e. all cohorts of interactions irrespectively of whether they are direct 
or indirect associations with RNAPII, and whether they are mediated by DNA-
protein, protein-protein or RNA-protein interactions. Briefly, pChIP is similar to 
DNA-ChIP, wherein mES cells are in-vivo crosslinked with formaldehyde to fix 
chromatin interactions, before nuclei are purified and sonicated to produce 
fixed chromatin. Using highly specific RNAPII antibodies, we 
immunoprecipitate chromatin, reverse crosslink chromatin and elute proteins 
to be further analysed either by western blotting or by high-throughput MS 
approaches (Fig. 3.8).  
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Figure 3.8 Overview of steps involved in Proteome-ChIP (pChIP). mES cells are 
crosslinked, cell lysis is followed by nuclei purification and sonication to produce fixed 
chromatin. Using highly specific antibodies, immunoprecipitation is performed and 
DNA and proteins are reverse crosslinked in parallel. Occupancy of RNAPII 
modifications is measured by qRT-PCR. Extracted proteins can be identified by MS 
or individually probed by western blotting. 
 
To test the conditions for pChIP, I started by performing RNAPII-S5p ChIP 
(along with mock ChIP), reverse crosslinking and analysing the protein 
composition using Coomassie staining of the SDS-PAGE gel (Fig. 3.9). There 
was clear Coomassie staining in the RNAPII-S5p pChIP (lane 4) in contrast 
with the Mock pChIP (lane 5) where little or no staining was detected. Proteins 
bands were not clearly visible in the RNAPII-S5p ChIP lane, either due to 
presence of DNA in protein sample or incomplete RCL that would prevent the 
definition of specific protein bands and would favour stacking of chromatin at 
the top of the lane. Western blotting for RNAPII-S5p further confirmed the 
enriched of RNAPII in the respective pChIP sample and not in mock pChIP. 
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Figure 3.9 Western blot analysis of RNAPII-S5p pChIP. pChIP was performed for 
RNAPII-S5p with mock in the absence of primary antibody, before samples 
separated by SDC-PAGE and stained with Coomassie to visualize distribution of 
proteins. Staining was observed in RNAPII-S5p but protein bands were not defined in 
comparison with WCE (whole cell extract) or input chromatin. Mock pChIP was clean 
and with little or no Coomassie staining. Western blotting for RNAPII-S5p further 
confirmed specificity of pChIP as RNAPII-S5p was observed in all lanes except mock 
pChIP.  
 
To improve the visualisation of proteins after SDS-PAGE and the protein 
extraction, I tested the effect of using different DNase treatments before 
elution of chromatin from the immunoprecipitating beads, sonication of the 
protein extract in Laemmli buffer and protein precipitation (Fig. 3.10). With 
most of these conditions, visualization was only partially improved, and at the 
cost of reduced protein amounts or increased processing steps. We chose to 
include a DNase (Benzonase) treatment at the last stage of 
immunoprecipitation, as standard condition to digest DNA before elution of 
proteins from the beads. 
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Figure 3.10 Testing conditions to improve protein visualisation after 
Coomassie staining. DNase (Benzonase, 25 units/final volume; MNase, 2 units/final 
volume) and sonication (10min 30sec on-off) were used to further fragment DNA in 
input, RNAPII-S5p and mock pChIP resulting in slightly improved visualization. TCA 
precipitation improved visualization of pChIP samples (S5p, S7p, S2p and Mock) but 
with reduced protein recovery. 
 
As a summary, the sample processing steps chosen for subsequent pChIP 
experiments up to MS analysis are briefly described in Fig. 3.11.  
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Figure 3.11 Samples processing steps for pChIP before MS data acquisition. 
Briefly samples are run on SDS-PAGE gel and Coomassie stained to visualise 
protein distribution. Accordingly complete gel or appropriate sections are cut and 
processed for in-gel reduction, alkylation and destaining. Proteins are digested by 
trypsin and tryptic peptides are extracted for chromatographic separation. Finally the 
different fractions are injected and analysed by tandem MS/MS. The spectra for 
peptides are generated and database search facilitates identification of peptides and 
therefore proteins present in sample. 
3.4.4. RNAPII-S5p pChIP 
To identify the cohorts of proteins interacting with RNAPII-S5p, I performed 
pChIP with RNAPII-S5p antibodies (along with mock pChIP) and analysed 
these two samples together with input fixed chromatin by MS. RNAPII-S5p is 
found predominantly at promoters but also at coding regions of both active 
and PRC-repressed genes (Fig. 3.5). MS analyses were performed at the 
CSC MS facility. After removal of known MS contaminants, 730 proteins were 
identified in RNAPII-S5p pChIP, 75 proteins were identified in mock pChIP 
and 2490 proteins were identified in input chromatin (Fig. 3.12).  
 
To measure the specificity of pChIP, I compared proteins identified in RNAPII-
S5p and mock pChIP and represented the results in a Venn diagram. 
Reassuringly, 96% of pChIP RNAPII-S5p proteins (706) were not detected in 
mock pChIP. I next asked whether RNAPII-S5p pChIP specifically enriched 
for proteins involved in RNAPII transcription and co-associated processes by 
comparing the MS datasets obtained with input fixed chromatin and RNAPII-
S5p pChIP. Using the MS with intermediate depth, of 2490 proteins detected 
in input chromatin, RNAPII-S5p pChIP specifically enriched for 545 proteins 
(overlap – 75% of RNAPII-S5p proteome). Performing gene ontology (GO) 
analysis, I observed that the proteome enriched for with RNAPII-S5p pChIP 
was enriched for ‘mRNA’, ‘RNA processing” terms and ‘chromatin 
remodellers’ (Fig. 3.12), while the input chromatin was composed of various 
nuclear processes. The identification of few proteins in RNAPII-S5p only (185 
proteins) reflects on incomplete protein sequencing depth of the more 
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complex input chromatin. A few examples of proteins enriched in RNAPII-S5p 
are listed in the Fig. 3.12.  
 
 
Figure 3.12 Specificity and robustness of proteins detected by RNAPII-S5p 
pChIP. (A) Specificity of RNAPII-S5p pChIP (dark blue) was measured by comparing 
with mock pChIP (light blue) in a Venn. (B) Robustness and specific enrichment of 
RNAPII-S5p over input chromatin proteins (grey) is displayed as Venn diagram. (C) 
Significant GO terms enriched in input chromatin and RNAPII-S5p pChIP. (D) 
Examples of proteins enriched in RNAPII-S5p. 
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3.4.5. RNAPII-S7p pChIP 
To further explore the specificity of the chromatin proteome associated with 
RNAPII, I next performed pChIP with RNAPII-S7p (along with mock pChIP). 
RNAPII-S7p marks transition from transcription initiation to elongation and is 
found enriched at promoters of actively transcribing genes (Fig. 3.5). After 
RNAPII-S7p pChIP, 357 proteins were identified and only 26 proteins were 
also detected in mock pChIP highlighting the specificity of RNAPII-S7p pChIP 
(Fig. 3.13). Comparing RNAPII-S7p with input fixed chromatin, 67% of 
proteins were specifically enriched from input and GO analysis confirmed 
enrichment of mRNA and RNA processing terms (Fig. 3.13). RNAPII-S7p only 
proteins (110 proteins) are attributed to low protein sequencing depth of input 
chromatin as with RNAPII-S5p MS run.  
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Figure 3.13 RNAPII-S7p pChIP. (A) RNAPII-S7p (green) enriches for proteins not 
identified in mock pChIP (grey) as plotted in a Venn diagram. (B) RNAPII-S7p (green) 
robustly and specifically enriches for proteins over input chromatin (grey). (C) 
Significant GO terms enriched in RNAPII-S7p pChIP. (D) Examples of proteins 
enriched in RNAPII-S7p.  
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To probe for the specificity of the proteome identified by pChIP with different 
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qualitative information on identified proteins is assessed i.e. a protein 
identified can be enriched/depleted between two samples whereas no 
evaluation can be done for proteins not identified. With this background, I 
asked how many proteins were identified in both RNAPII-S5p and RNAPII-
S7p pChIP.  
 
Interestingly 236 proteins were found common in the datasets, which included 
RNAPII subunits, histones, components of transcriptional co-processing 
machinery and splicing factors (Fig. 3.14). Unique proteins only identified in 
the RNAPII-S5p pChIP were 363 proteins, and in the RNAPII-S7p pChIP 140 
proteins. Reassuringly Polycomb proteins are consistently detected only with 
RNAPII-S5p and not with S7p, whereas Transcription associated factors 
(TAFs) and histone proteins are detected in the S7p, but not S5p pChIP MS 
datasets.  
 
 
Figure 3.14. pChIP comparison between RNAPII-S5p and RNAPII-S7p pChIP. 
(A) Venn diagram representing the proteins found common or selectively in pChIP 
experiments. Examples of proteins common in both RNAPII-S5p and -S7p. 
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co-transcriptionally. However, label-free MS analyses are mostly semi-
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pChIP (S5p or S7p), it is difficult to assess whether these proteins were not 
identified in one of the samples, e.g. due to technical (low sequencing depth) 
or actual biological affinity to different RNAPII modifications.  
3.5. Discussion 
ES cells are self-renewing and pluripotent cells that have a tightly regulated 
gene expression where chromatin forms the platform for TFs, chromatin 
modifiers and regulatory modules to cascade a range of downstream 
processes (Jaenisch and Young 2008; Melcer and Meshorer 2010). The 
diversity of mES cells chromatin can be understood at different levels owing to 
the resolution of chromatin (DNA and proteins) obtained by different chromatin 
preparations (Solomon et al. 1988; O'Neill and Turner 2003; Zeng et al. 2006). 
I first compared the DNA obtained from the three different chromatin 
preparations (native, crosslinked and double-crosslinked; Fig. 3.1). After 
optimising conditions for reverse crosslinking of chromatin, I measured 
observed the diversity of chromatin proteome from the three preparations by 
MS (and Coomassie staining) and further compared with published dataset to 
show specificity and robustness of our MS proteins detection (Fig. 3.2, 3.3, 
3.4 and 3.5). I choose fixed chromatin as starting material for subsequent 
experiments, owing to diversity and protein abundance. Next, I reproduced the 
DNA-ChIP results for RNAPII modifications at a panel of genes and single 
gene locus (Fig. 3.4, 3.5 and 3.6). Next I designed and optimised pChIP 
protocol, experimental and MS conditions (in collaboration with Bram 
Snijders). Finally I performed RNAPII-S5p and -S7p pChIP identifying range of 
known and novel protein interactions including independent confirmation for 
Polycomb proteins association with RNAPII-S5p on chromatin (Fig. 3.12), 
previously only identified for a small number of genomic regions by sequential 
ChIP (Brookes et al. 2012). 
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3.5.1. Chromatin diversity captured by different chromatin preparations. 
The resolution of native chromatin spans mono and di-nucleosomes that 
corresponds to 150-400 base pairs (bp) of DNA (O'Neill and Turner 2003). 
Active gene promoters have open chromatin characterised by spaced 
nucleosomes and at the resolution of native ChIP, only histones, histone 
modifications and strongly bound transcription factors can be studied. In fixed 
nuclear chromatin (fixed nuclear extract) formaldehyde crosslinks the 
interactions (DNA-protein, protein-protein and RNA-protein). Upon sonication 
we observe range of chromatin (DNA) fragments that span from 300bp -
1.2kbp representing larger fragments with crosslinked interactions. Fixed 
ChIP is therefore used to observe occupancy of transcription factors, 
enzymes and proteins that interact on chromatin and cascade downstream 
processes. In our intermediate depth MS analysis of chromatin proteome at 
intermediate depth presented here, we observed enrichment of 75% more 
proteins (978) in fixed chromatin (2298) compared to native chromatin (1320 
proteins) consistent with resolution and nature of chromatin preparation.  
The diversity of native chromatin proteome is evident with the enrichment for 
pluripotency factors, G-protein signalling and RNA processing factors 
suggesting strong and intricate link with chromatin (nucleosomes). Enrichment 
for Oct4, Nanog and other pluripotency factors in our limited depth native 
chromatin run suggests a closer and tightknit regulation of stem cell 
transcription factors on chromatin while composition of fixed chromatin 
proteome was diverse (transcriptional machinery, splicing factors, transport 
and metabolic proteins) consistent with composition of nuclear proteome.  
 
The ability to detect proteins from fixed chromatin preparation also depends 
upon our ability to efficiently reverse crosslink, elute and extract proteins. This 
step is quite critical, as un-crosslinked proteins tend to aggregate and not 
pass through the SDS-PAGE gel. In addition, MS allows identification of 
proteins present in these aggregates as peptides are eluted to allow protein 
identification. We observe that conditions for reverse crosslinking of chromatin 
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proteins (60°C o/n and 100°C for 10min) are optimal for most proteins tested 
by western blotting. However different proteins might have other optimal 
reverse crosslinking conditions and might therefore have lower identification in 
the dataset studied. 
3.5.2. Pattern of RNAPII modifications at Active and PRC-repressed 
genes  
RNAPII at PRC-repressed genes contain high levels of S5p but no detectable 
levels of S7p or S2p (Fig. 3.6) in spite of detection of S5p into coding regions. 
The levels of S5p are often higher in PRC-repressed genes compared to 
active genes (Fig. 3.6) while the levels of total RNAPII are similar between 
active and PRC-repressed genes (Stock et al. 2007b). Presence of S5p (in 
the absence of S7p and S2p) along with Polycomb proteins at coding regions 
of PRC-repressed genes is consistent with transcription without any 
expression and suggests a novel mechanism of RNAPII-S5p and Polycomb 
interplay at these genes. 
 
In addition the RNAPII antibodies used are extensively characterised and 
detect RNAPII occupancy across a single genes by qPCR and also genome-
wide (Brookes et al. 2012). However certain commercial antibodies (e.g. 
against RNAPII-S5p; Abcam ab5408) only detect RNAPII at promoter regions 
thereby affecting the coverage of proteins on DNA. For pChIP, variations like 
these may have strong effects. In addition my DNA-ChIP results are robust 
and consistent with our published work adding confidence to pChIP method. 
 
While ChIP-Sequencing (ChIP-Seq) measures the occupancy of a single 
protein on the chromatin genome-wide, it does not offer any information on 
other proteins that co-associate along with it on chromatin. Multiple ChIP-Seq 
can be performed to identify potential co-associations however this approach 
is very expensive and requires previous knowledge on proteins. Proteome-
ChIP on the other hand is a unbiased approach that dissects the chromatin 
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bound proteome associated with protein of interest. Further identifying cohorts 
of proteins that co-associate on chromatin thereby removing the need for 
hundreds of ChIP-Seq experiments. pChIP with MS provides global 
information on proteins co-associating on chromatin. Proteome-ChIP differs 
from conventional peptide pull-down and immunoprecipitations as we use in-
vivo chromatin extract to enrich for proteins association (rather than nuclear 
extract or whole cell extract).  
 
After immunoprecipitation, chromatin samples after pChIP are re-suspended 
in custom Laemmli buffer to effectively and efficiently reverse crosslink and 
denature chromatin-bound proteins allowing for peptide elution and detection 
by MS. One disadvantage is that quantification of proteins cannot be done 
while in Laemmli buffer, which precludes their analysis without separation by 
SDS-PAGE and in addition efficiency of reversal of crosslinks cannot be 
calculated (or normalised) between different experimental runs. Therefore I 
have always performed DNA-ChIP in parallel to pChIP and used the DNA 
yields after immunoprecipitation as test of robustness. pChIP proteins can be 
visualised by western blotting, however that severely restricts the applicability 
of pChIP due to the sample loss during SDS-PAGE ( and transfer onto 
nitrocellulose membrane) and much lower detection limit for proteins in 
western blot varies from 1-10ng. pChIP and MS analysis is much more 
sensitive detecting peptides instead of intact proteins, in addition MS sample 
processing steps (de-staining, alkylation, trypsinisation, chromatography) 
further remove salts, DNA, RNA, aiding the better separation and protein 
identification. The major advantage of pChIP and MS analysis is that one run 
provides identification on several co-associating proteins whereas pChIP with 
western blot can only provide information on individual protein. Another critical 
aspect of MS sample processing is the peptide sequencing depth. Complete 
sequencing depth is achieved when at least one peptide is detected for all the 
proteins present in the sample. However this equates to abundance of 
proteins in sample and also chance for MS to capture the peptide spectra for 
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tandem MS/MS analysis and unreasonably large MS run times. The choice of 
MS parameters during different runs depends therefore on the sample 
complexity, efficient chromatographic separation and important reasonable 
MS run times.   
3.5.3. RNAPII Proteome-ChIP 
We have demonstrated that pChIP is robust and specifically enriches proteins 
from input chromatin (Fig. 3.12 and Fig. 3.13). RNAPII-S5p peaks at promoter 
of active genes and is also present throughout coding regions. In RNAPII-S5p 
pChIP, we identify >700 proteins involved in range of diverse cellular 
processes. We identify many components of transcriptional machinery 
(General transcription factors, Splicing, RNA processing, Paf1 complex) 
associating with RNAPII-S5p consistent with role in transcription. In addition 
identify several metabolic proteins associating with S5p. Identification of 
Polycomb proteins exclusively associating with RNAPII-S5p is an independent 
validation for RNAPII-Polycomb interplay. RNAPII-S7p transitions transcription 
from initiation to elongation. RNAPII-S7p peaks at promoter with low levels 
during coding regions, consistently RNAPII-S7p pChIP identifies range of 
proteins involved in transcriptional initiation and elongation. Remarkably 
chromatin modifiers and metabolic proteins are identified suggesting role of 
metabolic protein during transcription. This diversity of proteins identified with 
S5p and S7p pChIP is remarkably and highlights the importance of RNAPII 
and its association. 
 
Using pChIP with conventional MS approaches provides only qualitative 
information of proteins and their associations. Due to the qualitative aspect of 
these analyses, we cannot compare the proteins identified from RNAPII-S5p 
and S7p pChIP with each other due to differences in antibody efficiency, 
reverse crosslinking and elution efficiency. In addition several normalization 
parameters would be required to equilibrate sample complexity and MS 
peptide analysis time for different samples. Even after these normalizations, 
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we cannot quantitatively associate protein binding to one RNAPII modification 
or the other. For effective comparison, we require a quantitative approach that 
can resolve protein dependencies to RNAPII modifications while normalizing 
the effects of antibody efficiency and MS parameters. 
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4. Optimising SILAC labelling and pChIP-SILAC in mES cells 
4.1. Research motivation       
To quantitatively investigate the chromatin-bound proteome associated with 
RNAPII modifications, I investigated and optimised conditions for SILAC 
labelling of mES cells, further performing quality control experiments to 
confirm similar behaviour of chromatin, DNA, proteins and pluripotency factors 
between unlabelled and SILAC cells. I aimed to investigate and quantify the 
proteomic differences between label-free and SILAC samples including 
chromatin and pChIP samples. I also aimed to adapt and extend the SILAC 
method to compare and contrast proteomes associated with different post-
translational modifications on single RNAPII molecules (S5p and S7p). 
Furthermore, I explored experimental strategies to best unravel and 
quantitatively dissect the chromatin proteome landscape associated with 
RNAPII modifications (S5p and S7p).  
 
All of the the MS experiments were carried out in collaboration with Dr. Bram 
Snijders at Proteomics facility at MRC-CSC. Dr. Snijders also helped with 
sample pre-processing for MS, performed all MS run time operations and 
quantified MS spectra. 
4.2. Culture conditions for mES cells. 
Embryonic stem (ES) cells derived from ICM can be proliferated in vitro under 
appropriate culture conditions (Evans and Kaufman 1981; Martin 1981). 
These cells have the ability to undergo cell divisions without differentiation so 
as to produce pluripotent progeny when cultured in vitro (Chambers and Smith 
2004) a property referred to as self-renewal, which occurs via symmetrical cell 
division. ES cells can be propagated under culture conditions in the presence 
of serum and in co-culture with a layer of fibroblasts (feeder layers) 
(Chambers and Smith 2004). These feeders act by producing a signal that 
inhibits ES cell differentiation (Smith and Hooper 1983). Subsequent studies 
of the conditioned medium identified the active component as leukaemia 
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inhibitory factor (LIF) (Smith et al. 1988; Williams et al. 1988). This finding 
indicated that LIF supplementation along with serum provides all necessary 
factors required for ES cell proliferation and maintenance. Other important 
signalling molecules, cytokines, extrinsic regulators and factors that contribute 
to ES cell self-renewal include, BMP4, BMP2 or GDF6, Wnt signalling, 
glycogen synthase kinase-3 (GSK-3) during clonal propagation of ES cells 
and during their de novo derivation (Ying et al. 2003; Chambers and Smith 
2004) The composition of media is also contains necessary growth factors 
that allow master regulators (Oct4, Sox2 and Nanog) to mediate 
transcriptional and protein interactional network for pluripotency in ES cells 
(Wang et al. 2006; Orkin et al. 2008; van den Berg et al. 2010).  
 
ES cells have a tightly regulated transcriptome and proteome that facilitates 
the need to self-renew, remain pluripotent and respond to appropriate 
differentiation cues. Proteomic studies have identified additional proteins and 
factors that are essential for mES cells and have further shed light on the 
tightly regulated protein network (Unwin et al. 2003; Prudhomme et al. 2004; 
Gesslbauer et al. 2006; Van Hoof et al. 2006; Graumann et al. 2008).  
4.3. SILAC labelling and MS quantification of proteins. 
Stable isotope labelling of amino acids in cell culture (SILAC) offers a simple 
and practical approach to perform quantitative proteomics (Ong et al. 2002). 
Briefly, essential amino acids (L-lysine and L-arginine) are replaced by their 
stable heavier isotopes and upon comparison with unlabelled cells, mass 
spectrometry (MS) efficiently distinguishes the heavier and lighter isotopes 
leading to quantification of proteomic differences between heavy and light 
sample. SILAC labelling methods have been further developed and applied to 
generate entire fly and mouse. Additionally SILAC approaches have also been 
applied to distinguish proteomic differences between control and disease 
samples (Mann 2006; Sury et al. 2010; Zanivan et al. 2012). SILAC MS 
methods and analysis are more expensive than conventional MS due to the 
media compositions and requirement of replicate samples (heavier and lighter 
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amino acids media). Further optimisation of MS conditions and run time are 
extremely significant and affect depth of proteome (Chen 2008). Due to the 
nature of the SILAC experiment, robust and quantitative information can be 
obtained without the need for multiple replicates.  
 
Our lab has previously identified distinct combinations of RNAPII 
modifications at important developmental regulator genes in mES cells that 
are silenced by Polycomb repressive complexes (PRC) to prevent aberrant 
activation of differentiation programs, but also associate with hallmarks of 
active chromatin (Brookes and Pombo 2009b; Brookes et al. 2012). We have 
also previously demonstrated the specificity of RNAPII antibodies using 
specific kinase inhibitors, phosphatase treatments (Xie et al 2006, Stock et al 
2007), and peptide assays (Brookes et al 2012; data not shown from H. 
Kimura and D. Eick laboratories). Distinctive genome-wide occupancy of 
RNAPII modifications was identified at the subgroup of genes associated with 
Polycomb repression, by ChIP-Sequencing (and by ChIP-qPCR at subset of 
genes) (Brookes et al. 2012). In particular with an interest in identifying 
proteins associated with RNAPII-S5p associated at Polycomb repressed 
chromatin, I have worked to develop an unbiased and quantitative assay to 
unravel the proteome associated with RNAPII-bound chromatin.  
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4.4. Results 
4.4.1. SILAC amino acid concentration is important for mES cells 
viability 
Standard conditions for culture of mES cells includes media (GMEM/DMEM - 
high glucose) supplemented with fetal calf or fetal bovine serum (FCS/FBS) 
and additional factors (L-glutamine, sodium pyruvate, non-essential amino 
acids, LIF and β-mercaptoethanol). Cells are grown at 37°C with 5% CO2 and 
in 95% humidity. The composition of FCS/FBS is highly undefined, containing 
a range of growth factors, proteins, chemokines, vitamins, minerals and 
complex lipids, which supplement the signalling, metabolism, and growth of 
mES cells. For SILAC labelling of mES cells, it was essential to use a defined 
culture medium wherein the concentration of essential amino acids (lysine, 
arginine and their heavier isotopes) can be appropriately added to support 
mES cell growth and maintained without affecting mES cell characteristics. 
 
Initially, I optimised the SILAC media and culture conditions for OS25-mES 
cells. Using SILAC-DMEM media (lacking lysine and arginine amino acids), I 
tried supplementing media with different concentrations of L-arginine (240, 
87.2 and 84 mg/L) and L-lysine (40, 152.8 and 146 mg/L), as reported in 
literature (Blagoev and Mann 2006; Bendall et al. 2008), along with the use of 
dialysed FCS or serum replacement media (Knockout serum replacement; 
KOSR). For OS25-mES cells, SILAC-DMEM supplemented with KOSR, L-
arginine (84 mg/L, or 0.398 mM) and L-lysine (146 mg/L, or 0.798 mM) were 
optimal. Other concentrations of SILAC amino acids and conditions either led 
to massive cell death or to differentiation (assessed by visual inspection of cell 
morphology). Table 4.1 lists the conditions found optimal for SILAC labelling 
of OS25-mES cells; they have also been successfully used for growing other 
mES cells lines, E14-mES and 46C-mES, in our laboratory.  
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Table 4.1 Media composition for SILAC labelling of mES cells. List of 
components added to SILAC-DMEM media along with concentrations of heavy and 
light isotopes of essential amino acids.  
 
 
4.4.2. Culturing mES-OS25 cells in SILAC conditions does not affect 
pluripotency markers 
Before using the SILAC-labelled mES cells for quantitative pChIP, I first 
performed different quality control assays to check whether the SILAC 
labelling affected mES cell characteristics (Fig. 4.1). Using alkaline 
phosphatase (AP) staining of OS25-mES cells grown in normal or SILAC 
conditions, I confirmed that cells acquired similar levels of AP staining in 
SILAC as in normal conditions, confirming their stemness or pluripotency 
potential (Fig. 4.1A). I also measured RNA levels of three genes fundamental 
for mES cell pluripotency and self-renewal (Oct4, Sox2 and Nanog), and I 
observed that similar levels of RNA were expressed in SILAC as in normal 
conditions (Fig. 4.1B). Next, I compared overall protein composition by 
Coomassie staining of whole cell extract proteins and observed overall similar 
distribution (Fig. 4.1C). Assessing protein levels of pluripotency genes (Oct4, 
Sox2 and Nanog) by western blotting showed similar protein amounts in 
normal and SILAC conditions (Fig. 4.1D). Finally, I checked the distribution of 
RNAPII-S5p and Nanog in normal and SILAC cells by 3D-
SILAC media composition!
Media components! Final volume/concentration!
SILAC-DMEM! 500 ml!
Knockout serum replacement! 15 %!
β-mercaptoethanol! 0.1 mM!
L-glutamine! 2 mM!
Sodium pyruvate! 1 mM!
Non-essential amino acids! 1%!
Leukemia inhibitory factor! 1000 U/ml!
Hygromycin! 0.1 mg/ml!
SILAC amino acids!
Heavy isotope!
L-Lysine HCl    (13C6 H14 15N2  O2 )! 0.798 mM!
L-Arginine HCl (13C6 H14 15N4 O2 )! 0.398 mM!
Light istope!
L-Lysine HCl    (12C6 H14 14N2 O2) ! 0.798 mM!
L-Arginine HCl (12C6 H1414N4  O2)! 0.398 mM!
Chapter 4          Optimising SILAC labelling and SILAC-pChIP in mES cells  
 
 103 
immunofluorescence. RNAPII-S5p is distributed throughout the nucleoplasm, 
excluding sites of heterochromatin (Xie and Pombo 2006; Silva et al. 2009). 
Nanog protein is known to fluctuate its expression in mES cells (Silva et al. 
2009) and fluctuating Nanog levels can be observed in normal and SILAC-
labelled cells. 
 
 
Figure 4.1 mES cell characteristics are not affected after SILAC labelling. (A) 
Alkaline phosphatase staining of normal mES cells (FBS cultured) and in SILAC 
conditions. (B) Measuring RNA levels of pluripotency genes Oct4, Sox2 and Nanog. 
RNA levels for normal and SILAC conditions were first normalised to expression of 
housekeeping genes (βactin, Ubiquitin-c, Glucose-6-phosphate dehydrogenase), 
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before normalizing SILAC samples to level of RNA produced in normal conditions. 
(C) Coomassie staining shows similar distribution of proteins in the whole cell extract 
(WCE) of normal and SILAC cells. (D) Western blotting confirms presence of 
pluripotency markers in all samples. (E) Immunofluorescence for RNAPII-S5p and 
Nanog protein shows similar pattern of protein distribution across cells in normal and 
SILAC conditions. 
4.4.3. Verifying incorporation of heavy and light amino acids in whole 
cell extract by MS 
After confirming the pluripotency markers of mES cells grown in SILAC 
conditions, I next checked the incorporation of lysine and arginine isotopes in 
the proteins in cells grown in SILAC conditions. Whole cell extracts (WCE) 
were prepared from SILAC cells (minimum 4-6 passages, equivalent to 8-12 
doubling times), mixed 1:1 (according to protein concentration determined by 
Bradford assay), before separation by SDS-PAGE and staining with 
Coomassie. One or two fractions per gel were analysed using low-depth 
(shorter) MS runs, which resulted in the identification of 170-392 proteins (Fig. 
4.2). We observed >97% labelling efficiency; only light peptides were detected 
in light samples and heavy peptides in heavy samples. Common MS 
contaminants (keratins, trypsin, control peptides, etc.) were identified and 
filtered, as they are consistently enriched only in light peptides. Examples of 
mass spectra of lysine and arginine containing heavy peptides are shown in 
Fig. 4.2. We also did not detect any proline conversion, a difficulty reported in 
the literature in different mES cell lines (Van Hoof et al. 2007). 
  
Figure 4.2 SILAC labelling efficiency measured by MS. Whole cell extracts were 
made from SILAC heavy and light labelled cells (minimum 4-6 passages) and 
analysed by MS.  
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Only heavy peptides were detected in the heavy-only sample, and only light 
peptides were detected in light-only samples. A few examples of mass 
spectra from heavy WCE samples after MS analysis and database searching. 
4.4.4. MS analysis on SILAC chromatin    
SILAC labelling allows the comparison of the relative amount of proteins 
present in a pair of samples. Given that our input chromatin is a complex MS 
sample due to the efficiency of reverse crosslinking, I tested how robustly 
could proteins be detected in the SILAC input chromatin, in comparison with 
input chromatin from mES cells grown in normal conditions (as in Fig. 3.12). 
Chromatin (heavy) was mixed with chromatin (light) in 1:1 ratio (by chromatin 
concentration) and analysed by MS in low-depth run. We identified ~2400 
proteins in input chromatin samples; >80% of these proteins (1905 proteins) 
had robust SILAC ratios (ratios 1.0±0.2; Fig. 4.3). Comparing SILAC with non-
SILAC input chromatin, there was large overlap of proteins common in both 
datasets (1340 proteins; Fig. 4.3B). Over 20 significant GO terms are 
enriched and shared between all the datasets (Fig. 4.3 C). Taken together, 
these results suggest similar chromatin composition the non-SILAC and 
SILAC chromatin, with an expected variation in number of proteins due to MS 
peptide sequencing depth. 
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Figure 4.3 MS analysis of SILAC input chromatin (heavy/light). Heavy and light 
input chromatin was mixed in 1:1 ratio as per chromatin concentration (alkaline lysis 
as described in section 2.2.1.1). (A) In low depth MS run, more than 80% of 
chromatin proteins were identified and quantified (ratio 1.0±0.2) (B) Comparison 
between SILAC and non-SILAC chromatin (as in Fig. 3.4). (C) Examples of 
significant GO terms in SILAC chromatin, overlap and in non-SILAC chromatin. More 
than 20 GO terms were enriched in all three groups. Percentages represent the 
proportion of identified proteins relative to the total number of annotated proteins in 
each GO category.  
4.4.5. RNAPII occupancy in SILAC mES chromatin 
To test whether the chromatin occupancy of RNAPII modifications was not 
affected, I performed DNA-ChIP on SILAC-labelled light and heavy 
chromatin, before performing pChIP with SILAC-labelled chromatin (Fig. 4.4). 
As observed in non-SILAC conditions (Fig. 3.7 and (Stock et al. 2007b)), 
RNAPII-S5p was enriched at promoters and coding regions of active and 
PRC-repressed genes in both Heavy and Light chromatin. RNAPII-S7p was 
enriched only at promoters and coding regions of active genes and RNAPII-
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S2p was also predominantly enriched at coding regions of active genes, as 
expected. Inactive genes had no enrichment for either RNAPII modification. 
Mock pChIP was performed in parallel to all pChIP experiments and 
demonstrates minor levels of non-specific ChIP enrichment.  
 
Figure 4.4 RNAPII occupancy in SILAC-labelled mES cells. Occupancy of 
RNAPII-S5p (dark and light blue), -S7p (dark and light green) and -S2p (dark and 
light pink) as measured by DNA-ChIP and qRT-PCR at promoters (P) and coding (C) 
regions of a panel of Active genes (Oct4, Sox2), PRC-repressed genes (Math1, 
Msx1) and Inactive genes (Gata1, Myf5) in SILAC-labelled light (light colours) and 
heavy (dark) cells. Dark and light grey bars represent background enrichment levels 
as measured by ChIP in the absence of primary antibody (Mock). Enrichment is 
expressed relative to input DNA using total amount of DNA in qRT-PCR. Mean and 
standard deviation are representative of 3 independent biological replicates. 
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4.4.6. Determining the proteome of chromatin occupied by RNAPII-S5p 
using SILAC pChIP 
Having performed several quality controls on SILAC cells and chromatin and 
confirmed the occupancy of RNAPII modifications, I next performed RNAPII-
S5p SILAC pChIP. RNAPII-S5p pChIP was performed on both heavy and light 
chromatin, before mixing heavy and light ChIP eluates (1:1 by volume) and 
analysing the extracted proteins by MS. SILAC ratios between heavy and light 
chromatin were obtained. To normalise for differences in the efficiency of 
protein elution and allow effective comparison of protein enrichment relative to 
Rpb1, all SILAC ratios were normalised to the ratio of Rpb1, the subunit 
immunoprecipitated. For example, in an initial low-depth MS run, I first 
observed that pChIP ratio for RNAPII subunit Rpb1 was enriched in heavy 
pChIP relative to light pChIP. This was mainly due to a slightly larger starting 
volume in heavy pChIP (700 μg of chromatin – 750 μl) than in the light pChIP 
(700 μg of chromatin – 630 μl), but will also depend on sample complexity 
when contrasting pChIP samples using different antibodies. Even at this 
relatively low depth, we could identify 309 proteins robustly with SILAC pChIP 
ratios (1.0±0.2), i.e. detected in light and heavy peptides with similar 
efficiency, including robust identification of six RNAPII subunits, three 
Polycomb proteins and, interestingly, also components of the DNA replication 
machinery (Fig. 4.5).  
 
I asked next whether proteins identified in RNAPII-S5p SILAC pChIP were 
similar to proteins identified in non-SILAC pChIP experiments and what GO 
terms were enriched. The number of proteins common to both datasets was 
133, with a further 176 proteins specifically identified in RNAPII-S5p SILAC 
pChIP (Fig. 4.5), which could be explained by limited depth, as previously 
observed in the comparisons between SILAC and non-SILAC input chromatin 
(section 4.3.4). GO analyses of RNAPII-S5p pChIP identified common terms 
in the SILAC and non-SILAC datasets, such as RNA splicing and mRNA 
processing. The relatively small overlap in these preliminary tests suggests 
significant complexity of the proteome of chromatin bound by RNAPII and the 
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importance of running the MS analyses at higher depth. GO analyses and 
scanning the datasets for specific proteins, such as RNAPII subunits and 
other RNAPII-associated proteins such as splicing factors, suggest that 
SILAC pChIP can specifically enrich and robustly identify proteins associated 
with chromatin occupied by RNAPII complexes characterized by different 
post-translational modifications. 
 
 
Figure 4.5 MS analysis of RNAPII-S5p SILAC-pChIP. Heavy and light RNAPII-S5p 
pChIP eluates were mixed (equal volume) and analysed by MS. (A) Low-depth MS 
run identified over 300 proteins including RNAPII subunits and other interesting 
proteins. (B) Comparison between RNAPII-S5p SILAC and non-SILAC pChIP (as in 
Fig. 3.12) represented by a Venn diagram. (C) Enriched GO terms for proteins 
shared and specific between SILAC and non-SILAC pChIP. 
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4.4.7. Comparison between heavy RNAPII-S5p pChIP and light RNAPII-
S7p pChIP 
To begin comparing the proteome associated with different forms of RNAPII 
modifications, I next performed SILAC pChIP experiments using antibodies for 
RNAPII-S5p and -S7p. In this experiment, I performed RNAPII-S5p pChIP on 
heavy chromatin and RNAPII-S7p pChIP on light chromatin. Protein eluates 
were mixed (equal volume) and analysed by MS producing a dataset with 593 
proteins. After normalization of SILAC ratios (Heavy/Light) to Rpb1 ratio 
(immunoprecipitated with both antibodies), we classified proteins according to 
whether they were more abundantly detected in association with one of the 
RNAPII modifications (S5p or S7p) if their ratios were >1.2 (for S5p; 382 
proteins) or <0.8 (for S7p; 109 proteins). Proteins enriched for S5p included 
chromobox proteins (involved with silencing and heterochromatin formation), 
DNA replication, DNA methylation and a protein essential for mES cell 
pluripotency (Fig. 4.6B). Proteins enriched for S7p have functional roles in 
transcription initiation and elongation. Common proteins (0.8 < ratio < 1.2) 
were enriched for RNAPII subunits, histones and components of co-
transcriptional processing, the latter consistent with the fact that RNAPII-S5p 
and S7p are detected in coding regions. GO analyses (Fig. 4.6) show 
enrichment for gene expression and mRNA related terms in both RNAPII-S5p 
and S7p datasets and specific enrichment for promoter terms in S7p.  
 
These preliminary pChIP analyses highlight the power of pChIP to capture 
dynamics of protein recruitment to chromatin during transcriptional processes. 
A more thorough analysis, that would include pChIP for RNAPII-S2p (hallmark 
of transcription elongation), would be necessary to distinguish components of 
transcriptional elongation from transcriptional initiation to allow finer 
unravelling of the chromatin communities associated with RNAPII during the 
sequence of co-transcriptional processes that take place from initiation to 
termination. Together with the preliminary analyses shown here, that put in 
evidence the importance of MS depth, it was also clear that the inclusion of 
replicate pChIP eluates, in both Heavy and Light chromatin (forward and 
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reverse SILAC experiments), for each antibody, would aid in identifying 
protein enrichments more robustly and in classifying their dependency with 
RNAPII modification on S5p, S7p or S2p. 
 
Figure 4.6 MS analysis of SILAC pChIP for RNAPII-S5p (Heavy) and RNAPII-S7p 
(Light). RNAPII-S5p (heavy) pChIP was mixed with RNAPII-S7p (light) pChIP (by 
volume) and analysed by MS. (A) Proteins enriched for RNAPII-S5p (ratio > 1.2), 
enriched for RNAPII-S7p (ratio < 0.8) and common (0.8 < ratio < 1.2) are represented 
in a Venn diagram. (B) Examples of proteins found in the different categories. (C) 
Significant GO terms enriched after pChIP in either the specific or shared RNAPII 
modifications. 
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(Brinster and Harstad 1977; Gassmann et al. 1996; Follmar et al. 2006). I 
tested and optimised the conditions for SILAC labelling of our OS25-mES 
cells. Remarkably, SILAC composition of amino acids between different mES 
cells (and between other cell types) can vary extensively and have to be 
optimised in each case to avoid mild and severe effects.  
 
Broad comparisons of SILAC and unlabelled mES cells showed (a) similar 
levels of alkaline phosphatase (Fig. 4.1), a marker for pluripotency, (b) RNA 
and protein levels of master regulator genes (Fig. 4.1; Oct4, Sox2 and Nanog) 
and overall similar protein size profile (Fig. 4.1; Coomassie staining).  Indirect 
immunofluorescence detection of RNAPII-S5p and Nanog proteins extends 
our observation that SILAC labelling does not affect mES cell characteristics. 
However, we have not performed a global genome, transcriptome and whole 
cell proteome analysis that might help negate any effect of SILAC labelling.  
4.5.2. Advantages and pitfalls of MS analysis on complex samples.  
The most important pre-requisite for SILAC is the identification of peptides in 
both the heavy and light samples, which can be challenging when studying 
complex samples, in particular for the least abundant proteins. However, 
SILAC approach is more robust, sensitive and specific towards identifying 
proteins than of  methods, and drastically reduces the need for large number 
of replicates. In addition, protein identification with conventional  and SILAC 
MS is also affected by PTMs of proteins. PTMs affect the migration of 
peptides during chromatography and alter the charge state of the peptides 
during MS analyses, thereby making the acquired spectra incomparable to 
reference database. In addition, MS works sequentially therefore only a few 
peptides (of the total peptides pool) are analysed for tandem MS/MS. The 
combination of PTM’s and sequential peptide analysis adversely affects the 
individual peptides corresponding to a single protein, in particular for SILAC 
quantification wherein peptides have to be identified in both heavy and light 
fractions within finite MS run time. Peptide sequencing depth is also 
interlinked with MS run time and complete sequencing depth would require 
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large amounts of starting material and unreasonable MS run times. The 
SILAC ratio for a given protein is computed as a median of the individual 
peptide ratios calculated from the spectra of peptides identified in both heavy 
and light. Many peptides are detected only in heavy or light version, and these 
peptides have often quite variable ratios.  
 
Our MS analysis of chromatin from SILAC-labelled heavy and light cells is a 
low-depth MS run allowed us to robustly identify ~1900 proteins in both heavy 
and light chromatin and with consistent SILAC ratios. Our threshold for 
comparing heavy and light SILAC ratios was relatively stringent (0.8 < Ratio < 
1.2) and was performed without any correction for volume or protein 
concentration. The inconsistency of the additional 381 proteins identified in 
Fig. 4.3A is attributed to the above MS issues. Comparisons of proteins 
identified in SILAC and unlabelled chromatin (Fig. 4.3B; 851 versus 701 
proteins) are also in the range expected for comparisons of equivalent 
samples, and these differences are attributed to limited sequencing depth, 
different MS run times and/or partial detection in SILAC samples. 
4.5.3. Quantitative analysis of RNAPII-S5p and S7p proteome. 
We have shown that RNAPII-pChIP specifically and robustly identifies 
chromatin-bound proteome over input chromatin. From low depth MS analysis 
of RNAPII-S5p pChIP done on SILAC chromatin, we identified 300 proteins 
with our stringent threshold (0.8 < Ratio < 1.2) after normalization to Rpb1 
pChIP-SILAC ratio. Even in the preliminary low depth run, we could 
remarkably observe proteins involved similar functions including transcription 
machinery and Polycomb proteins. Comparison SILAC RNAPII-S5p pChIP 
with label-free RNAPII-S5p pChIP yields enrichment of similar GO processes 
and extends our observation. 
 
Our analysis of SILAC pChIP with S5p and S7p RNAPII modifications 
(S5p/S7p; Fig. 4.6) highlights our ability to dissect the chromatin bound 
proteome and unravel specific protein communities bound to chromatin 
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occupied by RNAPII complexes with different levels of S5 or S7 
phosphorylation. Contrasting S5p with S7p pChIP, we robustly identify 
transcriptional apparatus (RNAPII subunits and co-transcriptional machinery) 
shared between both the marks, consistent with our genome-wide distribution 
and DNA-ChIP results (Stock et al. 2007b; Brookes et al. 2012). In spite of a 
lower number of proteins identified in the S7p pChIP, the proteins identified 
have roles in the transition between transcription initiation and elongation at 
active genes, consistent with the current literature of S7p interplay with S5p 
and S2p. Remarkably, S5p-only proteins (i.e. proteins associating on 
chromatin not at actively transcribing genes) are enriched for various non-
transcriptional processes. We identify Polycomb proteins exclusively 
interacting with RNAPII-S5p, confirming but going beyond limited analyses of 
RNAPII-S5p and Polycomb co-association on chromatin at a small number of 
genomic regions (Stock et al. 2007b; Brookes et al. 2012). The identification 
of several additional processes associated with S5p, including replication, 
DNA methylation, pluripotency and cell cycle, further elucidate the importance 
of RNAPII roles on chromatin beyond transcription itself and the novelty of 
pChIP to identify these interactions in an unbiased manner. 
 
Using pChIP on just two modifications on the RNAPII-CTD, we have been 
able to capture and dissect the chromatin-bound proteome further unravelling 
the landscape associated at actively transcribing genes (proteins common to 
S5p and S7p and S7p-only proteins) and at other chromatin regions including 
PRC-repressed genes (S5p only). To further unravel the RNAPII landscape, 
we require additional hallmarks of transcription stages (S2p; transcriptional 
elongation) and a comprehensive experimental scheme with redundant pChIP 
runs to avoid the need for replicates and robustly dissect protein 
dependencies to RNAPII modifications. 
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5. Unravelling the interactome in mES cells using pChIP 
5.1. Research motivation  
To investigate the chromatin processes that co-associate distinctly with 
specific RNAPII modifications on chromatin, we developed a novel unbiased 
comprehensive strategy involving 16 different SILAC pChIP samples for four 
kinds of immunoprecipitation (S5p, S7p, S2p and mock) using light or heavy 
chromatin, which were combined in 12 ways.  
To characterise the protein dependencies to specific RNAPII modifications 
identified across SILAC pChIP datasets that compare pChIP experiments 
using the four different immunoprecipitations, I devised a data analysis 
strategy to robustly identify the proteome associated with chromatin-bound 
RNAPII. In particular, I was interested in investigating and robustly identifying 
the chromatin processes that co-associate with PRC-repressed RNAPII 
(S5p+S7p-S2p-) in mES cells, by comparing these proteins (and processes) 
with those associated with RNAPII complexes engaged in productive 
transcription (S5p+S7p+S2p+). I was also interested in identifying other novel 
processes associated with RNAPII marked by S5p and, in addition, identifying 
further components of the general transcription machinery and proteins 
specific to mES cells. Identification of novel chromatin states associated with 
RNAPII-S5p would shed light on RNAPII interplay in dynamic gene regulatory 
network in mES cells. 
 
All of the MS experiments were carried out in collaboration with Dr. Bram 
Snijders at Proteomics facility at MRC-CSC. Dr. Snijders also helped with 
sample pre-processing for MS, performed all MS run time operations and 
quantified MS spectra. Borislav Vangelov and Prof. Mauricio Barahona 
performed the regression analysis (Table 5.2). 
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5.2. Distinct RNAPII complexes at Polycomb-repressed genes. 
RNAPII is present both at actively transcribing genes and at PRC-repressed 
genes in mES cells. RNAPII transcription at active genes is coupled with 
expression with Rpb1 modification S5p+S7p+S2p+; this configuration of the 
polymerase leads to the production of stable and mature mRNA that is 
translated into protein in the cytoplasm. RNAPII transcription at PRC-
repressed genes is remarkably different with a distinct Rpb1 conformation 
(S5p+S7p-S2p-) that does not lead to mRNA production (Stock et al. 2007b).  
 
Single gene analyses at a panel of active and PRC-repressed genes highlight 
the distinct differences in chromatin architecture (Stock et al. 2007b). Active 
genes contain open chromatin mark H3K4me3, while PRC-repressed genes 
are marked by bivalent chromatin, i.e. Polycomb instigated repressive 
H3K27me3 and H2Aub1, but also active H3K4me3. The pattern of individual 
RNAPII modification at active and PRC-repressed genes is distinct, although 
with similar total RNAPII occupancy (Stock et al. 2007b; Brookes and Pombo 
2009b). 
 
Preforming genome-wide ChIP-Seq analysis and correlating with mRNA-See, 
our laboratory has demonstrated that PRC-repressed genes encompass 25% 
of mES cell genome with distinct RNAPII conformation (S5p+S7p-S2p-) and 
bivalent histone marks (H3K4me3+H3K27me3+H2Aub+). PRC-repressed 
genes encode for important developmental regulators, metabolic genes and 
several signalling pathways (Brookes et al. 2012). Many of the silenced 
developmental regulator genes (PRC-repressed) in mES cells are activated 
upon appropriate differentiation cues and during lineage commitment 
highlighting the role for RNAPII-Polycomb interplay to balance the need of 
mES cells stemness and differentiation.  
 
My motivation was to develop pChIP to identify the proteins that 
simultaneously bind to PRC-repressed chromatin along with RNAPII and 
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Polycomb proteins. In order to do that, we aimed to robustly contrast the 
proteins that are involved in active transcription (marked by S5p+S7p+S2p+) 
and differentiate from PRC-repressed chromatin (S5p+S7p-S2p-).  
5.3. Re-plotting ChIP-Sequencing profiles for most robust active, PRC-
repressed and inactive genes 
 
To get a concise picture of the gene expression program coordinated by 
RNAPII on chromatin, I first started by re-plotting ChIP-Sequencing profiles for 
most robust active, PRC-repressed and inactive genes generated from our lab 
for RNAPII modifications in mES cells (Brookes et al. 2012). From the 
published classification, I took a subset of genes (representing core active, 
PRC-repressed and inactive genes based on RNAPII modifications and 
Polycomb mediated histone modification - H2Aub) and re-plotted the 
distribution of RNAPII and histone modifications across average normalised 
gene start and end sites (-3kb to +3kb). Active genes have high occupancy of 
all RNAPII modifications (S5p, S7p and S2p) with no H2Aub, while PRC-
repressed genes have high S5p and H2Aub with no detectable S7p or S2p. 
Inactive genes serve as baseline for comparison (Fig. 5.1). Of the different 
chromatin states present in mES cells, we hypothesised that pChIP using 
RNAPII antibodies should capture the cohorts of interactors associated with 
chromatin during transcription at active genes and also distinguish proteins 
involved in non-transcriptional processes bound to poised forms of RNAPII 
(for example, Polycomb proteins).  
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Figure 5.1. Average occupancy of RNAPII modifications in mES cells as 
mapped by ChIP-Sequencing. ChIP-Seq data from (Brookes et al. 2012) was re-
plotted for subset of genes (Active, PRC-repressed and Inactive genes) to represent 
average occupancy of RNAPII modifications (S5p, S7p and S2p) and Polycomb-
mediated repressive histone mark (H2Aub) across gene start sites (-3kb to +3kb) and 
end sites (-3kb to +3kb). Profiles at Inactive genes serve as baseline comparison for 
enrichment. The y-axis scales at PRC-repressed and Inactive genes are 4-5 fold 
lower than at Active genes. 
5.4. Results 
5.4.1. Experimental strategy to quantitatively distinguish proteins 
associating with different RNAPII modification - Universe and Pairwise 
approach  
To unravel the chromatin-bound proteome associating with different RNAPII 
modifications, we first set up a comprehensive experimental scheme that 
would robustly and specifically identify proteins and measure their enrichment 
relative to specific RNAPII modifications. We used the knowledge acquired in 
the preliminary SILAC and non-SILAC MS runs (chapters 3 and 4) to define a 
comprehensive and robust pChIP-SILAC experimental scheme, which 
included comparisons of the proteome associated with different RNAPII 
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modifications, the use of replicate pChIP experiments in Heavy and Light 
chromatin and the MS analyses of replicate forward and reverse pChIP SILAC 
experiments. 
 
Briefly, cells were grown in SILAC conditions to make light and heavy 
chromatin. pChIP was performed in replicate using heavy and light chromatin 
and highly specific RNAPII antibodies to S5p, S7p and S2p modifications; 
mock IP was performed in parallel as a control. Two different complimentary 
approaches were devised to combine Heavy and Light pChIP samples, with 
different advantages in identifying proteins co-associating with chromatin 
occupied by RNAPII depending on its post-translational modifications.  
 
In the first approach, termed ‘Universe approach’, we quantified the 
enrichment of one pChIP (heavy or light) over a defined universe sample (light 
or heavy, respectively). The universe sample was prepared by mixing equal 
volume of the four pChIP samples: S5p, S7p, S2p and mock. In the forward 
universe experiment, we contrasted each one of the four heavy pChIP 
samples with the light universe. In the reverse universe experiment, we 
contrasted each light pChIP with heavy universe (Fig. 5.2).  
 
In the second approach, termed ‘Pairwise approach’, we performed direct 
comparison between different pChIP (as in section 4.3.7) using the same 
pChIP eluates as used for the universe approach, and also including both 
forward and reverse experiments. We contrasted ‘S5p with S7p’ and ‘S5p with 
S2p’ in forward and reverse experiment (Fig. 5.2). S7p was not contrasted 
with S2p due to the complexity of the experiment, and to the fact that we were 
most interested in identifying proteins associated with poised states of RNAPII 
characterized with the presence of S5p only; both S7p and S2p are present at 
productively transcribed genes. 
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Since proteins cannot be amplified like DNA using PRC-like devices, we had 
to make sure that eluted pChIP material was processed extra-carefully for MS 
and importantly sufficient (and similar) total volume of sample was used for 
universe and pairwise experiments. Our experimental design was 
characterized by several redundant comparisons, and replicates in forward 
and reverse combinations of Heavy and Light samples. Performing each 
pChIP twice for every RNAPII modification (S5p, S7p, S2p and mock) with 
light and heavy chromatin resulted in a total of 16 different pChIP samples for 
4 experimental schemes in 2 biological replicates (light and heavy). 
 
The universe approach contrasts each pChIP relative to an equal mixture of 
four pChIP, allowing direct and robust quantification of the enrichment of 
peptides in a sample relative to all other samples investigated. The resulting 
pChIP-SILAC ratios are most stringent and enrichment is representative of the 
stoichiometry of protein abundance on chromatin relative to the amount of 
Rpb1 subunit. Owing to the highest protein complexity of these samples 
containing all possible proteins co-immunoprecipitated with RNAPII-bound 
chromatin in 4 different pChIP, we anticipated overall lower protein 
identification than in the pairwise approach. In the pairwise approach, only two 
pChIP samples are compared resulting in more robust and abundant 
identification of peptides and therefore proteins. Pairwise provides direct 
information on the two pChIP samples compared, but not the third or non-
specific binders. 
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Figure 5.2. Comprehensive experimental setup to robustly, specifically dissect 
and unravel the RNAPII chromatin bound interactome. pChIP was performed on 
heavy and light chromatin using RNAPII antibodies (S5p, S7p and S2p) along with 
mock pChIP. Universe approach involved mixing each pChIP (light and heavy) into a 
universe sample which was contrasted with each single pChIP as described, in 
forward and reverse experiments. In the pairwise approach, S5p pChIP was 
contrasted separately with S7p pChIP and S2p pChIP, in forward and reverse 
experiments. Advantages and caveats in universe and pairwise approach are 
highlighted in the grey boxes. 
 
  
Forward experiment:!
Universe approach!
S5p !
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S2p !
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Light!
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Universe – Four different pChIP compared 
•  Direct comparison between 4 pChIPs 
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complexity 
!
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•  Lower sample complexity and higher 
depth of protein mapping 
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5.4.2. Preliminary MS analyses of universe and pairwise pChIP mixtures 
for volume normalization 
Before running all the universe and pairwise pChIP samples on the MS, we 
first analysed a small sample of the forward universe experiment by MS to 
determine the efficiency of Rpb1 detection and whether the Rpb1 ratios were 
approximately 1, or whether an adjustment of the volumes mixed from each of 
the 8 pChIP samples needed correction. Reassuringly, Rpb1 and Rpb2 were 
the proteins with the most identified peptides in all experiments highlighting 
the specificity of our chromatin immunoprecipitation. As previously observed 
in pChIP SILAC experiments (section 4.3.6), the ratios of Rpb1 were different 
across different experiments but consistent with Rpb2, suggesting they 
represent technical variability (different efficiencies of antibody precipitation, of 
elution or reverse crosslinking) and/or biological variability between heavy and 
light chromatin. Only the non-modified Rpb1 peptides identified by mass 
spectrometry are used for the quantification of Rpb1 proteins and its pChIP-
SILAC ratio. This helps in minimising the biases associated with Rpb1 
quantification (used to normalise each dataset) that potentially results from 
differences in CTD peptide detection due to complex post-translational 
modification associated with distinct chromatin states.  
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Figure 5.3. Preliminary MS analyses of the forward universe pChIP series to 
assess variability in pChIP-SILAC ratios. Small volumes (10 μl) of forward 
Universe pChIP samples were analysed in a shorter (low-depth) MS run to measure 
Rpb1 and Rpb2 SILAC ratio. Rpb1 and Rpb2 were robustly detected in all 
experiments with high peptide count. 
 
5.4.3. Summary of pChIP-SILAC experiment run 
The preliminary MS analyses of the forward universe pChIP samples showed 
Rpb1 and Rpb2 ratios different from 1, in particular for S2p(H)/Universe(L) 
(Fig. 5.3). In order to minimise the difference in pChIP-ratios, we next adjusted 
the volumes of individual pChIP and Universe to allow more robust ratios. 
Volumes were adjusted as follows:   
 
We next set up the full pChIP experiment for high-depth MS analyses as 
described in the experimental setup in Fig. 5.2. Heavy and light pChIP 
samples were mixed together, based on their ratios in preliminary MS 
analyses, to make a final volume of 30 μl. Each pChIP mixture of Heavy and 
Light ChIP samples (12 experiments) was subsequently loaded on a 10% 
SDS-PAGE gel and run until 1/3rd of the gel length. After Coomassie staining 
4 gel slices were cut per lane and pre-processed (de-staining, reduction and 
alkylation, trypsinisation, extraction of peptides and chromatographic 
S5p !
Light!
Universe !
S2p !
Light!
Universe !
S7p !
Light!
Universe !
Mock!
Light!
Universe !
! ! ! !1.1314 (142) ! ! ! !1.142 (103)!
! ! ! !0.4942 (133) ! ! ! !0.5810 (100)!
! ! ! !0.7815 (80) ! ! ! !0.84519 (57)!
! ! ! !0.0694 (38) ! ! ! !0.0783 (29)!
Experiment ! ! !Rpb1 ratio ! ! ! !Rpb2 ratio !
! ! ! !(# of peptides) ! ! !(# of peptides)
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separation). The resulting 48 samples were analysed by MS using parameters 
listed in Table 5.1 and resulted in the overall identification of 737 proteins 
(after filtering common MS contaminants). 
 
Table 5.1. Summary of experimental steps and parameters for MS analysis. 
Briefly 12 pChIP experiments were partially separated on a 10% SDS-PAGE gel and 
Coomassie stained, before gel fractions were cut, processed for MS analysis and 
analysed separately. Listed are parameters used for MS database search resulting in 
identification of 737 proteins. 
 
5.4.4. Steps involved in pChIP-SILAC data analysis. 
For analysing the pChIP-SILAC data from our comprehensive experiment, I 
followed the data analysis steps summarised in Fig. 5.4. Briefly, common MS 
contaminants (including trypsin, keratins, heavy and light chains of antibody, 
and reference peptides) and proteins enriched in mock pChIP were removed. 
We compared two different normalizations of the pChIP SILAC ratios to 
analyse the dataset: to Rpb1 SILAC ratio in each MS dataset and to the 
average between SILAC ratios of Rpb1 and Rpb2. The former would be 
consistent with the fact that all antibodies used are directly targeted to 
modifications of the Rpb1 subunit, whereas the latter could improve the 
overall performance of the analysis if it made the ratio used for normalisation 
more robust.  
 
1.  Twelve pChIP SILAC samples were loaded on 10% SDS-PAGE gels and run upto 1/3 of the length of the gel. "
2.  Gels were coomassie stained overnight and washed to visualise protein distribution. "
3.  48 gel slices (4 gel slices per experiment for 12 experiments) were cut and pre-processed for MS."
 "
Parameters for MS analysis"
"
MaxQuant version – 1.1.1.36"
Peptide and protein FDR < 0.01"
Min razor peptides – 1"
Min ratio count – 1"
Total MS/MS identified – 64660"
Total peaks - 25248636 "
"
Total number of proteins identified – 843 proteins"
"
Number of MS contaminants – 106 proteins"
"
Total number of proteins for data analysis – 737 proteins"
"
"
Chapter 5 Unravelling the RNAPII-associated interactome 
in mES cells using pChIP 
 
 125 
Firstly, I analysed the proteins identified in the universe and pairwise 
approach separately to identify dependencies to specific or common RNAPII 
modifications. Secondly, the proteins enriched in universe and pairwise 
approaches were combined together in basic classification table to further 
delineate dependencies to RNAPII modifications. Finally, in collaboration with 
Prof. Mauricio Barahona and Borislav Vangelov, we have applied a systems 
biology approach to integrate the whole table of normalised SILAC ratios to 
identify ‘chromatin communities’ that depend on each RNAPII modification 
studied here (Discussed in detail in Chapter 6). 
 
 
Figure 5.4. Steps involved in analysis of pChIP-SILAC data analysis to dissect 
dependencies to RNAPII modifications. Common MS contaminants and mock 
pChIP enriched proteins were filtered and pChIP ratios were normalized to Rpb1 
ratios in each SILAC MS dataset. In both universe and pairwise approaches, pChIP-
SILAC ratios are used to identify proteins that are enriched for a single RNAPII 
modification (i.e. S5p, S7p, S2p) or common (S5p&S7p, S5p&S2p, S7p&S2p, 
S5p&S7p&S2p). Finally, SILAC ratios from both approaches are combined to identify 
proteins dependencies relative to RNAPII modifications.  
Normalization of each pChIP MS dataset to the SILAC ratio of Rpb1 or average (Rpb1,Rpb2)!
(To facilitate cross comparison between different pChIP experiments)!
Second round of filtering contaminants!
(Proteins enriched in Mock pChIP)!
pChIP-SILAC ratios from MS analysis!
Clustering table - Combine universe and pairwise approach to Identify proteins enriched for RNAPII !
(Single RNAPII modification or common)!
Filter common MS contaminants (Keratin, trypsin, IgG etc)!
Universe approach! Pairwise approach!
Identify proteins enriched for RNAPII !
(Single RNAPII modification or common)!
Identify proteins enriched for RNAPII !
(Single RNAPII modification or common)!
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5.4.5. Filtering contaminants 
To filter the proteins enriched in mock pChIP experiments, we used a 
stringent criteria that identifies proteins enriched in both mock pChIP 
experiment (pChIP experiment contaminants). Histograms of pChIP-SILAC 
ratios measured in the mock pChIP datasets highlight that most proteins are 
specifically enriched for the ‘Universe’, whereas very few proteins are 
enriched in the mock pChIP, in both forward and reverse mock-Universe 
pChIP-SILAC experiments (Fig. 5.5). To remove mock-pChIP contaminants, a 
stringent ratio cut-off of 1.0±0.2 (forward ratio > 0.8 and reverse ratio < 1.2) 
identified 32 proteins that were removed from all datasets (including the 
pairwise comparisons). These results confirm the specificity of our ChIP 
protocol and RNAPII antibodies in immunoprecipitating chromatin bound by 
RNAPII (see also DNA-ChIP results, Figs. 3.6 and 4.4). Several proteins 
removed with this stringent threshold appeared irrelevant (such as 
desmoplakin and junction plakoglobin), but other proteins appeared 
interesting, which could have accidentally been identified in the mock pChIP 
with a larger SILAC ratio due to their respective lower number of peptides 
(peptide h/l count). The latter group included five interesting proteins: Mybbp1 
(essential for mES cell pluripotency; Universe/mock ratio = 0.002; peptide h/l 
count =1), Baf190 (chromatin remodeller; Mock/universe ratio = 1.946; 
peptide h/l count =1), Pcna (proliferating cell nuclear antigen; Mock/universe 
ratio = 6.6138; peptide h/l count =2) and RNA helicases (Dhx38 and Ddx1; 
Mock/universe ratio = 1.2172 and 6.605; peptide h/l count =1 for both). This 
filtering step was nevertheless kept to minimise biases in the pChIP dataset 
analyses. As with any MS analysis, lower abundancy proteins in particular 
with lower number of detectable peptides (e.g. if they are small) are more 
difficult to detect and therefore can be missed. 
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Figure 5.5. Identification of contaminant proteins enriched in mock pChIP 
relative to Universe. Stringent criteria were applied to identify proteins enriched in 
mock-pChIP based on SILAC ratios from Forward and Reverse mock-Universe 
experiments. Forward (< 0.8) and reverse (> 1.2) threshold ratios were applied to 
identify proteins enriched in the mock-pChIP datasets relative to the universe 
mixture, identifying 32 proteins which were filtered out from all MS datasets (universe 
and pairwise). 
5.4.6. RPB1 normalization 
Before starting to analyse the pChIP-SILAC dataset, we first explored the 
options to normalise the data given the comprehensive, complimentary 
experimental setup and for effective comparison of both universe and pairwise 
approach. 
 
It is important to note that we have used highly specific antibodies against 
Rpb1-CTD of RNAPII and a ChIP protocol carefully optimised to produce good 
chromatin yield with minimum background (Xie and Pombo 2006; Stock et al. 
2007b; Brookes et al. 2012). Given that all modifications occur on Rpb1-CTD 
and that our aim is to understand association of proteins relative to RNAPII, it 
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seemed most intuitive to normalise all SILAC ratios to the SILAC ratio of the 
Rpb1 subunit of RNAPII in each MS dataset. However, protein detection by 
MS depends on its amino-acid composition and length, as it depends on 
proteolysis of lysine peptide bonds and the size of the resulting peptides. To 
determine whether Rpb1 is robustly detected in our MS analyses, we 
measured the number of Rpb1 peptides used to calculate the Rpb1-SILAC 
ratio in each dataset (Fig. 5.6; all Rpb1 peptides were used including any 
detected unmodified CTD peptides). The lowest number of Rpb1 peptides (34 
peptides) was detected in “S7p/Universe” and this experiment had overall the 
lowest number of proteins identified (230 proteins in comparison with ~550 
proteins in all the other datasets). Looking at the distribution of Rpb1 peptides, 
most have SILAC ratios close to the log of median Rpb1 ratio, and few 
peptides were specifically enriched in either heavy or light, resulting in outlier 
ratios (Fig. 5.7). Some CTD peptides were distinctly enriched either in heavy 
or light samples (e.g. ‘YSPTSPTYSPTSPK’, ‘YSPTSPTYSPTSPVYTPTSPK’) 
indicating the possibility of post-translational modification on these peptides. 
Although analysis of protein modification is an obvious exciting further 
development of pChIP, we have not at this stage expanded our analyses of 
MS spectra to explore this issue; our superficial analyses indicate this will 
certainly be possible, but due to the proteome complexity observed in each 
pChIP dataset, may require more targeted MS analyses of specific proteins. 
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Figure 5.6. Robust detection of Rpb1 peptides across all MS SILAC datasets. 
Rpb1 (polr2a) subunit of RNAPII was robustly detected in all pChIP experiments 
(forward and reverse) with a large number of peptides detected in both heavy and 
light samples (represented by peptide count). All detected unmodified Rpb1 peptides 
were used for calculating pChIP ratios. The unmodified CTD peptides detected in 
each experiment are also listed. 
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Figure 5.7. Detailed analysis of pChIP SILAC ratios for Rpb1 and its peptides. 
Peptides corresponding to Rpb1 subunit were plotted in order (from N- to C-terminal) 
as barplots to observe the distribution of their H/L enrichment in specific pChIP H/L 
mixtures. Most peptides follow a similar distribution within each experiment with only 
a few outliers deviating from the log of the median of SILAC ratio used for the whole 
subunit. Grey line represented the MS reported pChIP ratio for Rpb1 (Also displayed 
as Ratio H/L). Numbers of identified peptides are shown in the title of each graph 
(pepcount) along with experiment name (as H/L). X-axis represents the different 
Rpb1 peptides detected in both heavy and light pChIP in order from N- to C-terminus, 
Y-axis represents peptide ratios in log scale. 
 
I next asked whether other Rpb subunits were also well detected after the 
pChIP experiments with antibodies against Rpb1 modifications, and how their 
SILAC ratios were distributed relative to Rpb1 ratio. In all SILAC MS datasets, 
4-8 RNAPII subunits were detected, and their ratios were relatively close to 
the Rpb1 ratio. For example, plotting the distribution of all protein ratios in a 
scatter plot for three of the Pairwise MS datasets (Fig. 5.8) shows that most of 
the detected RNAPII subunits have SILAC ratios close to Rpb1 (axis at 0,0). 
Rpb subunits with fewer peptides, such as Rpb7 (Polr2g) have SILAC ratios 
more distant from the Rpb1 ratio, as expected (not shown). 
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Figure 5.8. Position of pChIP SILAC enrichments from detected Rpb subunits 
relative to Rpb1. Scatter plot for proteins identified in pairwise approach. Rpb1 
subunit is located at (0,0) and marked by black triangle. Other Rpb subunits lie 
mostly adjacent to Rpb1. Number of proteins identified and their distribution is shown 
in axis labels and as box plots (next to axes) 
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5.4.7. Proteome of RNAPII-bound chromatin; universe approach 
To begin dissecting the protein dependencies to RNAPII modifications, I first 
started to analyse the universe dataset, based on whether proteins showed 
ratios H/L >1 in the light universe datasets or ratios H/L <1 in the heavy 
universe datasets. In these initial analyses of the pChIP datasets, proteins 
that consistently appeared enriched relative to the pChIP experiments of only 
a single RNAPII modification and not the other two modifications, across all 6 
Universe datasets, were considered ‘specific’ for association with chromatin 
enriched for RNAPII containing this modification. The numbers of proteins 
enriched for S5p, S7p and S2p, or shared between modifications are 
represented as a Venn plot in Fig. 5.9.  
 
As expected from the observation that all three studied Rpb1 modifications 
(S5p, S7p and S2p) are simultaneously present at RNAPII transcribing active 
genes (Brookes et al 2012), we observed that the majority of proteins are 
shared between S5p and S2p (155 proteins), or between S5p, S7p and S2p 
(24 proteins). We also find a large cohort of proteins enriched only in pChIP 
for S2p (197 proteins). Very few proteins are detected enriched in the S7p 
datasets relative to Universe (18 proteins), but interestingly this small group 
appears biologically relevant as it includes five transcription initiation factor 
subunits (TAFs) and the transcription pausing factor (Nelf-D, negative 
regulator of transcription elongation), all proteins with known roles in the 
transition between initiation and productive elongation of RNAPII, a role also 
recently associated with the S7p modification. Interestingly, I detected 183 
proteins enriched only relative to S5p in the S5p/Universe datasets and 197 
proteins in the S2p/Universe datasets. The former could consist of proteins 
specifically associated with RNAPII-S5p+S7p-S2p- at Polycomb repressed 
genes (Brookes et al. 2012), and the latter with proteins associated with 
elongating RNAPII, which although marked by S5p, may be more effectively 
immunoprecipitated with the S2p antibody.  
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To explore the lists of proteins in each group, I performed GO analyses (Fig. 
5.9). Proteins common to all modifications (i.e. co-associated with RNAPII-
bound chromatin independently of S5p, S7p or S2p) were enriched for 
histones (GO term: ‘nucleosomal assembly’), proteins in the S7p&S2p, 
S5p&S2p and S2p groups were characterized by GO terms related with active 
transcription and co-transcriptional RNA processing such as ‘mRNA 
processing’, ‘RNA processing’, ‘RNA transport’, ‘transcription’ and ‘H2B 
monoubiquitination’, consistent with the fact that S2p is a mark of 
transcriptional elongation. Ribosomal proteins were also identified in this 
group (GO term ‘translation’, consistent with reports for nuclear translation 
(Iborra et al. 2004; David et al. 2012), and biochemical purification of 
ribosomes with RNAPII (Das et al. 2007; Moller et al. 2012). Remarkably, 
proteins in the S5p-only group were enriched for a more diverse range of 
processes. Most significant terms included ‘Negative regulation of 
transcription’, ‘DNA replication’ and ‘chromatin remodelling’ (Fig. 5.9). 
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Figure 5.9. Classification of the chromatin-bound proteome that co-exists with 
different RNAPII modifications from the universe approach datasets. Left, Venn 
diagram representing proteins with SILAC ratios consistently enriched for a specific 
RNAPII modification, or shared between modifications. Right, significant GO terms 
(p-value <10-6) for each group of proteins enriched in different category; no GO terms 
were enriched in S7p-only due to the low number of proteins in this group. 
5.4.8. Proteome of RNAPII-bound chromatin; pairwise approach 
I applied similar data analysis steps to ask which proteins were enriched only 
for S5p, S7p, S2p and those shared between RNAPII modifications in the 4 
pairwise approach MS datasets (S5p.S7p and S5p.S2p in forward and in 
reverse h/l combination). In the S5p/S7p datasets (Fig. 5.10), most proteins 
are enriched for S5p (415 proteins), and very few for S7p only (28 proteins); 
57 proteins had SILAC ratios, between 0.8 and 1.2, therefore not consistently 
enriched relative to a single modification and were therefore considered as 
common to the two modifications. The total number of S7p proteins (common 
and S7p only) was 85 and it was very similar to the number of S7p proteins 
identified from universe approach (92 proteins; Fig. 5.9). This raises an 
important question whether the low numbers of proteins detected after S7p 
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immunoprecipitation are due to technical or biological constraints. The former 
could be due to lower efficiency of the immunoprecipitation with the S7p 
antibody, whereas the latter could result from S7p existing in a very short 
window of the transcription cycle, and co-associating with a smaller number of 
proteins. The latter would be consistent with the perceived role of S7p in the 
transition between initiation and productive elongation (Czudnochowski et al. 
2012). 
 
As observed previously for the universe approach, GO analysis showed that 
common proteins were enriched for translation and mRNA processing terms, 
whereas S5p only proteins were involved in mRNA processing, RNA splicing, 
RNA export and DNA replication (Fig. 5.9). The detection of GO terms related 
to productive elongation, is likely due to the fact that elongating RNAPII is 
marked by S5p, and in this pairwise comparison of S5p with S7p, we do not 
distinguish proteins more highly associated with S5p-only or S2p-only. In 
relation to S7p-only proteins, due to the low number of proteins detected (28), 
GO analysis did not yield specific terms, but interestingly this small group of 
proteins again included Transcription initiation factor subunits (TAFs), 
Transcription pausing factor (Nelf-D) and CDK-activating kinase assembly 
factor (Mnat1; essential for RNAPII promoter escape and elongation), proteins 
known to act at the transition between RNAPII initiation and elongation, some 
of which are also detected as S7p specific in the universe pChIP approach. 
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Figure 5.10. Identifying proteins dependencies to RNAPII-S5p and/or RNAPII-
S7p from pairwise experiments. Proteins were classified either enriched for S5p, 
S7p or common based on pChIP-SILAC ratios and represented as a Venn diagram. 
Significant GO terms (p-value <10-5) for proteins enriched in S5p-only and common 
S5p.S7p. No significant terms were observed for proteins enriched in S7p-only. 
 
Performing analysis on S5p/S2p pairwise approach datasets identified almost 
30% more proteins than in the S5p/S7p datasets (686 compared to 500 
proteins). We identify 249 proteins not specifically enriched in S5p or S2p (i.e., 
shared between the two marks), 287 proteins enriched for S2p and 150 for 
S5p. As with the S5p.S7p pairwise experiment, this analysis is blind to how 
specific proteins associate with the S7p mark. 
 
GO analysis (Fig. 5.11) showed that the group of proteins enriched for S2p or 
common to S2p and S5p is characterised by terms related with productive 
mRNA transcription, i.e. ‘mRNA processing’, ‘RNA splicing’ and ‘translation’, 
as seen previously, while the group of proteins enriched for S5p-only also 
resulted in more diverse GO terms, such as ‘DNA replication’, ‘chromatin 
modifications’, and ‘chromatin remodelling’.  
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Figure 5.11. Identifying proteins dependencies to RNAPII-S5p and/or RNAPII-
S2p from pairwise experiment. Top, Proteins were classified either as enriched for 
S5p, S2p or shared, based on pChIP-SILAC ratios, and represented as a Venn 
diagram. Bottom, Significant GO terms (p-value <10-5) for proteins enriched in S5p-
only, S2p-only and common.  
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S7p, 61 proteins specifically associating with S2p and 185 proteins 
specifically associating with S5p.  
 
Looking at significant GO terms, we observe that all groups of proteins related 
with S2p, either alone or with the other marks (S5p&S7p&S2p, S5p&S2p and 
S2p) are characterized with ‘mRNA processing’, ‘RNA splicing’, ‘nucleosome 
assembly’ and ‘RNA transport’, processes downstream of transcription 
initiation as expected for the S2p mark. Interestingly, ‘translation’ and 
‘ribosome biogenesis’ are two terms that are consistently enriched with 
S5p&S2p shared proteins, and may be related with observations of 
transcription-dependent translation in association with RNAPII transcription 
sites (Iborra et al. 2001). 
 
As hinted in the previous separate analyses of universe and pairwise 
approaches, the group of S5p-only proteins have GO terms markedly different 
from those seen in association with S2p, and productive RNAPII elongation. 
The most significant term is ‘negative regulation of gene expression’, which 
includes Polycomb proteins, previously shown to co-occupy chromatin bound 
by RNAPII-S5p+S2p-, by sequential DNA-ChIP experiments for a small 
number of genomic regions (Brookes et al. 2012). In the S5p-only group of 
proteins, we also consistently enrich for ‘chromatin remodellers’, and perhaps 
more unexpectedly for ‘DNA replication’ and ‘metabolic terms’. 
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Figure 5.12. Combining universe and pairwise approaches to dissect proteins 
dependencies to RNAPII modifications. Proteins identified and enriched from 
universe and pairwise approach were combined together in a simple classification 
table. Protein enriched only in S5p from both universe and pairwise approach 
datasets was classified as S5p only and similarly for S7p, S2p and common proteins. 
Venn diagram represents classification of proteins with respect to RNAPII 
modifications and significant GO terms for the enriched proteins.  
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5.4.10. Examples of proteins associating with RNAPII as identified 
by pChIP. 
We next analysed in more detail some of the important GO terms and the 
distribution of SILAC ratios for specific proteins across our comprehensive 
pChIP-SILAC experiment. We first looked at distribution of exemplars of 
proteins that were detected in our experiment, interact with RNAPII and were 
also identified in all the ten separate SILAC MS datasets. We also discuss 
proteins with varying pChIP ratios across pChIP experiments that are not 
enriched for any RNAPII modification. 
5.4.11. Chromatin remodellers 
During the process of transcription, RNAPII is recruited to promoters of active 
genes having open chromatin architecture characterised by tri-methylation of 
lysine residue at position 4 of histone H3 (H3K4me3). H3K4me3 is also 
present at PRC-repressed genes along with repressive H3K27me3 and 
H2Aub1 catalysed by Polycomb proteins.  
 
In our pChIP datasets, we observe selected chromatin remodellers selectively 
associating with RNAPII-S5p. These subunits are part of multi-protein 
complexes that include NuRD, Swi/Snf (BAF and PBAF) and CHRAC 
chromatin-remodelling complex. Plotting the distribution of pChIP-SILAC 
ratios demonstrates consistent enrichment of S5p from universe and pairwise 
experiments while no enrichment for S7p or S2p (Fig. 5.13). Other chromatin 
remodellers that associate with RNAPII-S5p include Rbbp4/7, Mta2, Arid1a 
and Baz1b.  
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Figure 5.13. Chromatin remodellers also specifically co-exist on chromatin 
with RNAPII-S5p. Barplot for some chromatin remodellers (Baf155, Smarca5 and 
Chd4) that specifically co-exist with RNAPII-S5p. Proteins with positive log ratios are 
enriched heavy pChIP while proteins with negative log ratios are enriched for light 
pChIP. pChIP-SILAC ratios are plotted in log scale and number of peptides are 
represented next to ratios on barplot. 
 
5.4.12. Polycomb proteins 
Our lab has previously identified RNAPII-S5p+S7p-S2p- selectively co-existing 
with Polycomb proteins on chromatin after sequential-ChIP across ~20 
genomic regions analysed by qPCR (Stock et al. 2007b; Brookes et al. 2012). 
Across our pChIP datasets, Polycomb proteins are not as abundantly 
detected as the MCM proteins discussed above, but when detected they 
selectively associate with RNAPII-S5p only, and not S2p or S7p. These 
proteins are in general detected with lower peptide count, probably due to 
their smaller size or potentially due to incomplete separation in 
chromatography or MS charge detection on proteins. We identify 4 Polycomb 
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proteins (Ring1b, Eed, Suz12 and Jarid2; with peptide h/l count of 3, 17, 5 and 
10, respectively) in our datasets and, even at low peptide detection, we see 
clear association only with RNAPII-S5p and not with S7p or S2p.  
 
 
Figure 5.14. Polycomb proteins associate on chromatin with RNAPII-S5p. 
Barplot for Polycomb proteins (Ring1b and Eed) and their pChIP-SILAC ratios 
highlight specific association on chromatin with RNAPII-S5p, albeit at low peptide 
count. Other core Polycomb proteins (Jarid2 and Suz12) were also identified as 
RNAPII-S5p only; note consistent enrichment detected in pair-wise experiments 
characterized by higher ability to produce measurable H/L ratios for less abundant 
proteins associated with a specific modification. H/L SILAC ratios were inverted in the 
reverse (to be similar to forward) experiments and represented as indicated. pChIP-
SILAC ratios are plotted in log scale and number of peptides are represented next to 
ratios on barplot. 
 
5.4.13. DNA replication 
Stem cells proliferate rapidly and actively replicate to produce cells that are 
pluripotent and undifferentiated. Understanding replication in stem cells has 
been a major focus in the field and several papers have put forward ideas 
linking transcription and replication in mammalian cells (Jackson and Pombo 
1998; Hiratani et al. 2008). We identify all components of the Mcm2-7 
complex selectively associating on chromatin along with S5p. Looking at the 
distribution of pChIP-SILAC ratios across different experiments, we observed 
that Mcm proteins were enriched for S5p in universe and pairwise 
experiments while being depleted for S7p and S2p consistently in pairwise 
and universe approaches (Fig. 5.15).  
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RNAPII-S5p (without S7p and S2p) is found at approximately 25% of the 
RefSeq gene promoters, and many of their coding regions, in mES cells 
(Brookes et al. 2012). For most of their short cell cycle, with average doubling 
time ~12 hours, ES cells are in S phase, having a very short G1 phase (Udy 
et al. 1997; Azuara et al. 2006). Given this, the simultaneous association of 
RNAPII-S5p and replication proteins on chromatin raises an interesting 
prospect of what comes first and how it influences mES cell architecture and 
dynamic cellular organisation.  
 
Figure 5.15. MCM2-7 complex is robustly identified across pChIP datasets and 
is enriched specifically on chromatin containing RNAPII-S5p. Barplot for three 
MCM proteins and their pChIP-SILAC ratios highlight specific association on 
chromatin with RNAPII-S5p. H/L SILAC ratios were inverted in the reverse (to be 
similar to forward) experiments and represented as indicated. pChIP-SILAC ratios 
are plotted in log scale and number of peptides are represented next to ratios on 
barplot. 
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5.4.14. Ribosomal proteins 
Ribosomal proteins are very abundant and are often considered contaminants 
and filtered during MS analysis of immunoprecipitates (e.g. (Das et al. 2007). 
In our cohort of pChIP datasets obtained after in vivo crosslinking of 
chromatin, we consistently detect ribosomal proteins, found more significantly 
associated with chromatin co-occupied with RNAPII-S5p and S2p. RNAPII-
S5p and -S2p are hallmarks of active transcription (initiation and elongation), 
with S5p being present at both promoters and coding regions of active genes, 
whereas S2p is abundant through coding regions. Ribosomes (and 
translation) have previously been described in association with active 
transcription sites in mammalian cells (Iborra et al. 2001), and in the 
interbands of Drosophila polytene chromosomes known to contain active 
genes (Brogna et al. 2002). The specific enrichment of ribosomal and 
translation GO terms with S5p and S2p suggests that we are capturing similar 
phenomenon of nuclear transcription-coupled-translation in mES cells. The 
concept of nuclear translation has been challenged and debated (Dahlberg et 
al. 2003), but reinforced in a recent study (David et al. 2012). 
5.4.15. S2p-associated proteins 
In our SILAC MS dataset, we also observe some proteins specifically enriched 
for S2p only. Interestingly, all these proteins are involved in splicing, mRNA 
processing and RNA processes and astonishingly these proteins have no 
peptides detected in the S5p/S7p pairwise experiment (both forward and 
reverse), thereby reinforcing evidence for a specific association with S2p.  
 
Prpf4 and Prpf38b are pre-mRNA splicing factors, central components of 
spliceosome (Uniprot 2012). Prpf4 is part of U5 snRNP complex and also 
interacts with splicing dependent exon-junction complexes (EJC). Prpf4 and 
Prpf38b have identical patterns of pChIP ratios and were enriched for S2p in 
both the universe dataset (no enrichment for S5p or S7p universe datasets) 
and enriched for S2p in pairwise dataset (S5p.S2p).  
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Cpsf3 is a component of cleavage and polyadenylation specificity factor 
(CPSF) complex recruited at the 3’UTRs of pre-mRNA and fundamental to 
3’end formation. Cpsf3 was enriched for S2p in universe dataset 
(S2p.Universe and no enrichment for S5p or S7p) as well in pairwise dataset 
(S5p.S2p). Cbp80 is a component of the cap-binding complex (CBC), which 
co-transcriptionally binds to pre-mRNAs (5’ cap; (Izaurralde et al. 1994). It is 
involved in various processes such as pre-mRNA splicing, translation 
regulation, nonsense-mediated mRNA decay, RNA-mediated gene silencing 
(RNAi) by microRNAs (miRNAs) and mRNA export. Consistent with other S2p 
proteins, pattern for Cbp80 was similar and enriched for S2p in universe and 
pairwise dataset. 
 
Figure 5.16. Examples of proteins associated with RNAPII-S2p on chromatin.  
Barplot for S2p associating proteins and their pChIP-SILAC ratios across 10 pChIP 
MS datasets (clockwise from left top; Prpf38b, Cbp80, Cpsf3 and Prpf4). Proteins 
with positive log ratios are enriched heavy pChIP while proteins with negative log 
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ratios are enriched for light pChIP. pChIP-SILAC ratios are plotted in log scale and 
number of peptides are represented next to ratios on barplot. 
5.4.16. Proteins without any specific enrichment for RNAPII 
modifications 
In our pChIP MS dataset, we also observed some proteins that had no 
specific enrichment for RNAPII modifications. These included Paf1 complex 
among other proteins. Paf1 complex includes Paf1, Cdc73, Leo1, Ctr9, Rtf1 
and Wdr61 proteins and has multiple functions during RNAPII transcription 
and is also fundamental to mES cell pluripotency (Ding et al. 2009; Uniprot 
2012). The Paf1 complex interacts with both un-phosphorylated RNAPII-CTD 
and S5p/S2p RNAPII and is involved in transcriptional elongation, histone 
H2B, mRNA 3' end formation and polyadenylation (Ding et al. 2009). We 
observed Paf1 complex subunits having varying pChIP-SILAC ratios within 
the forward and reverse experiments and in addition without much enrichment 
across 10 MS datasets (Fig. 5.17; Log10 ratios within ± 0.2). As expected, 
RNAPII subunits also exhibit similar behaviour i.e. no enrichment for specific 
RNAPII modifications and in addition are not particularly enriched across 10 
MS datasets. 
 
The Paf1 complex (and other proteins with similar behaviour) has a pattern of 
pChIP-SILAC ratios across 10 MS experiments that is closely similar to the 
ratios of the RNAPII subunits, being therefore more closely affected by Rpb1 
normalization (see also Fig. 5.8). Depending on our normalization, these 
proteins accordingly affected and therefore exhibit a variation in pChIP-SILAC 
ratios that accompanies the RNAPII subunits. Cases such as this one justify 
our subsequent use of a systems biology approach in which proteins are 
clustered based on their SILAC enrichments and not simply on the direction of 
enrichment, a procedure that by definition can more successfully measure 
coincidences in protein association and stoichiometry
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Figure 5.17. Examples of proteins with varying pChIP-SILAC ratios across 10 
SILAC MS dataset.  Barplot with pChIP-SILAC ratios across all 10 datasets for 
proteins  (Paf1 complex and RNAPII subunits) that lacking any specific enrichment 
for RNAPII modifications. Proteins with positive log ratios are enriched heavy pChIP 
while proteins with negative log ratios are enriched for light pChIP. Ddx5 and Hnrnpk 
are involved in pre-mRNA splicing; Histone H3.2 is histone variant and Paf1 protein 
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is involved in transcriptional elongation and important for stem cell pluripotency. 
pChIP-SILAC ratios are plotted in log scale and number of peptides are represented 
next to ratios on barplot. 
 
5.1.1. Comparison between different normalizations 
 
As briefly mentioned in section 5.3.5.2, we also explored other normalization 
strategy to analyse our pChIP SILAC data to identify dependencies to RNAPII 
modifications. Rpb1 and Rpb2 were the most robustly detected subunits of 
RNAPII in all pChIP-MS runs and with highest peptide count, as expected 
from their larger size. Additionally, as each residue of the Rpb1-CTD is a site 
of dynamic PTM, we therefore explored if normalization with average of Rpb1 
and Rpb2 pChIP-SILAC ratio was more robust than with Rpb1 ratio alone. 
The regression analysis was performed by Borislav Vangelov and Prof. 
Mauricio Barahona. All proteins and their pChIP-SILAC ratios were plotted on 
regression plots and the average distance of Rpb1, Rpb2, average (Rpb1, 
Rpb2) and all subunits was measured to the regression line using two 
different measures including Total Least Squares (TLS) and Random Sample 
Consensus (RANSAC) as highlighted in Table 5.2.  
 
Table 5.2. Regression analysis and distances of Rpb1 and Rpb2 ratios. Distance of 
Rpb1, Rpb2 and Average (Rpb1, Rpb2) was calculated from the regression line. Two 
methods were used including Total Least Square (TLS) and Random Sample consensus 
(RANSAC). Analyses performed by Borislav Vangelov and Prof. Mauricio Barahona. 
        
We observed the lowest RANSAC distance compared to all subunits average 
(Rpb1, Rpb2) ratio. Subsequently, I also measured the effect of normalising 
with Average (Rpb1, Rpb2) instead of Rpb1 only, by repeating the data 
classification steps according to Fig. 5.4 and compared the results (Fig. 5.18). 
Reassuringly, similar distribution of proteins associating with specific or all 
Normalisation
Preprocessing
Protein Grouping
Results
Method RPB1 RPB2 RPB1 + RPB2 all subunits
TLS 0.35 0.25 0.29 0.36
RANSAC 0.26 0.19 0.18 0.26
Borislav Vangelov Analysis
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RNAPII marks was observed, with major shifts being observed for proteins 
moving between S5p&S7p&s2p (all modifications) to S5p&S2p (common). We 
observed 73 proteins associating with all RNAPII modifications (92 in Rpb1 
normalization) while 327 proteins were associating with S5p&S2p (297 in 
Rpb1 normalization). Remaining protein groups were relatively unchanged. 
 
S5p proteins were remarkably consistent between both normalizations (178 
common out or 185 in Rpb1 and of 188 in average normalisations). 
Performing GO analysis, we observed almost all similar terms in all proteins 
groups, however with slightly different p-values and percentage of proteins in 
each GO category (Fig. 5.18). 
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Figure 5.18. Different normalisation of pChIP ratios have minor effects in 
protein dependencies with S5p, S7p and S2p modifications. Normalization was 
done with Rpb1 ratio as before and with average (Rpb1, Rpb2) and proteins 
dependencies are highlighted in Venn diagram. Table representing number of 
proteins in both normalizations with majority of proteins common between different 
normalizations. Significant GO terms for both normalizations are very similar.  
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5.4.17. Summary of the simple binary classification analysis 
To summarise the protein dependencies captured by our comprehensive and 
redundant experimental setup using pChIP-SILAC ratios, we schematically 
represented proteins and their associations to different RNAPII modifications 
(Fig. 5.19). Briefly, we separated active genes from genes containing only 
RNAPII-S5p (as described at Polycomb targets; (Brookes et al. 2012)) and 
highlighted proteins based on association with specific RNAPII modifications. 
 
Figure 5.19. Summary of proteins and their association with different RNAPII 
modifications. Schematic representation of proteins and their association to RNAPII 
modifications during active transcription (left) and proteins with non-transcriptional 
biological functions. 
 
5.5. Discussion 
Genome-wide ChIP-Seq analysis from our lab has demonstrated the RNAPII-
Polycomb in mES cells chromatin and have identified genes with distinct 
RNAPII conformation (S5p+S7p-S2p-) encoding important developmental 
regulators, metabolic genes and several signalling pathways in a distinctly 
different conformation to active genes (S5p+S7p+S2p+) (Brookes et al. 2012). 
Before performing pChIP, we obtained the most conservative estimate of 
distinct RNAPII states by re-plotting the ChIP-Seq profiles at actively 
transcribing genes (30% of Refseq genes) and PRC-repressed genes (10% of 
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Refseq genes). Given this information, I hypothesised that pChIP proteins 
observed on chromatin co-associating with all RNAPII modifications 
(S5p&S7p&S2p) would be representative of at least 30% genes (actively 
transcribing) of Refseq genome. In addition, we should be able to detect 
Polycomb proteins specifically co-existing with S5p only (without S7p and 
S2p). Moreover, we aimed to identify if other S5p only protein cohorts existed 
and their biological function. 
5.5.1. Proteome-ChIP identifies large cohorts of RNAPII-bound proteins 
on chromatin 
Our comprehensive pChIP experiment containing inherent replicates has 
identified >700 proteins associating on chromatin along with RNAPII 
modifications. We have identified the largest cohort of RNAPII associating 
proteins and include several known interactors and many novel interactions 
(Das et al. 2007; Jeronimo et al. 2007; Moller et al. 2012). Remarkably, our 
dataset also identifies several novel and uncharacterised proteins that further 
extend the repertoire and knowledge of RNAPII interactome. Our unbiased 
pChIP approach sheds light on the dynamics of interactions and further 
elucidates the complex RNAPII regulation on chromatin and such a 
systematic process has not been performed before. Our aim of elucidating the 
RNAPII proteome is technically quite challenging as we apply pChIP to 
identify and unravel chromatin proteins associated with three distinct post-
translational modifications on a single protein (Rpb1) and next to each other 
on the Rpb1-CTD region that consists of multi-heptad repeats (instead of 2 
different proteins). This task has been aided by our knowledge and use of 
highly specific RNAPII antibodies and their genome-wide ChIP-Seq profiles.  
5.5.2. Universe approach and Pairwise approach 
The universe and pairwise approaches are complementary to dissect the 
proteome associated on chromatin bound by RNAPII differently modified. 
Standalone, both universe and pairwise approach have their advantages and 
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caveats. While universe approach can unravel dependencies across three 
RNAPII modifications in a single experiment and MS run, it suffers from higher 
sample complexity leading to lower identification and coverage of proteins 
(also limited by MS depth and run-time issues). The pairwise approach on the 
other hand has lower complexity with better protein identification, but however 
it cannot identify dependencies for more than two modifications. We have 
demonstrated that most proteins identified in universe and pairwise 
experiments are complimentary to each other in identifying of proteins and 
their dependencies relative to RNAPII modifications. 
 
To compare the chromatin-bound proteome between two different proteins, 
one could either apply just the universe approach or the pairwise approaches 
to reduce overall cost of experiment, but still obtain basic and simple 
information on candidates. However, combining the complimentary strategies 
adds additional layers of information towards selecting candidate interactors 
for biological validation. In summary, we have robustly demonstrated that 
pChIP using complimentary approaches robustly and succinctly identifies 
chromatin-bound protein cohorts. 
5.5.3. Proteins co-existing with S5p only. 
Our unbiased simple binary classification robustly identifies several protein 
cohorts that specifically associate with only S5p (no S7p or no S2p). 
Remarkably, very little has been reported so far about these interactions with 
RNAPII-S5p in the literature. Our laboratory has previously reported the 
RNAPII-S5p and Polycomb interplay and confirmed their co-association on 
chromatin by sequential-ChIP for a small number of genomic regions 
(Brookes et al. 2012). The identification of specific chromatin remodellers with 
S5p raises an intriguing possibility about whether additional genes (along with 
PRC-repressed genes) are kept in this unusual state and what factors co-
associate at these regions. Further questions can also be asked about the 
role of RNAPII and chromatin remodellers in maintaining chromatin 
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architecture and genome plasticity in mES cells. Identification of DNA 
replication proteins with S5p-only is not only fascinating, but it also raises a 
range of possibilities especially in mES cells. Comparing the distribution of 
replication origins (Ori) in mES cells, it is striking to observe that profile of S5p 
completely mirror distribution of Ori observed across average gene promoters 
. (Cayrou et al. 2012). In addition, genome-wide distribution of replication 
timing in mES cells also provides further cues to a link with RNAPII (Hiratani 
et al. 2008). Our observation that all Mcm2-7 complex subunits were 
consistently enriched for S5p and depleted for S7p and S2p in both universe 
and pairwise experiments (Fig. 5.15), adds an interesting layer to the long-
standing relationship between replication and transcription. Over several 
decades now, a relationship had been observed between early origins of 
replication in mammals and gene activity (Hassan et al. 1994; de Jong et al. 
1996; Gilbert 2002; Hiratani et al. 2009). However this relationship seems to 
be distinct in ES cells, where many silent development regulator genes, 
repressed by Polycomb proteins, were found to be early replicating(Azuara et 
al. 2006). The discovery that Polycomb target genes are associated with 
RNAPII-S5p and the striking and robust detection of replication proteins in our 
pChIP experiments specifically associated with RNAPII-S5p sheds new light 
into a relationship between replication and RNAPII-S5p and not necessarily 
with productive transcription; in the pChIP experiments, active (S7p+S2p+) 
RNAPII complexes are clearly not correlated with co-association with 
replication proteins. 
5.5.4. Proteins co-existing with combinations of RNAPII modifications. 
We have demonstrated that our pChIP results robustly identify known and 
novel components of the transcription machinery. From our analysis, >400 
proteins are associated with different combinations of RNAPII modifications. 
The majority of these proteins belong to S5p&S7p&S2p and S5p&S2p and are 
involved in various transcriptional and co-transcriptional processes. We 
identify many major components of the spliceosome, splicing factors and RNA 
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processing machinery. In addition, quite a few metabolic proteins are 
associated with specific combinations of modification (S5p and S2p), 
suggesting additional roles for these proteins and importantly the balance 
between mES cell metabolism, energy demands and transcription control 
(Brinster and Harstad 1977; Chen et al. 2012). We also identify proteins with 
GO terms related with protein synthesis, including ribosome biogenesis and 
translation. This result is consistent with the concept of nuclear transcription-
coupled-translation, a topic which has been debated in past, but more recently 
further reinforced (Iborra et al. 2001; Dahlberg et al. 2003; Iborra et al. 2004; 
David et al. 2012).  
 
The identification of S2p only proteins from the pChIP dataset also raises 
interesting insights in our ability to capture simultaneous modifications on the 
Rpb1-CTD. S5p and S2p are found to co-exist through the coding regions of 
active genes (genome-wide ChIP-Seq), and as measured for some genes at 
the same chromatin regions simultaneously (by sequential-ChIP;(Brookes et 
al. 2012). These results raise the possibility that some genomic regions, or 
particular transcriptional states are either associated with RNAPII-S5p-S2p+, 
or may be associated with RNAPII-S5p+S2p+ on RNAPII complexes where the 
S5p antibody (4H8; Table 2.1) does not bind. Interestingly, ELISA results from 
the laboratories of Dirk Eick and Hiroshi Kimura (referred as ‘not shown’ in 
(Brookes et al. 2012), show that S5p in the Rpb1-CTD heptad (C Y1-S2-P3-T4-
S5-P6-S7 N terminal) can successfully detect C-S5p-S2p-N peptides (with 3 
unmodified amino acid residues in between), but not C-S2p-S5p-N residues 
with 2 residues in between; in the case of the H5 antibody, used to 
immunoprecipitate S2p, it is not affected by the double modification C-
S2pS5p-N. It is interesting to speculate whether the S2p-only proteins may 
correspond to heavily phosphorylated CTD repeats, where the 4H8 antibody 
fails to access. To this date, of all S5p antibodies tested by ELISA, 4H8 is the 
one least affected by other modifications, so it is still the option of choice, but 
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future experiments with novel S5p antibodies designed to capture more 
complex phosphorylation patterns would shed further light on this topic. 
5.5.5. Rpb subunits and normalization.  
Our pChIP experiments consistently and robustly detect both Rpb1 and Rpb2 
across all 10 MS dataset. We have demonstrated that normalization to Rpb1 
or Rpb2 or average (Rpb1, Rpb2) does not affect the overall dependencies of 
protein to RNAPII modifications. However, there is a minor re-arrangement of 
proteins between groups. We suspect that these proteins are not consistently 
enriched in a particular modification or are not always detected across most 
experiments and therefore are susceptible to normalization. We also observed 
proteins that do not have specific enrichment for RNAPII modifications (Fog. 
5.17; Paf1 complex and others) and most of these proteins have inconsistent 
ratios between replicate pairs (forward and reverse). The pattern of pChIP 
ratios for some of these proteins are extremely similar to Rpb subunits (Fig. 
5.8; lie in the vicinity of Rpb1) and therefore normalization affects their pChIP-
SILAC ratios. We can only perform limited visual confirmation for these 
varying ratios, and in additional only detect patterns which are compatible with 
our a priori knowledge of RNAPII regulation and chromatin interactome. 
Therefore, an additional and unbiased systems biology approach is required 
to unravel novel patterns (including stoichiometry of interactions) inherent to 
our pChIP MS dataset that cannot be resolved from visual observation or 
simple classification. 
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6. Unravelling the network landscape of RNAPII interactome 
6.1. Research motivation 
The chromatin-bound RNAPII proteome and its landscape is quite diverse in 
mES cells. In Chapter 5, I describe a comprehensive pChIP experiment and a 
simple classification that unravels proteins cohorts and dependencies on 
specific RNAPII modifications. Moreover, our pChIP-SILAC ratios encompass 
information on stoichiometry of interactions, relative affinity and strength of 
interaction on chromatin relative to Rpb1. My aim in this chapter was to apply 
an unbiased machine learning approach to sensitively explore, detect patterns 
of proteins enrichment for RNAPII modifications that cannot be unravelled by 
visual or simple classification. We aimed to perform integrative systems 
biology analysis on pChIP-SILAC ratios to efficiently group the proteins based 
on pChIP-SILAC ratios relative to RNAPII and generate a protein network to 
visualise the patterns. 
Borislav Vangelov and Prof. Mauricio Barahona performed all mathematical 
analyses in an active collaboration between our laboratories. I performed the 
GO analyses (along with other auxiliary analyses) and interpretation was 
achieved in collaboration between our two laboratories.    
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6.2. Results 
Our pChIP comprehensive experiment which includes 12 datasets (Fig. 5.2) 
was carefully devised to contain replicate information and to capture both the 
transient and more robust protein associations occurring on chromatin along 
with distinct RNAPII modifications, S5p, S7p and S2p. Using a simple 
classification system based only on the direction of SILAC ratios (positive or 
negative; Fig. 5.12), we have highlighted and began to dissect the interesting 
and specific cohorts of proteins that bind to chromatin with RNAPII 
modifications; this led us to unravel interesting and, in some cases, 
unexpected cohorts of proteins that co-associate with RNAPII-S5p on 
chromatin. However, the information encoded in the SILAC ratios is much 
deeper including the magnitude of the ratios, which bears information on 
stoichiometry of protein co-association with chromatin, which will depend on 
whether protein associations are inter-dependent (for example for subunits of 
the same protein complex) or not (for complexes that may independently 
associate with chromatin-bound by the same RNAPII variant, for example, on 
different genomic regions. Therefore we decided to use an unbiased 
approach, based on machine learning to unravel patterns of protein co-
association with RNAPII-bound chromatin, and systematically dissect protein 
associations that could not be unravelled by visual inspection of the complex 
pChIP datasets. We used a novel clustering approach, Markov stability for 
community detection (Delvenne et al. 2010). Vangelov and Barahona have 
further developed this approach through the construction of a network from 
the similarity/distance matrix by using a perturbative minimum spanning tree 
(PMST) method (B. Vangelov and M. Barahona, in preparation). These novel 
clustering and network approaches have recently been applied on large and 
complex networks characterized by the presence of communities of 
communities (multiscale communities; (Schaub et al. 2012) or locally sparser 
networks where not all components are connected to each other but instead 
locally related. This could be the case in our global analyses of proteome 
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associated genome-wide with RNAPII, as we will have proteins that coincide 
on chromatin on the same genes but not others, or during a given cell cycle 
stage but not another. If two proteins (or protein complexes) are functionally 
related, the magnitude of their SILAC enrichment (a measure of stoichiometry) 
is more likely to be well correlated across all datasets, than if the association 
of the two proteins with chromatin characterized by a given RNAPII 
modification occurs on separate genomic regions or cell cycle stages. In this 
scenario, subunits of the same protein complexes should show the strongest 
correlation between SILAC enrichments across the ten-pChIP datasets. 
6.2.1. Summary of network and clustering analysis 
For analysis of pChIP-SILAC ratios, we used Markov stability for community 
detection (Delvenne et al. 2010), followed by the construction of a network 
from the similarity/distance matrix by using a perturbative minimum spanning 
tree (PMST) method (B. Vangelov and M. Barahona, in preparation) following 
the steps outlined in Fig. 6.1; data imputation, network, clustering and network 
property analyses were done by Borislav Vangelov.  
 
The set of ten pChIP-SILAC MS datasets is composed of a list of all proteins 
detected in at least one of the MS datasets. As highlighted in Chapter 5 (Figs. 
5.13 – 5.17), some proteins are detected in all MS datasets (e.g. chromatin 
remodellers and Paf1 complex; Figs. 5.15 and 5.17), whereas other proteins 
are identified in only some datasets (Figs. 5.14 and 5.16). Missing values are 
not allowed in the networking analysis, and require imputation.  
 
Imputation is a process of substituting missing data with a probable value 
estimated from the other available information, in our case from the 
relationship between ratios available across datasets. To explore the effect of 
imputation, we started by considering different sub-lists of proteins from the 
total list, which contained proteins with fewer or larger number of missing 
values (requiring lower or higher extent of imputation, respectively): 
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A. List of 446 proteins identified in a minimum of five pChIP MS datasets 
(out of 10), with at least one value in the Forward or the Reverse 
dataset for a given pChIP. 
B. List of 702 proteins (including the above 446 proteins) identified in 
minimum of three pChIP MS datasets (out of 10), with at least one 
value in the Forward or the Reverse dataset for a given pChIP. 
C. List of 858 proteins, identified in a subsequent re-analysis of the pChIP 
MS spectra. 
 
In this chapter, I will first describe the analyses of the dataset with 702 
proteins. The comparison between the first two lists (446 and 702 proteins) 
gave similar results and is described at the end of this chapter. The analyses 
of the larger dataset (858 proteins) also produced similar results, but required 
extensive imputation, and for this reason was not followed further and is not 
shown or discussed further in this thesis. 
 
Before performing the data analysis, we first looked at individual experiments 
and how well proteins were detected across the ten-pChIP experiments as 
previously, mock/Universe (F) and (R) datasets were used to identify 
contaminants. Since data imputation is required before clustering to yield a 
dataset without missing values, we inspected the extent of protein detection 
across each dataset. We observed that most proteins were robustly detected 
in all experiments except ‘S7p/Universe (F)’ experiment where only 21% of 
protein ratios were observed. To minimise the imputation of ratios, we chose 
to exclude this dataset from the following steps of clustering and network 
analyses; in this process we loose two proteins only detected in this dataset, 
resulting in a list of proteins with 700 proteins, instead of 702. The analysis 
pipeline is summarized in Fig. 6.1.  
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Figure 6.1. Data analysis pipeline involved in clustering and network analysis. 
pChIP-SILAC dataset generated by MS analysis comprehensive experimental setup 
(as described in Fig. 5.2) was used for clustering and network analysis. The pChIP 
experiments and values for 700 proteins (after removing S7p/Universe experiment) 
were imputed to estimate missing values. 
6.2.2. Data Imputation  
The SILAC ratios are traditionally represented as the ratio between heavy and 
light peptides. To facilitate visualisation and comparison of the pChIP ratios 
between Forward and Reverse datasets in the same kind of pChIP 
experiment, we first inverted the reverse experiment ratios. Imputation for the 
pChIP-SILAC datasets was performed using k-nearest neighbour imputation 
(Cover 1982). We used a weighted Euclidean distance to find the nearest 
neighbour (Fig. 6.2). 
 
Protein partitioning and network construction!
pChIP-SILAC ratios from MS analysis (702 proteins)!
Imputation of missing values (700 proteins)!
- Removing S7p/Universe (F) experiment!
Clustering!
Network analysis!
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Figure 6.2. Example of missing value imputation by k-nearest neighbour. 
Weighted Euclidean distance was calculated for all proteins in the nine-pChIP 
experiments considered (excluding S7p.U_F) to find the k-nearest neighbour and to 
impute the missing value.  
 
To test whether the imputation process could have added many outliers to the 
pChIP-SILAC ratio dataset, we measured the distribution of pChIP-SILAC 
ratios before and after imputation for all pChIP-SILAC forward and reverse 
experiments. The distribution of pChIP-SILAC ratios was maintained after 
imputation and in addition the median values were relatively unchanged. The 
Reverse and Forward pChIP datasets after imputation were treated as 
separate pChIP experiments, as opposed to being averaged to keep our 
analysis unbiased and to observe any variation due to imputation. 
6.2.3. Protein grouping, network construction and partitioning. 
Protein ratios across the 10-pChIP datasets are represented in a nine-
dimensional space. Each point in the multi-dimensional space corresponds to 
a single protein and connections (i.e. edges) between the proteins are 
calculated based on pChIP ratios by Clustering and Network algorithm 
Delvenne et al. PNAS; (Schaub et al. 2012); B. Vangelov and M. Barahona, in 
preparation. Briefly, our algorithm identifies at least one connection between 
each pair of proteins in the multi-dimensional space and iteratively identifies 
connections for all. This is in contrast with other clustering methods where 
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distances between all proteins against each other are computed in single 
step. During our iterative algorithm, protein ratios are perturbed in multiple 
iterations and connections are overlaid in multi-dimensional space. The union 
of these multiple iterations forms the minimum skeleton base network of 
connections between all proteins. 
 
The rationale for partitioning of network follows the pattern of pChIP-SILAC 
ratios for proteins across nine MS datasets. Briefly, proteins that have similar 
pattern of distribution of pChIP-SILAC ratios across the nine different MS 
datasets proteins are well connected with shorter distances. In addition, they 
are preferentially placed close to each other in multi-dimensional space. 
Whereas proteins with dissimilar pattern have larger distances and are more 
separated.   
 
‘Stability’ is additional mathematical parameter applied to partitioning of 
network and robustly reinforces the identification of partitions. Briefly, ‘stability’ 
measures the network architecture identifying the optimal transitions between 
clusters and computing number of stable clusters from the network itself. 
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Figure 6.3. Simplistic representation of protein grouping, partitioning and 
network construction. Protein (with pChIP-SILAC ratios) are plotted in nine-
dimensional space (9 experiments) and iteratively perturbed to construct a base 
skeleton for the network. The stability parameter is calculated by an algorithm and 
identifies robust number of clusters by examining the transitions between clusters in 
base skeleton (Bottom left graph; number of breaks).  
6.2.4. Clustering of protein groups 
Clustering and network analysis of the pChIP datasets identified eight clusters 
as most relevant and robust, which can be visualised in the form of a 
hierarchical tree (Fig. 6.4A). Each of the nine pChIP experiments form the 
columns of the clustering tree with intensities across each row representing 
the pChIP-SILAC ratio for each protein across the nine pChIP experiments 
(Fig. 6.4A; following inversion for the Reverse datasets, for simplicity). The 
length of the dendrogram represents the robustness in separation of clusters 
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as distance metric, i.e. the longer the length of dendrogram, the more robust 
and dissimilar are the clusters.  
 
Visual inspection of the pChIP SILAC ratios across the eight clusters derived 
after clustering shows that they contain groups of proteins characterized by 
specific levels of SILAC enrichment relative to specific RNAPII modifications. 
Proteins in the top three clusters (Clusters 1- 3; dark blue, blue and light blue) 
are highly enriched in the S5p pChIP's only (with low or no enrichment for S7p 
and S2p). Cluster 4 contains proteins enriched for S5p and at low levels for 
S2p (Orange). Proteins in Clusters 5 and 6 had basal level of enrichment for 
all three RNAPII marks (pink and grey). Proteins in clusters 7 and 8 have high 
enrichment for S2p with varying enrichments for S5p. Numbers of proteins in 
each cluster are also represented in Fig. 6.4A. A simplistic table with cluster 
names and RNAPII enrichments is described in Fig. 6.4B. Some examples of 
proteins in each cluster are highlighted in Fig. 6.4C (and also described in 
detail below) and significant GO terms for enriched proteins in different 
clusters is represented with cluster colours in bar-plot (Fig. 6.4D). 
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Figure 6.4. Clustering of pChIP-SILAC ratios results in eight stable, robust 
clusters delineating a gradient separation of proteins. (A) Clustering of pChIP-
SILAC ratios resulted in robust separation of 8 stable and robust clusters with 
different pChIP enrichments for different RNAPII modifications. Each experiment is 
represented as a column in the clustering image. Cluster names were defined based 
on enrichment and the functionality of proteins in each clusters as identified by visual 
inspection of the list and by GO analyses. Intensity values (-6 to +6) represented Log 
scale and represent values of enrichment. (B) Simplified representation of RNAPII 
enrichment levels across different clusters. (C) Examples of proteins present in the 
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different clusters. (D) Significant GO terms for different clusters; cluster 1 did not yield 
any GO term enrichment as expected for its low number of proteins. Bar colours in 
bar-plot are representative of cluster colours. 
 
The top three clusters enriched for S5p only were termed ‘S5p enriched (A)’, 
‘S5p enriched (B)’ and ‘S5p enriched (C)’. Cluster 1 consists of 16 proteins 
including Utf1 (undifferentiated stem cell transcription factor), Edc4 (enhancer 
of decapping), Baz2a (essential component of nucleolar remodeling complex) 
and Prdm2 (methyltransferase). Due to small number of these proteins, 
significant GO terms are not observed, however the discrete clustering and 
enrichment levels suggest the strongest association of this small group of 
proteins with RNAPII-S5p only and highlights the ability of the clustering 
approach to identify a small group of proteins which were not yet know to be 
related with RNAPII modification. The presence of Utf1, an obscure 
pluripotency factor until recently(Jia et al. 2012), was particularly noteworthy, 
along side with ill-characterized chromatin remodelers and RNA processing 
component, Edc4. 
 
Cluster 2, ‘S5p enriched (B)’, consists of 109 proteins and includes Polycomb 
proteins (Suz12, Ring1b, Jarid2, Rbbp7, Rbbp4), DNA replication (all MCM2-7 
subunits), chromatin remodellers (Smarcc1, Mta2, Smarca5, Rbbp7), negative 
regulators of transcription (Hdac2, Sin3a, Kdm1a, Cobra1) and proteins 
involved in histone acetylation (Ruvbl1-2, Dmap1).  
 
Cluster 3, ‘S5p enriched (C)’, consists of 57 proteins involved in protein folding 
(Cct2, Cct3, Cct5), transcriptional regulation (Klf5, Sirt1, Mta1, Mta3) and 
metabolic processes (Aldoa, Pkm2). Pkm2 works as a chromatin modifier 
(Yang et al. 2012), although previous association with RNAPII has not been 
highlighted. Notably, we identify three peptidyl-prolyl cis-trans isomerases 
(Fkbp3, Ppig, Ppid), the latter two not previously related with nuclear 
processes. 
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Cluster 4 is predominantly enriched for ribosomal proteins and metabolic 
proteins. These 154 proteins have low levels of enrichment relative Rpb1 in 
the S5p and S2p pChIP experiments (not for S7p) and include proteins Cdk7 
(cyclin-dependent kinase and transcription), Arid1a (SWI-SNF protein) and 
Hmgb1/2 (high mobility group proteins that directly bind and bend DNA). 
Enriched GO terms include ‘translation’, ‘DNA repair’ and ‘ATP catabolic 
processes’.  
 
The central clusters, 5 and 6, consist of RNAPII subunits, TAFs (transcription 
associated factors) and histones. These proteins have similar enrichment 
relative to Rpb1 and showed not consistent preference for RNAPII 
modification. Cluster 5 consists of 83 proteins including 8 RNAPII subunits. 
Remarkably we also identify all components of the Paf1 complex, which are 
involved in transcription elongation, but also have important roles in regulation 
of development and maintenance of stem cell pluripotency (Ding et al. 2009). 
Cluster 6 consists of 44 chromatin proteins, predominantly histones and few 
transcription-associated-factors (TAFs). Only significant GO term is 
“nucleosome remodelling”.  
 
Clusters 7 and 8 have proteins with high enrichment for S2p, but varying 
levels of S5p and enrichment for transcription elongation proteins including 
mRNA processing, spliceosome subunits, splicing factors and RNA export 
factors. 
6.2.5. Network landscape and properties 
To understand the relationships between clusters and proteins in each cluster, 
we next constructed a network model of the partition with eight clusters. In the 
network model, every node represents a cluster and two nodes are connected 
if any two nodes from the corresponding clusters are connected. The 
simplistic network model of the partition with eight clusters is shown in Fig. 
6.5A. The complete pChIP network with cluster names, colors and 
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connections is shown in Fig. 6.5B. The network was plotted with package 
Gephi (version 0.8.1) and the layout was done using ‘force atlas layout’. 
 
 
Figure 6.5. Network landscape of clustered proteins and connections. (A) 
Estimation of network model of a partition with each node representing a cluster and 
edges representing connections between clusters. (B) Visual representation of 
protein network based on pChIP-SILAC ratios using Gephi (version 0.8.1). Nodes 
represent individual proteins and edges represent distance vector between the 
nodes. Weight of the edges is indicative of the strength of association (similar vector 
distances). Cluster colours are overlaid on the proteins. Clear separation of proteins 
in different clusters is a first indication of robust partitioning. 
 
Looking at the pChIP protein network characteristics, the clear separation of 
proteins and cluster colours is the first indication of the robustness of 
clustering and efficient partitioning. The high density of connections within the 
network indicates similar behaviour of proteins relative to RNAPII 
modifications (either stoichiometry or similar protein complexes) and their 
association. The intra-cluster connections indicate transition between clusters 
and highlight the importance of bridging proteins that link the clusters. 
Figure 1: The network model of the partition with eight clusters
ilar between the original partition and the two additional partitions (T2 and T3).
We performed the clustering analysis on the expression profiles of proteins observed in at
least four of the five pair of experiments (S2P/Uni, S5P/Uni, S7P/Uni, S5P/S2P, S5P/S7P).
The distribution of proteins in the original partition with eight clusters and in the new par-
tition with seven clusters is shown in T1. The proteins are partitioned in a similar way. This
means that the imputation does not have a significant influence on the clustering results.
3
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To visualise how the network structure related with the original pChIP-SILAC 
ratios, we averaged forward and Reverse pChIP ratios and represented the 
average ratio for each protein overlaid on the network separately for the five-
pChIP types of experiment (Fig. 6.6). These average enrichment profiles, 
represented over the network structure, highlight the successful gradient 
separation of proteins across different clusters and proteins within specific 
clusters. For example, in the pairwise S5p.S2p experiment, the average plot 
(Fig. 6.6, far right) shows proteins enriched for S5p in the top, proteins in the 
middle have low levels of enrichment relative to all RNAPII modifications 
(have enrichment similar to Rpb1), and finally proteins towards the bottom are 
enriched relatively to the S2p modification. These average intensity profiles 
offer an alternative way to explore the protein behaviours relative to the 
network structure and to evaluate the quality of the clustering and network 
produced. 
 
 
Figure 6.6. Visualising individual protein intensities across different 
experiments on the network structure. Average pChIP enrichments were 
represented for each protein on the network after averaging forward and reverse 
pChIP values, except for the S7p/Universe experiment for which on the Forward 
values were represented. 
6.2.6. Important proteins in each cluster 
Further exploring the properties of the pChIP network, we next zoomed in to 
different clusters and observed the protein connections. As the pChIP 
experiment was performed to identify the proteome of RNAPII-bound 
chromatin, we first asked how many RNAPII subunits were captured by pChIP 
clustering and network analyses and their positioning within the network. 
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Strikingly, we identify seven RNAPII subunits within the same cluster and 
importantly connected with each other with similar weights (Fig. 6.7, bottom 
right). Interestingly, other proteins such as Smc2, Ell and Dnmt3a/b are found 
directly connected to Rpb1 subunits, which results from similar behaviours of 
pChIP ratios across experiments. 
 
 
Figure 6.7. Snapshot of Rpb subunits and chromatin communities captured by 
pChIP. Eight RNAPII subunits (all connected within Cluster 5) are identified from 
pChIP network. Gephi (version 0.8.1) was used to visualise the network. 
 
We next looked at Polycomb proteins (cluster 2) and more specifically at one 
of the PRC1 (Polycomb repressive complex 1) subunits, Ring1b (Fig. 6.8). 
Ring1b is a nuclear protein with E3 ubiquitin ligase activity and is responsible 
for mono-ubiquitination of lysine residue of histone H2A (H2Aub). Polycomb-
repressed genes are occupied by high levels of RNAPII-S5p (without S7p or 
S2p) along with H2Aub (Stock et al. 2007, Brookes et al. 2012; see also Fig. 
5.1 and section 5.3.1). In our pChIP network, we observe three Polycomb 
Chromatin communities (Rpb subunits)!
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proteins (Suz12, Jarid2 and Ring1b) and components of chromobox proteins 
(Cbx3 and Cbx5) in the same cluster. Interestingly, Ring1b protein was found 
directly and strongly connected to O-GlcNAc transferase subunit p110 protein 
(Hoffmeyer et al. 2012). 
 
Ogt is the only nuclear protein known to catalyse transfer of β-N-
acetylglucosamine (O-GlcNAc) to serine or threonine residues of target 
proteins. Ogt had previously been shown to co-associate with Polycomb 
proteins in mES cells (Myers et al. 2011), and has been recently shown to 
modify RNAPII-CTD (Ranuncolo et al. 2012). Interestingly, Ogt is robustly 
identified in our dataset co-existing only with S5p and it bridges most 
connections between clusters 2 and 3. Our results suggest that the functional 
relationship between Ogt and Polycomb, previously identified by in vitro 
approaches, co-exists with RNAPII-S5p (not S7p or S2p) on chromatin. 
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Figure 6.8. Snapshot of Ring1b and chromatin communities captured by 
pChIP. Ring1b (Cluster 2) are identified from pChIP network and was directly linked 
to Ogt protein. Gephi (version 0.8.1) was used to visualise the network. Barplots of 
Ring1b and Ogt proteins with pChIP-SILAC ratios after imputation. H/L SILAC ratios 
were inverted in the reverse (to be similar to forward) experiments and represented 
as indicated. pChIP-SILAC ratios are plotted in log scale and numbers of peptides 
are represented next to ratios on barplot. 
 
Understanding replication control in stem cells has been of intense focus in 
the last couple of years with many studies, including genome-wide datasets,  
shedding light on need for dynamic and fast replication in stem cells and 
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coordinated genome integrity (Azuara et al. 2006; Hiratani et al. 2008; 
Sequeira-Mendes et al. 2009; Cayrou et al. 2012). In our pChIP-network, we 
identify all subunits of MCM2-7 complex, remarkably within the same cluster 
with association on chromatin with S5p only (no S7p or S2p) and with robust 
connections between themselves. Our finding that RNAPII-S5p specifically co-
exists on chromatin along with DNA replication components raises an 
interesting viewpoint on dynamic between replication and RNAPII coordination 
specifically from the context of mES cell biology.  
 
 
Figure 6.9. Consistent detection of DNA replication proteins with S5p only 
(after imputation). Barplot for three MCM proteins (Mcm4, 5 and 7) and their pChIP-
SILAC ratios highlight specific association on chromatin with RNAPII-S5p. H/L SILAC 
ratios were inverted in the reverse (to be similar to forward) experiments and 
represented as indicated. pChIP-SILAC ratios are plotted in log scale and numbers of 
peptides are represented next to ratios on barplot. 
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We next looked at cluster 1 that consisted of only 16 proteins and were 
specifically and mostly enriched for S5p only (without S7p or S2p; Fig. 6.8). It 
is remarkable that none of these proteins has been shown in the literature to 
associate with RNAPII and in our experiment these proteins were more robust 
S5p associations on chromatin than Polycomb protein or other known 
processes (such as splicing factors with S5p&S2p). This result highlights the 
power of an unbiased systems approach to uncover novel regulators of 
RNAPII, chromatin and RNA processing through pChIP experiments using 
RNAPII immunoprecipitation. Edc4 is a component of the mRNA decapping 
and degradation-based post-transcriptional gene silencing (PTGS) complex. It 
is thought to associate and enhance the activity of Dcp2 in decapping the 
m7G cap from the mRNA (Tritschler et al. 2009). Baz2a is essential 
component of the NoRC (nucleolar remodeling complex) complex and 
mediates silencing rDNA by recruiting chromatin remodelers and DNA 
methyltransferases, leading to heterochromatin formation and transcriptional 
silencing (Uniprot 2012). An association with RNAPII had not been previously 
uncovered. Prdm2, a ‘S-adenosyl-L-methionine-dependent histone 
methyltransferase’, specifically methylates H3K9 in humans and may interplay 
with RNAPII in setting up heterochromatin formation; this association was not 
previously reported (Wu et al. 2010). 
 
Utf1 is an essential stem cell transcription factor, which may associate with 
the TFIID complex via TBP-mediated interactions in mES cells (Fukushima et 
al. 1998). More recently, Utf1 has been related with silencing of PRC-
repressed genes through RNA pruning and association with decapping 
proteins (Edc3/Edc4; (Jia et al. 2012). This study has failed to identify an 
association with RNAPII-S5p on chromatin probably due to the use of non-
chromatin extracts in non-native in vitro conditions. Future analyses of Utf1 
co-association with RNAPII-S5p occupied chromatin by sequential-ChIP at 
panel of few genes would provide further evidence for this association, but 
requires knowledge of the genomic regions where this association may exist. 
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Bioinformatic analyses of genome-wide maps of Utf1 and RNAPII-S5p would 
identify candidate regions occupied by both markers. Currently, available 
commercial antibodies for Utf1 are not ChIP grade and work only with western 
blotting. 
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Figure 6.9. Snapshot of proteins in cluster 1 and representative chromatin 
communities captured by pChIP. Utf1 protein (Cluster 1) was central to the cluster 
and with connections to most other proteins within cluster 1 (including Edc4). Gephi 
(version 0.8.1) was used to visualise the network. Bar-plots of Utf1, Edc4 and Edc3 
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proteins with pChIP SILAC ratios across all experiments. H/L SILAC ratios were 
inverted in the reverse (to be similar to forward) experiments and represented as 
indicated. pChIP-SILAC ratios are plotted in log scale and numbers of peptides are 
represented next to ratios on barplot. 
   
6.2.7. Proteins important for network and properties 
We next explored the pChIP-network to unravel and identify proteins that are 
inherently important for its architecture. Eigenvector centrality is one approach 
to identify important nodes in networks, in which a score is defined for every 
node in a network that measures how influential that node is for the network. 
A node is considered influential if it is connected to other influential nodes 
(One noted application of eigenvector centrality is Google PageRanks that 
ranks and arranges which webpages are important). The eigenvector 
centrality scores were measured for every cluster independently, and for the 
entire network. 
 
We first looked at the proteins that had highest eigenvector centrality for the 
complete network and also individually for each cluster (Fig. 6.10). The 
proteins with highest eigenvector centrality were: Rps9, a component of 
mRNP granule complex known to interact with several polyA-binding proteins 
involved in RNA export processes; Aurk2 (Aurora kinase B), a 
serine/threonine kinase that plays important roles in mitosis; and Cdk7, also a 
serine/threonine kinase that is involved in RNAPII mediated transcription. 
Cdk7 is the enzyme that catalyzes the phosphorylation on serine residues 
(S5p and probably S7p) and directly interacts with Rpb1-CTD. 
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Figure 6.10. Identifying proteins most important for network structure. Proteins 
with highest eigenvector centrality, i.e. proteins that influence most of the network 
and the connections thereby being most important for network construction. Proteins 
with highest eigenvector centrality for the network and for individual clusters are 
highlighted in table. 
 
We used another measure to find proteins most important for the connection 
between clusters by analyzing the sub-networks in the network model of 
partition. We identified bridge nodes (i.e. pairs of connecting nodes from two 
different clusters) and computed the shortest paths between every pair of 
nodes from the two clusters. The most important bridge nodes are those 
through each most shortest paths go through. Bridge edges are important 
because they highlight the transition between clusters. Fig. 6.11 lists all the 
bridge nodes and scores for all clusters. Remarkably, we see interesting 
proteins that bridge different clusters including Eed (Polycomb protein cluster 
2 and 3), RNAPII subunits (Polr2a and Polr2b: cluster 3 and 4) and as 
expected components of spliceosome coordinate transition between cluster 7-
8. 
 
Network Cluster 1 Cluster 2
Eef1d;mCG 22130 Pole;Pole1 Jmjd1b;Kdm3b
Rps9 Gtpbp9;Ola1 Sir2l1;Sirt1
Ark2;Aurkb Prdm2;RP23-185C16.1-001 Ywhab;mCG 5429
Acta;Acta1 Cxn-43;Gja1 Gm16409;mCG 22088
Cdk7;Cdkn7 Utf1;mCG 21628 mCG 12245;Rbbp4
Cluster 3 Cluster 4 Cluster 5
Eef1d;mCG 22130 Polr2e;mCG 13422 H1f5;Hist1h1b
Rps9 Polr2c;Rpo2-3 Hist1h2bp;H2b-f
Ark2;Aurkb Polr2h Gtf2f1;mCG 5591
Acta;Acta1 Ell;mCG 23118 H1ft;H1t
Gm5451;Gm9822 Polr2b;rpB2 H1f3;Hist1h1d
Cluster 6 Cluster 7 Cluster 8
D10Wsu52e Ptpn14;Safb2 Ddx23;mCG 18410
Hnrpq;Nsap1 Cdc2l5;Cdk13 Rbm17;Spf45
Hnrpdl;Jktbp Np220;Zfml Bcas2;Dam1
Tial1;mCG 21017 Hnrnpc;Hnrpc Smu1;mCG 9820
Ptbp1;PTB4 Elavl1;Elra Cwc15;Ed1
Table 4: Table 4 - The first five proteins with highest eigenvector centrality in every cluster
and in the entire network
5
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Figure 6.11. Identifying bridge nodes – Edges that link nodes between two 
clusters thereby maintaining network architecture. Bridge nodes that form at 
least 10% of shortest path between two clusters are listed in table. 
 
Protein Score Protein Score
Cluster 1 Cluster 2
Baz2a;Kiaa0314 0.46 Esg;Tle3 0.45
Cnot1;Kiaa1007 0.35 Tif1;Tif1a 0.32
Tjp1;Zo1 0.13
Cluster 2 Cluster 3
Eed 0.10
Cluster 3 Cluster 4
Tcea1;Tceat 0.25 Ell;mCG 23118 0.24
Smc2;Smc2l1 0.18 Polr2b;rpB2 0.18
Ints4 0.17 Polr2a;Rpii215 0.10
Fam129c;Bcnp1 0.11
Cluster 3 Cluster 5
Rpl18;RPL18 0.31 RP23-59M10.1-002;Th1l 0.22
Mat1;Mnat1 0.23 H1f5;Hist1h1b 0.16
Polr2l 0.21 Rbm12;mKIAA0765 0.14
Cluster 3 Cluster 6
Cstf2t;Kiaa0689 0.11 D10Wsu52e 0.14
Rps6kl1 0.11 Fact140;Factp140 0.12
Kiaa1470;Rcc2 0.10
Cluster 4 Cluster 5
D15Ertd682e;Rpap3 0.86 RP23-59M10.1-002;Th1l 0.68
Kiaa1111;Phf8 0.18
Cluster 4 Cluster 6
Ell;mCG 23118 0.33 Ssrp1;RP23-232L15.5-001 0.53
Polr2b;rpB2 0.26 Kiaa0852;Morc2a 0.15
Polr2j;mCG 1879 0.12 Supt5h 0.12
Nosip 0.10
Cluster 5 Cluster 6
Rbm12;mKIAA0765 0.59 D10Wsu52e 0.31
Kiaa1111;Phf8 0.22 D14Abb1e;Kiaa1105 0.18
Tox4;mKIAA0737 0.13
Cluster 6 Cluster 7
Tardbp;Tdp43 0.10 Hnrnpa0;Hnrpa0 0.13
Cluster 6 Cluster 8
Pc4;Rpo2tc1 0.25 Cwc27;Sdccag10 0.24
Kiaa0907 0.16 Cpsf6 0.10
Reps1 0.12
Rbm8;Rbm8a 0.10
Cluster 7 Cluster 8
Snrpf;mCG 4969 0.36 Sr140 0.23
Lsm8;Naa38 0.12 Snrpd3 0.13
Cpsf5;Nudt21 0.10
Table 5: Table 5 - The computed bridge nodes between clusters connected in the network
model of a partition.
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6.2.8. Robustness of network analysis of pChIP datasets 
6.2.8.1 Stability of network when using smaller number of pChIP 
datasets: only reverse or forward datasets 
Our pChIP experimental setup was highly redundant and composed of 
replicate complimentary experiments. To test the robustness of our clustering 
and network results, we analysed for comparison a subset of the pChIP 
datasets (either using only the forward or reverse replicate experiments. We 
also analysed a random choice of replicates from our pChIP MS dataset and 
the results were similar (data not shown) 
 
Applying the clustering to only the five reverse or the five forward datasets 
produced 9 or 7 clusters, respectively, with similar structure to the 8 clusters 
observed for the full dataset. To assess the reproducibility of our pChIP 
analyses, we compared the distribution of proteins in different clusters using 
only 5 datasets with the clusters observed for the whole pChIP dataset (Fig. 
6.12). Although shuffling of proteins was detected for the reverse dataset, the 
major changes occurred within Clusters 5, 6 and 7 and between 2 and 3 
(relative to the whole dataset). Using the five forward datasets, we observe 
that the core architecture is retained (Fig. 6.12), with only finer separation of 
Cluster 6 (seen in the Forward clustering) into two clusters (named Clusters 5 
and 6 in the 9 dataset clustering). Reassuringly, the core components of the 
clusters were retained when using only 5 or 9 datasets, highlighting the 
reproducibility of our pChIP experiments and the robustness of our clustering 
analyses. 
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Figure 6.12. Comparing the robustness of clustering and network analysis by 
using a subset of pChIP datasets. Minimum number of experiments to obtain 
enrichments for S5p, S7p and S2p were taken and clustering/network analysis was 
repeated. (A and B) Clustering with whole data set (9 pChIP datasets) compared 
clustering with either five reverse only or forward only pChIP experiments. Protein 
network for both reverse only (9 clusters) and forward only (7 clusters) highlights the 
distribution of clusters and proteins within. Remarkably, the core architecture of 
clustering is retained irrespective of the replicate experiments used.  
 
 
C1 C2 C3 C4 C5 C6 C7
C1 6 0 0 0 0 0 0
C2 0 85 3 0 1 0 0
C3 0 1 108 0 10 0 0
C4 0 0 0 1 10 0 0
C5 0 0 0 15 0 0 0
C6 0 0 1 0 24 20 3
C7 0 0 0 0 0 62 0
C8 0 0 0 0 0 1 94
Table 1: Table 1 Comparison of the partition extracted from the entire dataset and from
dataset with proteins observed in at least four of the five experimental pairs (S2P/Uni,
S5P/Uni, S7P/Uni, S5P/S2P, S5P/S7P)
C1 C2 C3 C4 C5 C6 C7 C8 C9
C1 9 5 0 0 0 0 0 0 0
C2 10 115 28 7 1 0 0 0 0
C3 3 8 102 69 2 2 3 1 2
C4 0 0 3 0 0 12 0 0 0
C5 0 0 0 3 16 2 1 0 0
C6 0 0 1 8 0 1 16 47 0
C7 0 0 0 0 0 0 10 65 1
C8 0 0 1 3 0 0 34 6 70
Table 2: Table 2 Comparison of the partition extracted from the entire dataset and from
the dataset comprised of S5P(l)/Uni(h), S2P(l)/Uni(h), S7P(l)/Uni(h), S5P(l)/S7P(h), and
S5P(l)/S2P(h)
C1 C2 C3 C4 C5 C6 C7
C1 14 2 0 0 0 0 0
C2 3 39 56 41 0 8 3
C3 1 0 66 84 0 21 8
C4 0 0 0 11 3 1 0
C5 0 0 1 0 21 3 1
C6 0 0 5 7 1 53 3
C7 0 0 0 3 0 71 1
C8 1 1 0 2 0 6 100
Table 3: Table 3 Comparison of the partition extracted from the entire dataset and from
the dataset comprised of S5P(h)/Uni(l), S2P(h)/Uni(l), S7P(l)/Uni(h), S5P(h)/S7P(l), and
S5P(h)/S2P(l)
4
W
ho
le
 d
at
as
et
!
All reverse pChIP experiments!
C1 C2 C3 C4 C5 C6 C7
C1 6 0 0 0 0 0 0
C2 0 85 3 0 1 0 0
C3 0 1 108 0 10 0 0
C4 0 0 0 1 10 0 0
C5 0 0 0 15 0 0 0
C6 0 0 1 0 24 20 3
C7 0 0 0 0 0 62 0
C8 0 0 0 0 0 1 94
Table 1: Table 1 Comparison of the partition extracted from the entire dataset and from
dataset with proteins observed in at least four of the five experimental pairs (S2P/Uni,
S5P/Uni, S7P/Uni, S5P/S2P, S5P/S7P)
C1 C2 C3 C4 C5 C6 C7 C8 C9
C1 9 5 0 0 0 0 0 0 0
C2 10 115 28 7 1 0 0 0 0
C3 3 8 102 69 2 2 3 1 2
C4 0 0 3 0 0 12 0 0 0
C5 0 0 0 3 16 2 1 0 0
C6 0 0 1 8 0 1 16 47 0
C7 0 0 0 0 0 0 10 65 1
C8 0 0 1 3 0 0 34 6 70
Table 2: T ble 2 Comparison of the partition extracted from the entire dataset and from
the dataset comprised of S5P(l)/Uni(h), S2P(l)/Uni(h), S7P(l)/Uni(h), S5P(l)/S7P(h), and
S5P(l)/S2P(h)
C1 C2 C3 C4 C5 C6 C7
C1 14 2 0 0 0 0 0
C2 3 39 56 41 0 8 3
C3 1 0 66 84 0 21 8
C4 0 0 0 11 3 1 0
C5 0 0 1 0 21 3 1
C6 0 0 5 7 1 53 3
C7 0 0 0 3 0 71 1
C8 1 1 0 2 0 6 100
Table 3: T ble 3 Comparison of the partition extracted from the entire dataset and from
the dataset comprised of S5P(h)/Uni(l), S2P(h)/Uni(l), S7P(l)/Uni(h), S5P(h)/S7P(l), and
S5P(h)/S2P(l)
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6.2.8.2 Comparing all proteins with the subset of proteins most 
consistently detected at least once in all pChIP pairs. 
To further test the reproducibility and robustness of pChIP SILAC analysis, we 
repeated the clustering and network analyses using a smaller subset of 446 
proteins, that were most consistently detected across the nine pChIP datasets 
(i.e. proteins identified in one of the Forward or Reverse datasets for all pChIP 
combinations, i.e. in four or five experiment pairs).  
 
With the 446-protein dataset, we identified 7 robust and stable clusters 
compared to 8 clusters in whole dataset. Reassuringly, the core architecture 
of the clustering is retained and remarkably the core proteins between 
clustering are unchanged (Fig. 6.13). We observed that with the 700-protein 
dataset, the additional information allows for finer partitioning of the dataset 
and network properties (Fig. 6.13 clusters 6 and 7 – whole dataset), as 
expected due to the presence of replicate information.  
 
 
Figure 6.13. Comparing clustering portioning using the proteins detected 
consistently in at least one of the pChIP experimental replicates in 4 or 5 
experimental pairs to the whole dataset clustering. The core architecture of the 
clustering is retained between both datasets using 445 proteins most consistently 
detected across pChIP experiments. Cluster 1 is still observed, albeit with 6 proteins, 
all of which are conserved between clustering’s. Very few proteins are detected in 
cluster 4 of the whole dataset. For the proteins detected they mostly reshuffle 
between adjacent datasets; additionally with whole dataset there is a finer separation 
of proteins (cluster 6 and 7 – whole dataset). 
C1 C2 C3 C4 C5 C6 C7
C1 6 0 0 0 0 0 0
C2 0 85 3 0 1 0 0
C3 0 1 108 0 10 0 0
C4 0 0 0 1 10 0 0
C5 0 0 0 15 0 0 0
C6 0 0 1 0 24 20 3
C7 0 0 0 0 0 62 0
C8 0 0 0 0 0 1 94
Table 1: Table 1 Comparison of the partition extracted from the entire dataset and from
da aset with proteins observed in at least four of the five experimental pairs (S2P/Uni,
S5P/Uni, S7P/Uni, S5P/S2P, S5P/S7P)
C1 C2 C3 C4 C5 C6 C7 C8 C9
C1 9 5 0 0 0 0 0 0 0
C2 10 115 28 7 1 0 0 0 0
C3 3 8 102 69 2 2 3 1 2
C4 0 0 3 0 0 12 0 0 0
C5 0 0 0 3 16 2 1 0 0
C6 0 0 1 8 0 1 16 47 0
C7 0 0 0 0 0 0 10 65 1
C8 0 0 1 3 0 0 34 6 70
Table 2: Table 2 Comparison of the partition extracted from the entire dataset and from
the dataset comprised of S5P(l)/Uni(h), S2P(l)/Uni(h), S7P(l)/Uni(h), S5P(l)/S7P(h), and
S5P(l)/S2P(h)
C1 C2 C3 C4 C5 C6 C7
C1 14 2 0 0 0 0 0
C2 3 39 56 41 0 8 3
C3 1 0 66 84 0 21 8
C4 0 0 0 11 3 1 0
C5 0 0 1 0 21 3 1
C6 0 0 5 7 1 53 3
C7 0 0 0 3 0 71 1
C8 1 1 0 2 0 6 100
Table 3: Table 3 Comparison of the partition extracted from the entire dataset and from
the dataset comprised of S5P(h)/Uni(l), S2P(h)/Uni(l), S7P(l)/Uni(h), S5P(h)/S7P(l), and
S5P(h)/S2P(l)
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We next investigated the network architecture and connections within the 
pChIP-network. On visual inspection, the networks look entirely similar to 
each other and their partitions (Fig. 6.14). In the whole dataset, we had finer 
partitioning and additional proteins (254 proteins) spread non-preferentially 
across all clusters. Notably, we identify a large S5p cluster (cluster 3 whole 
dataset that is partitioning of cluster 2 (446 proteins) and additional proteins 
(254 proteins). Looking at the average intensity profiles for whole dataset and 
446 proteins, we observed similar profiles across all experiments. The 
gradient separation of proteins again is best described by S5p/S2p 
experiment in both the datasets. 
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Figure 6.14. Comparing protein-network between whole dataset (700 proteins) 
and most consistently detected proteins in at least one of the pChIP pairs (446 
proteins).  445 proteins were found most consistently detected in all experiments (5 
or 4 pairs) and partitioned into 7 clusters. Comparing the different networks, the 
overall shape and architecture between the two clustering’s is maintained; 
additionally, the similarity of average intensity plots highlights the robustness of our 
pChIP method.  
6.3. Discussion 
Our analyses of the proteome associated with chromatin-bound proteome in 
association with RNAPII complexes modified on S5p, S7p or S2p show that 
RNAPII is involved in a diverse range of biological process fundamental for 
mES cells. Using novel clustering and network algorithms, we have further 
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detected patterns and unravelled associations not previously identified. The 
novelty of our clustering and network algorithm is that all analysis is done on 
pChIP-SILAC ratios in an unbiased manner without the need for any prior 
information on proteins (including protein length, subunit structure, size, 
abundance or properties); this approach requires redundancy (replicates) and 
slight differences between experiments (e.g. pairwise and universe 
approaches).  
 
6.3.1. Clustering sensitively detects a gradient partitioning of protein 
association with chromatin bound by different RNAPII variants 
From our simple pChIP classification system, we observed proteins enriched 
specifically for S5p only and proteins detected with a combination of 
modifications. Our clustering and network algorithm sensitively detects the 
association of proteins relative to RNAPII and partitions them based of their 
pChIP-SILAC ratio. The gradient separation flows from proteins enriched for 
S5p only (no S7p or S2p) to proteins with basal RNAPII modifications and 
finally proteins enriched for S5p and S2p. This remarkable gradient separation 
and novel partitioning was not anticipated and highlights the sensitivity and 
need for our systems approach and contrasts from conventional methods. 
Proteins with varying ratios across experiments which were difficult to 
understand in the simple classification used in Chapter 5 (example Paf1 
complex in Fig. 5.17; Cluster 5-pink colour in Fig. 6.5) could be elucidated by 
our clustering approach as robustly detected in correlation with the behaviour 
of Rpb subunits without any specific enrichment for RNAPII modifications.  
6.3.2. Robust partitioning unravels novel patterns within S5p proteins 
and common proteins. 
The clustering algorithm dissects the wealth of information contained in 
pChIP-SILAC ratios and identifies novel patterns that are biologically 
meaningful including stoichiometry of interactions and relative affinity to 
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RNAPII. Moreover we are able to demarcate protein association with RNAPII 
on chromatin based on levels of enrichment of pChIP-SILAC ratios.  
 
We identify two clusters (Cluster 7 and 8) both enriched for S5p&S2p with 
varying levels and consisting of co-transcriptional machinery (including RNA 
processing, splicing, polyadenylation and export). Interestingly, we observe 
enrichment for export factors in Cluster 8 than Cluster 7 suggesting the 
transition of transcriptional process. We also distinctly separate RNAPII 
subunits (cluster 5) from histones (cluster 4) even with basal levels of RNAPII 
modifications. We demarcate and robustly identify three clusters associated 
with RNAPII-S5p only based on their affinities of interaction. Both Polycomb 
and replication proteins are identified in cluster 2, however cluster 3 consists 
of groups of proteins involved in other repressive complex, chromatin 
remodellers and metabolic proteins. It is apparent that clustering senses the 
variation of proteins association between cluster 2 and cluster 3. Remarkably, 
we also identify a small robust cohort of proteins (cluster 1) with strongest 
enrichment for RNAPII-S5p including an essential stem cell transcription 
factor, chromatin remodellers and proteins of uncharacterised functions 
previously unknown to functionally interact with RNAPII. We suspect that 
these proteins (given their roles in fundamental processes and S5p-only 
association) regulate important stem cell processes and such systems 
approach is required to uncover them.  
6.3.3. Systems approach uncovers novel biological insights 
The clustering and network algorithm apart from partitioning the proteins also 
provides high level of information including the nodes important for cluster 
architecture and within each cluster. The edge weight further signifies the 
similarity of association relative to RNAPII and further predicts co-association 
along with RNAPII modification. These parameters play an important role for 
choosing candidates and understanding their regulation. For example, we 
observe Ring1b protein directly connected with Ogt protein in cluster 2 with a 
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stringent edge weight (Fig. 6.8). Not surprisingly, very recently Ogt has been 
shown to interact with Polycomb proteins and also RNAPII-CTD (Myers et al. 
2011; Ranuncolo et al. 2012). Other linked proteins in cluster 2 would provide 
important candidates that might be involved during the Ogt-Polycomb-RNAPII 
interplay.   
 
Our large pChIP experiment was designed to have comprehensive and 
complimentary replicate information encoded within it. Performing analysis 
with replicates (i.e. forward only or reverse only or random selection), we 
robustly observe the retention of core network architecture and highlight 
weaker associations. In summary, the analyses presented in this chapter 
clearly demonstrate the robustness, strength and sensitivity of our systems 
biology approach to capture and dissect RNAPII-bound chromatin 
interactions. 
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7. Comparing RNAPII pChIP with mRNA bound proteome 
dataset and mitotic RNAPII  
7.1. Research motivation 
Proteome-ChIP captures cohorts of interactions occurring on chromatin. In 
Chapters 5 and 6, I describe the experimental strategy, simple classification 
analysis and systems biology approach to dissect and unravel these 
interactions and their biological relevance. My aim in this chapter was to 
further explore the basis of these biological interactions by distinguishing 
mRNA-protein interactions from protein-protein interactions and other 
interactions. I also aimed to integrate the types of interactions to our system 
biology analysis using both simple classification and network analysis. 
Borislav Vangelov and Prof. Mauricio Barahona performed the network 
analysis (Figs. 7.5 and 7.8) in an active collaboration between our 
laboratories.  
7.2. RNAPII regulation on chromatin  
RNAPII transcription is a highly regulated and dynamic process involving 
several components that sense the local environment and cascade a range of 
feedback, feed-forward and downstream processes.  
A plethora of dynamic associations with RNAPII or chromatin of a range of 
regulatory complexes occurs during transcription; these associations include 
DNA-protein interactions on chromatin, protein-protein interactions (forming 
protein complexes) and protein-RNA interactions (e.g. direct binding of the 
RNA processing machinery to the nascent RNA). During transcription, the 
Rpb1-CTD is known to act as a scaffold for interactions (protein-protein) that 
further regulate distinct stages of transcription and interactions with DNA 
(chromatin remodellers), mRNA (splicing factors) and protein (RNAPII-
recycling). 
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Figure 7.1. Schematic representation of steps involved during transcription 
and different types of interactions. Transcription involves range of interactions 
occurring on proteins, DNA and mRNA. During transcription, distinct modifications on 
Rpb1-CTD assist in recruitment of range of chromatin modifiers, capping enzyme, 
RNA processing factors, splicing machinery and transcription termination machinery 
to produce a stable mRNA transcript completing one round of transcription. 
7.3. Capturing different types of interactions. 
With the advent of newer technologies and significant improvements in high-
throughput techniques like mass spectrometry and next generation 
sequencing, newer methods are developed to identify different interactions 
and their biological validity. DNA-Protein interactions were conventionally 
detected by electrophoretic mobility shift assay (EMSA; (Garner and Revzin 
1981), DNase footprinting (Galas and Schmitz 1978) or yeast One-hybrid 
assays (Ouwerkerk and Meijer 2001). More recent, high-throughput genome-
wide methods, like DNA-ChIP, sensitively identify and provide protein 
occupancy maps across the whole genome (Gilmour and Lis 1984; Solomon 
et al. 1988). Methods for detection of RNA-protein associations include more 
recent high-throughput technologies including RNA-immunoprecipitation, 
PAR-CLIP and further developments like HITS-CLIP and CLIP-Seq (Keene et 
al. 2006; Hafner et al. 2010; Konig et al. 2011). Conventional and more recent 
large-scale proteomic studies have also identified and elucidated protein-
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protein interaction maps leading to an availability of resourceful databases 
(Phizicky and Fields 1995; Prieto and De Las Rivas 2006). 
7.4. Results 
The protein interaction landscape captured by pChIP using RNAPII antibodies 
includes protein-protein, protein-DNA, protein-RNA and other interactions 
dependent on chromatin state. I next asked if we could further dissect these 
interactions and highlight them. The obvious approach is to perform the 
comprehensive pChIP experiment with RNase to identify the non-RNA bound 
interactions, however with caveats including overall lower number of proteins 
(per sample volume), normalization issues and variance in stoichiometry of 
proteins and their pChIP-SILAC ratios; even then, treatment with RNAse will 
not remove proteins that interact both with RNA and with protein. To identify 
the proteins identified in our network that also directly associate with RNA, we 
instead compared our dataset with a published human mRNA-bound 
proteome (MBP) dataset produced using  (APPROACH and what it captures) 
(Baltz et al. 2012).  
 
To capture and highlight interactions with RNAPII in our pChIP dataset, we 
compared our pChIP dataset with a dataset of RNAPII interactors produced in 
native chromatin-depleted protein extracts. Our lab has previously published 
the protein interactome of RNAPII complexes isolated in native conditions 
during mitosis in HeLa cells, a transformed human cell line (Moller et al. 
2012), after separation from mitotic chromosomes and DNAse I treatment. 
Briefly, the majority of the interactions captured in this dataset should 
represent protein-protein interaction (non-chromatin). 
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7.4.1. Summary of steps involved in comparing mouse RNAPII pChIP 
dataset with published human datasets 
 
To compare the published human datasets with pChIP dataset from mES 
cells, I followed a simple strategy (Fig. 7.2). Published MS protein datasets 
from PAR-CLIP or mitotic RNAPII co-immunoprecipitation were converted 
from the human protein/gene identifiers to corresponding orthologs, i.e. 
protein/gene identifiers in mouse. The orthologs in the two published datasets 
were then compared with simple pChIP classification and also overlaid on 
pChIP-network to visualise their distribution. 
  
 
Figure 7.2. Steps involved in comparing human published datasets with 
RNAPII pChIP dataset. Proteins identified in published human dataset (mRNA 
bound proteome and Mitotic RNAPII proteins) are first converted to orthologous 
mouse identifiers and compared with simple pChIP classification (Fig, 5.12) and with 
pChIP network (Fig. 6.7) 
 
7.4.2. Comparing human mRNA bound proteome (MBP) dataset with 
RNAPII pChIP dataset. 
Conversion of the original human MBP dataset into ortholog protein identifiers 
in mouse gave rise to a list of 760 proteins. Interestingly, we observed a 
significant overlap of 40% (301 proteins) between MBP and the 702 proteins 
identified by pChIP (Fig.7.2), suggesting that their strategy may capture many 
RNA processing and transport regulators that associate with RNA on 
chromatin during transcription. Looking at GO terms reassuringly, the 
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common proteins were all enriched in RNA-associated terms including ‘mRNA 
processing’, ‘RNA splicing’ and ‘mRNA polyadenylation’. Interestingly, 
ribosomal proteins were also common and enriched GO terms included 
‘translation’ and ‘ribosome biogenesis’, which may be explained in this case 
due to the association of mRNA with the functional ribosome.  
 
Looking at the remaining pChIP-only proteins (436 proteins), we observed 
significant enrichment for DNA-associated processes including ‘chromatin 
assembly’, ‘histone mono-ubiquitination’, ‘histone acetylation’ and ‘DNA 
replication’ (Fig. 7.3). 
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Figure 7.3. Comparing of proteins identified in mRNA bound proteome (MBP) 
dataset and RNAPII pChIP. Venn diagram highlights significant overlap of proteins 
(301 proteins) between MBP dataset and RNAPII pChIP. Significant GO terms for 
proteins enriched in MBP dataset, common and RNAPII pChIP proteins are 
represented by barplot. Grey, orange and red barplots represent GO terms for MBP 
proteins, common and RNAPII pChIP proteins respectively.  
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7.4.3. Comparing MBP dataset with simple pChIP classification 
Successful rounds of transcription involve phosphorylation of RNAPII (i.e. S5p 
followed by S7p and S2p) on chromatin thereby recruiting co-transcriptional 
machinery to stabilize and process the nascent RNA to produce mRNA. 
Therefore, we anticipated that most of the interactions common to pChIP and 
MBP datasets would be associated with S2p marks (i.e. ‘S5p & S7p & S2p’, 
‘S5p & S2p’ and ‘S2p only’). When compared the proteins common to MBP 
and pChIP (301 proteins; Fig. 7.3) to the simple pChIP classification shown in 
Chapter 5 (Fig. 5. 12), we find as anticipated that the majority of MBP proteins 
were enriched with ‘S5p & S2p’ (55% of 301 common proteins) and ‘S5p & 
S7p & S2p’ (18%). We plotted a pie chart of the distribution of proteins (Fig. 
7.4) and the table highlights the number of proteins. We observe clear 
enrichment for transcriptional elongation (S2p processes) with the MBP 
dataset and this further highlights the specificity of pChIP and its multiple 
applications to identify and dissect interactions. 
 
 
Figure 7.4. Preferential association of MBP proteins to elongating RNAPII 
(S5p&S2p) visualised by pie chart. Pie chart represents different RNAPII 
classifications and percentage of proteins in each group. Table consisting of number 
of protein identified in MBP and their percentages along with number of proteins in 
each pChIP classification. 
 
7.4.4. Overlaying common proteins pChIP protein network 
 
We next asked what was the position of the MBPs common to our pChIP 
dataset on the protein community network presented in Chapter 6 (Fig. 6.5), in 
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particular to asked if the proteins were preferentially associated with ‘S5p & 
S2p’ clusters. Overlaying the common proteins on the pChIP network, we 
observed that proteins were specifically enriched in clusters 4, cluster 7 and 
cluster 8 (Fig. 7.5). Cluster 7 contained 85 proteins (31%), while cluster 8 and 
4 contained 66 (24%) and 56 (20%) proteins. The preference for MBP 
proteins for ‘S5p & S2p’ clusters is visually striking (enlarged nodes in Fig. 
7.5) and further highlights the specificity and necessity to use machine-
learning approach to unravel interaction dependencies. 
  
 
Figure 7.5. MBP are preferentially located in clusters with S5p&S2p. MBP 
protein overlaid on pChIP network with enlarged nodes representing proteins 
identified in both dataset. Preferential association is observed in clusters (cluster 7,8 
and 4) containing S5p&S2p. Table consisting of number of proteins in each category. 
7.4.5. Comparing human RNAPII-mitotic interactome with RNAPII pChIP 
dataset. 
We next compared our pChIP dataset with RNAPII-mitotic interactome 
dataset (Moller et al. 2012) to identify and highlight protein-protein interactions 
from other interactions. We identified 409 mouse protein orthologs in the 
Moller dataset, and observed an overlap of 200 proteins between RNAPII-
mitotic interactome and RNAPII pChIP. It is worthwhile remembering that 
mitotic RNAPII is heavily phosphorylated on S2p, in spite of being dissociated 
from chromatin, a process thought to prevent reinitiation of RNAPII complexes 
during mitosis; in agreement with this RNAPII state, Moller and colleagues 
showed that their dataset is enriched for proteins involved in mRNA 
processing and suggested that the association in mitosis between RNAPII 
and the RNA processing machinery, in the absence of active transcription, 
pChIP clusters! Total number of proteins!
Number of 
proteins found 
in MBP dataset!
S5p enriched (A)! 16! 2 (1%)!
S5p enriched (B)! 57! 12 (4%)!
S5p enriched (C)! 109! 15 (5%)!
Translation! 154! 56 (20%)!
Transcription machinery! 83! 29 (11%)!
Histones! 44! 13 (4%)!
mRNA processing (A)! 119! 85 (31%)!
mRNA processing (B)! 118! 66 (24%)!
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could be important for the coordinated import of nuclear components once the 
nuclear membrane reforms and to promote efficient activation of mRNA 
synthesis in G1 phase of the cell cycle. 
 
Looking at GO terms for common proteins, we enrich for protein-protein 
interaction with biological functions in ‘mRNA processing’, ‘translation’ and 
‘ATP metabolic processes’ (Fig. 7.6). The pChIP-only proteins as expected 
are now enriched for a range of RNA, chromatin and nuclear processes 
including ‘mRNA processing’, ‘chromatin assembly’ and ‘DNA replication’ (Fig. 
7.6). 
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Figure 7.6. Comparing the mitotic RNAPII proteome with RNAPII pChIP dataset. 
Venn diagram with proteins identified in both RNAPII pChIP dataset and mitotic 
RNAPII interactome. 200 proteins were identified in both datasets. Significant GO 
terms for proteins enriched in different categories are represented as barplots.  
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7.4.6. Comparing mitotic RNAPII interactome with simple pChIP 
classification and pChIP-network. 
Unlike RNA-protein interactions and comparison with MBP dataset, protein-
protein interactions can occur on DNA during different stages of transcription. 
Consistently, we observe enrichment in different pChIP classifications, 48% of 
the proteins associated with RNAPII in mitosis were enriched with ‘S5p & 
S2p’, 23% proteins were enriched for ‘S5p & S7p & S2p’ and 21% proteins 
were enriched for S5p (Fig. 7.7).  However, it is interesting to observe that 
many more proteins in the GO term ‘mRNA processing’ are identified in the 
RNAPII pChIP dataset (35% of 200 proteins common to both dataset), than in 
the mitotic RNAPII proteome dataset (15% of 200 proteins common to both 
dataset), suggesting that although some processing components may remain 
associated with RNAPII during mitosis, that the majority only associates co-
transcriptionally. This highlights the power of pChIP in freezing and retaining 
co-associations that only exist on chromatin, and are likely missed after 
protein purifications. Comparisons between the mRNA processing proteins 
present throughout mitosis, and those only present on chromatin, may yield 
interesting insights on the dynamics of recruitment of the RNA processing 
machinery, but were not further explored in this thesis.  
 
 
Figure 7.7. Subsets of mitotic RNAPII interactions are captured by RNAPII 
pChIP. Pie chart of proteins identified in both mitotic RNAPII proteins and RNAPII 
pChIP. Colours represent different pChIP classification with percentage of proteins 
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identified in mitotic dataset. Table on right consists of protein numbers in pChIP 
classification and shared mitotic proteins. 
 
We next overlaid the RNAPII-mitotic proteins onto pChIP-network to observe 
whether there is any preferential association of the RNAPII-bound proteins in 
mitosis with the pChIP classification (Fig. 7.7). We observed random 
distribution of common proteins (enlarged nodes in Fig. 7.8) spread across 
different clusters, which suggests that proteins across various processes 
retain association with RNAPII through mitosis. Future work may highlight 
whether these proteins are pioneers in establishing the chromatin-associated 
proteome identified with RNAPII, or whether they simply result of our technical 
ability to detect some proteins and not others.  
  
 
Figure 7.8. Overlaying mitotic RNAPII proteins over pChIP network. Proteins 
common in both mitotic RNAPII and pChIP are overlaid and represented by enlarged 
nodes in pChIP network. No specific enrichment of mitotic proteins is observed in any 
clusters. 
 
The main advantage of comparing pChIP dataset with published datasets is 
that we can dissect and predict the interaction landscape at a minimum cost 
of bioinformatics analysis and no experimental cost. The pChIP network offers 
a visual representation of the interactions and comparison between different 
networks (Figs. 7.5 and 7.8), helping to find DNA-protein interactions and 
interactions dependent on chromatin state. 
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7.5. Discussion 
RNAPII regulation in mES cells is complex, dynamic and not only restricted to 
actively transcribing genes but also to PRC-repressed genes and other 
fundamental biological processes as unravelled by pChIP. In Chapters 5 and 
6, I have demonstrated that pChIP captures and dissects the biological basis 
of RNAPII chromatin-bound proteome and unravels its dependencies. 
Comparisons of the pChIP datasets with the MBP and mitotic-RNAPII 
interactome datasets shed further insights into the types of interactions 
represented in the pChIP classification and network. These comparisons also 
allow us to correlate and predict which interactions (DNA-protein, RNA-protein 
or protein-protein) serve as primary steps and further cascade of downstream 
interactions (secondary). For example, chromatin remodellers involved in 
transcription elongation (maintaining open chromatin) are not identified in 
MBP or mitotic RNAPII datasets, however many, but not all, splicing factors 
are identified in MBP and mitotic-RNAPII dataset (Interactions with RNA and 
proteins). 
 
A comparison of pChIP with published datasets provides a cost effective 
option of asking specific questions and obtaining biologically relevant insights. 
For example, RNA-associated proteins are enriched in S5p&S2p clusters 
(clusters 7, 8 and 4) and consist of splicing factors and interestingly proteins 
involved in translation. Intriguingly, the few proteins identified in S5p clusters 
(clusters 1, 2 and 3) raise interesting hypothesis including the role in abortive 
transcription, ncRNA regulation and also miRNA-mediated regulation. 
  
These comparisons also provide interesting candidates that form a bridge 
between RNAPII-CTD, RNA and co-transcriptional machinery. And add an 
additional layer of information about which subunits of complexes may directly 
interact with RNAPII, chromatin or RNA, and the ancillary subunits. Indeed, 
these analyses provide us a starting point to perform further experiments 
including treatment of pChIP samples with RNase, removing DNA and RNA to 
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identify the protein only cohorts. Identification of types of interactions also 
allows us to robustly select candidates for further analysis and appropriate 
experimental design. For example, a protein-protein interaction occurring on 
chromatin and dependent on chromatin state is unlikely to be identified from 
immunoprecipitation from whole cell extract preparations or nuclear extract 
preparations, the standard approach currently in the literature to identify 
protein co-associations.  
 
Ideally, we would like to perform RNAPII pChIP experiments that interfere with 
the cohorts of associated proteins, such as inhibiting of transcription 
elongation (with drugs DRB or flavopiridol) and global RNAPII transcription (α-
amanitin). But we also believe that our comparisons with MBP dataset and 
mitotic RNAPII proteome provide insights into understanding and interpreting 
the drug inhibition results. 
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8. Extending pChIP using Native chromatin and Gradient 
pChIP for crosslinked chromatin  
8.1. Research motivation 
In the previous chapters, I investigated the RNAPII-bound chromatin 
proteome using pChIP on crosslinked chromatin, unravelling and dissecting 
dependencies to RNAPII. My aim in this chapter was to extend pChIP and 
explore the RNAPII-bound chromatin proteome in non-crosslinked native 
chromatin preparations and in fractionated-chromatin preparations (both lower 
complexity samples). I aimed to perform DNA-ChIP and pChIP on histone 
modifications, Polycomb proteins and RNAPII modifications on native 
chromatin. To unravel the chromatin proteins that co-exist with RNAPII and 
Polycomb at PRC-repressed genes towards investigating the RNAPII-
Polycomb interplay on chromatin, I aimed to optimise the Gradient-pChIP 
protocol, which focuses on Polycomb proteins associated with chromatin and 
excludes chromatin-free Polycomb complexes. 
 
All of the MS experiments were carried out in collaboration with Dr. Bram 
Snijders at Proteomics facility at MRC-CSC. Bram also helped with sample 
pre-processing for MS and performed all MS run time operations. Dr. Carmelo 
Ferrai from our group helped with guidance and assistance in gradient 
fractionation of crosslinked chromatin. MS analyses on gradient samples are 
current being carried out by Dr. Guido Mastrobuoni and Dr. Stefan Kempa at 
Max Delbrück Centre for Molecular Medicine (Berlin) in an active collaboration 
between the two laboratories. 
8.2. Native chromatin 
Native chromatin is prepared by micrococcal nuclease (MNase) digestion of 
cell nuclei that leads to chromatin resolution of nucleosomes (Hebbes et al. 
1988). MNase cuts DNA between the nucleosomes where it is not protected 
by histones, proteins and multi-protein complexes; therefore, it can be 
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optimised to obtain nucleosomal resolution. Owing to its resolution and native 
extraction conditions, native-ChIP is thought to be applicable for histones, 
histone modifications and proteins that remain tightly associated to chromatin 
during the fractionation procedure. At active gene promoters, RNAPII is 
thought to bind at the nucleosome free region (NFR) between spaced 
nucleosomes and recruit pre-initiation complex (PIC). During native chromatin 
preparation, these interactions are thought to be lost owing to excessive 
purification of mono-nucleosomes. 
 
Bivalent domains present at the chromatin of PRC-repressed genes have 
been identified by native-ChIP (Bernstein et al. 2006; Mikkelsen et al. 2007; 
Ku et al. 2008; Brookes et al. 2012). These genes are simultaneously marked 
by active H3K4me3 and repressive chromatin marks (H3K27me3 and 
H2Aub1). RNAPII at these genes assessed by crosslinked DNA-ChIP was 
observed in a novel S5p-only state without productive mRNA production. 
 
In Chapter 3, the large diversity of native chromatin proteins has been 
demonstrated (Fig. 3.4), owing to more sensitive mass spectrometry 
techniques. Therefore to push the envelope, I further tested and performed 
DNA-ChIP and pChIP experiments on histone modifications, Polycomb 
proteins and RNAPII modifications (hallmarks of PRC-repressed state) using 
native chromatin.    
8.3. Chromatin fractionation by salt gradient  
Early DNA-ChIP protocols involved in-vivo fixation of living cells by 
formaldehyde, followed by purification of nuclei, sonication to break chromatin 
fragments of appropriate size range and purification of chromatin by cesium 
chloride gradient centrifugation. The chromatin fragments containing protein of 
interest are enriched by immunoprecipitation and finally DNA enrichment is 
measured after reverse crosslinking (Solomon et al. 1988; Orlando et al. 
1997). The initial studies had observed that bulk crosslinked chromatin 
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fragments were enriched in defined density gradients, distinctly different from 
the density of free DNA. In addition estimation of protein-to-DNA ratios by 
radioactive labelled amino acids and nucleotides in bulk crosslinked chromatin 
confirmed the same. These studies highlighted the use of density 
centrifugation to purify crosslinked chromatin (nucleo-histone fractions) from 
free DNA and protein for DNA-ChIP.  
 
In more recent DNA-ChIP protocols, the additional gradient separation step 
was removed primarily to save time and sample, without much effect on DNA 
yields (Schwartz et al. 2005). More importantly, it was reported that certain 
specific chromatin regions had lower density than bulk chromatin in specific 
cell type and these regions were not effectively captured in the bulk chromatin 
by gradient centrifugation (Ip et al. 1988; Reneker and Brotherton 1991; 
Schwartz et al. 2005). Salt fractionation has been more recently used to 
obtain classical transcriptionally active chromatin prepared from native 
micrococcal nuclease digestion of chromatin (Henikoff et al. 2009). Separation 
of nucleo-histone fractions having lower complexity (than unfractionated 
crosslinked chromatin) would enable pChIP to more specifically capture 
different chromatin states. Therefore, I aimed to first test the fractionation and 
perform quality control experiments to avoid any gradient biases, further 
performing pChIP with RNAPII and Polycomb proteins on nucleo-histone 
fractions to specifically identify co-existing protein cohorts. 
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8.4. Results 
The resolution of native chromatin ranges primarily from mono- and di-
nucleosomes to few nucleosomal repeats. This resolution in turn highlights 
the applicability of native ChIP for identifying closely associated, strong, more 
robust interactions occurring within the span for few hundred base pairs. The 
other advantage is the lack of crosslinking and therefore avoids sample (and 
peptide) loss during reverse crosslinking and elution steps. However, the 
resolution also restricts the overall amount of protein and its complexity, 
thereby narrowing native ChIP towards asking more specific questions. 
Generally, native chromatin is used to observe occupancy of histones, histone 
modifications and abundant transcription factors across a genome. 
8.4.1. Diversity and composition of Native chromatin proteins analysed 
using mass spectrometry 
To understand the diversity and composition of proteins in native chromatin, 
we first analysed input native chromatin proteins by MS. Sample preparation 
for MS and its analysis was done by Bram Snijders (Proteomics facility at 
MRC-CSC). I performed quality control experiments for the native chromatin 
(Coomassie staining and Agarose gel) and these results were consistent with 
previous results described in Chapter 3. 
 
We identified 2070 proteins from native input chromatin prepared from ES 
cells, and subsequently explored the major classes of proteins observed. 
Briefly, we observed abundance of few groups of proteins involved in 
‘Transcriptional regulation’, ‘Chromatin remodelling’, ‘Pluripotency’, 
‘Metabolism’ and several groups of enzymes. Examples of proteins and their 
functions also listed in Fig.  8.1.  
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Figure 8.1. Composition of proteins identified in native input chromatin and 
their functions. MS analysis of native chromatin input identified 2070 proteins with 
functions in diverse biological processes including transcription, co-transcriptional 
processing, metabolism and other cellular processes. A large number of enzymes 
were also identified as listed.  
 
8.4.2. Distribution of histone modifications captured on Native 
chromatin. 
From our MS analysis of native chromatin, we observed an abundance of 
histones, repressive protein complexes and transcription related GO terms. In 
addition, we have previously identified the novel interplay between repressive 
histone modifications co-existing along with Polycomb and RNAPII in mES 
cells (Brookes et al. 2012). Therefore, we next decided to check the 
occupancy of a few histone modifications, Polycomb proteins and RNAPII 
modifications in our mES cells using native chromatin. Emily Brookes (from 
our lab) had optimised DNA-ChIP for histone modifications H3K27me3, 
H2Aub and H3K36me3 and these DNA-ChIP results were used as standard 
for positive controls while performing Polycomb and RNAPII DNA-ChIP on 
native chromatin.  
8.4.3. H3K27me3 and H2Aub1 
I first started by reproducing previous DNA-ChIP analysis of repressive 
histone modifications (H3K27me3 and H2Aub) across a panel of genes in 
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mES cells (Stock et al. 2007b; Brookes et al. 2012). H3K27me3 is a 
repressive histone mark, catalysed by Polycomb protein Ezh2 (PRC2 subunit) 
and is mainly observed as islands demarcating promoters of PRC-repressed 
genes and sometimes in gene body (albeit to a much lower extent). H2Aub is 
also a repressive histone mark, catalysed by Polycomb protein Ring1b (PRC1 
subunit) and occurs to a lower extent than H3K27me3 and is enriched at 
promoters of PRC-repressed genes. From our lab’s work, we now know that 
H3K27me3 is observed in 30% of gene promoters and H2Aub is enriched at 
20% of gene promoters (Brookes et al. 2012). 
 
I performed DNA-ChIP using highly specific antibodies directed against 
H3K27me3 and H2Aub and consistent with published data (Stock et al. 
2007b; Brookes et al. 2012). H3K27me3 was enriched at promoters and 
coding (+2kb downstream of TSS) regions of only PRC-repressed genes 
consistent with a role as a repressive mark (Fig. 8.2). H2Aub also has similar 
pattern and is enriched at promoters and coding regions of PRC-repressed 
genes (Brookes and Pombo 2009b). No significant enrichment was observed 
at either active or silent genes (Fig. 8.2). Mock ChIP demonstrates the 
specificity of our ChIP protocol, with no detectable enrichment compared to 
ChIP with H3K27me3 or H2Aub. 
Chapter 8 Extending pChIP using Native chromatin and 
Gradient pChIP for crosslinked chromatin 
 
 209 
 
Figure 8.2. Occupancy of repressive histone modifications (H3K27me3 and 
H2Aub1) across a panel of active, PRC-repressed and silent genes on native 
chromatin in mES cells. Occupancy of H3K27me3 (light and dark purple) and 
H2Aub (light and dark cyan) as measured by DNA-ChIP on native chromatin and 
qRT-PCR at promoters (P) and coding (C) regions of panel of two active, four PRC-
repressed and two inactive genes. Coding region primers map to ~2kb regions 
downstream of the TSS, except for Sox2 (-670bp). Light and dark grey bars 
represent background enrichment levels as measured by control immunoprecipitation 
with the Digoxigenin antibody (Mock). Enrichment is expressed relative to input DNA 
using total amount of DNA in qRT-PCR. A single replicate is represented but 
additional samples were analysed with similar results. 
8.4.4. H3K4me3 and H3K36me3 
Next, I performed DNA-ChIP analysis of active histone modifications  
(H3K4me3 and H3K36me3) across a panel of genes in mES cells (Stock et al. 
2007b; Brookes et al. 2012). H3K4me3 is a hallmark of open, accessible 
chromatin and marks actively promoters and PRC-repressed gene promoters 
(Jenuwein and Allis 2001; Brookes and Pombo 2009b). H3K36me3 is mark of 
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transcribing gene bodies (Brookes and Pombo 2009b; Sims and Reinberg 
2009). I performed DNA-ChIP using highly specific antibodies directed against 
H3K4me3 and H3K36me3 and observed H3K4me3 enrichment at promoters 
of active and PRC-repressed genes. H3K4me3 was comparatively lower at 
coding regions (+2kb downstream of TSS) than at promoter (Fig. 8.3). 
H3K36me3 was found enriched at coding regions of only active genes and not 
at PRC-repressed genes consistent with role as mark of transcriptional 
elongation (Fig. 8.3). Mock ChIP demonstrates the specificity of our ChIP 
protocol, with no detectable enrichment across active, PRC-repressed or 
silent genes.  
 
Figure 8.3. Occupancy of active histone modifications (H3K4me3 and 
H3K36me3) across a panel of active, PRC-repressed and silent genes on 
native chromatin in mES cells. Occupancy of H3K4me3 (light and dark blue) and 
H3K36me3 (light and dark orange) as measured by DNA-ChIP on native chromatin 
and qRT-PCR at promoters (P) and coding (C) regions of panel of two active, four 
PRC-repressed and two inactive genes. Coding region primers map to ~2kb regions 
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downstream of the TSS, except for Sox2 (-670bp). Light and dark grey bars 
represent background enrichment levels as measured by control immunoprecipitation 
with the Digoxigenin antibody (Mock). Enrichment is expressed relative to input DNA 
using total amount of DNA in qRT-PCR. A single replicate is represented but 
additional samples were analysed with similar results. 
8.4.5. Ezh2 and Ring1b 
Polycomb proteins Ezh2 and Ring1b catalyse repressive histone 
modifications H3K27me3 and H2Aub respectively. I next performed DNA-
ChIP analysis for these two proteins across a panel of genes in mES cells 
(Stock et al. 2007b). In our results, Ezh2 is enriched promoters and coding 
regions (+2kb downstream of TSS) of only PRC-repressed genes (Fig. 8.4); 
consistent with H3K27me3 occupancy (Fig. 8.2). Ring1b follows a similar 
pattern and is enriched only at promoter and coding regions PRC-repressed 
genes (Fig. 8.4). Both Polycomb proteins were not enriched at active or silent 
genes. Mock ChIP demonstrates the specificity of our ChIP protocol, with no 
detectable enrichment across active, PRC-repressed or silent genes. 
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Figure 8.4. Occupancy of repressive Polycomb proteins (Ezh2 and Ring1b) 
across a panel of active, PRC-repressed and silent genes on native chromatin 
in mES cells. Occupancy of Ezh2 (PRC2 subunit; light and dark orange) and Ring1b 
(PRC1 subunit; light and dark brown) as measured by DNA-ChIP on native chromatin 
and qRT-PCR at promoters (P) and coding (C) regions of panel of two active, four 
PRC-repressed and two inactive genes. Coding region primers map to ~2kb regions 
downstream of the TSS, except for Sox2 (-670bp). Light and dark grey bars 
represent background enrichment levels as measured by control immunoprecipitation 
with the Digoxigenin antibody (Mock). Enrichment is expressed relative to input DNA 
using total amount of DNA in qRT-PCR. A single replicate is represented but 
additional samples were analysed with similar results. 
8.4.6. RNAPII modifications (S5p, S7p and S2p) 
Native chromatin has much higher resolution spanning only mono- and di-
nucleosomes and therefore DNA-ChIP with RNAPII is often not attempted, 
under the assumption that RNAPII is lost. In addition, it is known that RNAPII 
binds at the nucleosome free region (NFR) at +1 nucleosome and this 
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potentially limits the detection and capture of RNAPII using native chromatin. 
However, native chromatin followed by low salt extraction has been recently 
used to map RNAPII and nucleosome turnover in D. melanogaster (Teves and 
Henikoff 2011).  
 
I next performed DNA-ChIP on native chromatin using our highly specific and 
optimised protocol (Stock et al. 2007b) to measure the occupancy of RNAPII 
modifications (S5p, S7p and S2p) in native chromatin. Consistent with 
crosslinked DNA-ChIP results (Figs. 3.6 and 4.4; (Stock et al. 2007b), 
RNAPII-S5p is enriched at promoters and coding regions of active and PRC-
repressed genes in native chromatin (Fig. 8.5). RNAPII-S7p is enriched only 
at promoters and coding regions of active genes. RNAPII-S2p is also 
predominantly enriched at coding regions of active genes. Inactive genes had 
no enrichment for either RNAPII modification (Fig. 8.5). Mock pChIP was 
performed in parallel to all pChIP experiments and demonstrates minor levels 
of non-specific ChIP enrichment. We observe differential levels of RNAPII 
enrichment (S5p, S7p and S2p) between native ChIP and crosslinked ChIP 
due the different complexity and resolution of chromatin (Figs. 8.4 and 3.6). 
Our ability to detect RNAPII modifications using native chromatin highlights 
the sensitivity of our DNA-ChIP protocol and additionally allows capturing 
chromatin interactions at much lower resolution (than crosslinked chromatin) 
in mES cells. It is interesting to note that for S2p DNA-ChIP, DNA yields were 
proportionally lower in native than crosslinked ChIP. 
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Figure 8.5. Occupancy of different RNAPII modifications across a panel of 
active, PRC-repressed and silent genes on native chromatin in mES cells. 
Occupancy of RNAPII-S5p (light and dark blue), -S7p (light and dark green) and -S2p 
(light and dark red) as measured by DNA-ChIP and qRT-PCR at promoters (P) and 
coding (C) regions of panel of two active, four PRC-repressed and two inactive 
genes. Coding region primers map to ~2kb regions downstream of the TSS, except 
for Sox2 (-670bp). Light and dark grey bars represent background enrichment levels 
as measured by control immunoprecipitation without primary antibody (Mock). 
Enrichment is expressed relative to input DNA using total amount of DNA in qRT-
PCR. A single replicate is represented but additional samples were analysed with 
similar results. 
 
0!
10!
20!
30!
S5p (P)!
S5p (C)!
Mock (P)!
Mock (C) !
0!
30!
60!
90!
S7p (P)!
S7p (C)!
Mock (P)!
Mock (C) !
0!
3!
6!
9!
S2p (P)!
S2p (C)!
Mock (P)!
Mock (C) !
Oct4! Sox2! Gata4!Msx1! Hoxa7!Math1! Gata1! Myf5!
Active! PRC-repressed! Silent!
RNAPII-S7p!
RNAPII-S5p!
RNAPII-S2p!
Re
lat
ive
 e
nr
ich
m
en
t o
ve
r i
np
ut
!
Chapter 8 Extending pChIP using Native chromatin and 
Gradient pChIP for crosslinked chromatin 
 
 215 
8.4.7. Western blotting for RNAPII-S5p in pChIP samples performed on 
native chromatin. 
After confirming the occupancy of RNAPII modifications (S5p, S7p and S2p) 
in native chromatin using DNA-ChIP, I next performed pChIP with RNAPII, 
histone modifications and Polycomb antibodies to check if the amount of 
protein extracted in each case could be visualised by western blotting. 
Sensitivity of western blot ranges from 1-10ng for most proteins and 
visualization aids in determining roughly protein amounts. Approximation of 
protein amounts also aids in selecting appropriate MS pre-processing steps 
and MS run-time albeit not essential for MS analysis.  
 
After performing pChIP with RNAPII (S5p, S7p and S2p), histone 
modifications (H3K27me3 and H2Aub), Polycomb proteins (Ezh2 and Ring1b) 
and mock, I denatured and eluted the immunoprecipitated proteins by boiling 
the beads in custom Laemmli buffer (95°C for 10min) and removed the 
supernatant from beads. Protein samples were separated on 15% SDS-
PAGE, followed by western blotting using anti-RNAPII-S5p antibody; 
Coomassie staining was not attempted to measure yield of protein extraction 
due to the low protein yields in pChIP and low sensitive of Coomassie. We 
observe that S5p is robustly enriched in multiple pChIP samples including S5p 
and S7p, consistent with the highest abundance of both marks on chromatin 
in these samples. S5p was also detected above control IP in the Ezh2 and 
Ring1b pChIP lanes after long exposure (Fig. 8.6; Lane 4,5,9 and 10). Low 
level of signal was observed in H3K27me3, H2Aub and S2p pChIP upon 
overnight exposure (Fig. 8.6; Lanes 6, 7 and 8; data now shown). Mock pChIP 
was clean and even on long exposure (overnight) no S5p signal is observed 
demonstrating the specificity of our pChIP and western blotting.  
Elongating RNAPII is marked by both S5p and S2p as demonstrated by 
sequential ChIP analyses (Brookes et al. 2012). It is possible that in these 
brief preliminary analysis S2p pChIP has lower yields of proteins that prevent 
robust detection of S5p by western blotting. It is also interesting to notice the 
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lower S2p enrichments in native DNA-ChIP (Fig. 8.5). Future western blot 
analyses with S2p antibodies will be help understand the low RNAPII-S5p 
detection in the S2p pChIP sample. 
 
Figure 8.6. Western blotting confirms immunoprecipitation of RNAPII-S5p with 
different pChIP samples on native chromatin. Western blotting was performed 
using anti-RNAPII-S5p antibody on pChIP samples (S5p, S7p, S2p, H3K27me3, 
H2Aub, Ezh2, Ring1b and mock) and clearly show enrichment for S5p in S5p, S7p, 
Ezh2 and Ring1b pChIP samples (lanes 4,5,9,10). Lower levels of signal were 
obtained in other samples (S2p, K27me3, and H2AUb; Lanes 6,7 and 8) on long 
exposure. Mock (lane 11) was consistently devoid of S5p band. Proteins were 
denatured by boiling beads after pChIP at 95°C for 10min in custom Laemmli buffer 
and eluting supernatant from beads.  
 
8.4.8. pChIP-MS on native chromatin 
After confirming the occupancy of histone modifications, Polycomb proteins 
and RNAPII modifications on native chromatin, I next performed pChIP using 
a subset of antibodies (S5p, Ring1b, H3K27me3, H2Aub, H3K36me3) along 
with mock (Digoxigenin and no antibody) and analysed the proteins by MS. 
MS processing steps were performed by Dr. Bram Snijders (at Proteomics 
facility at MRC-CSC). We first removed common MS contaminants (keratins, 
immunoglobulins, etc.) and used both of our mock pChIP experiments to filter 
contaminants. As in this case, we have not used SILAC labelling we used 
standard MS scoring (Mascot score) for peptide and protein identification. 
Mascot score is probability based scoring that matches observed peptide 
mass values (from tandem MS/MS fragment ion masses) against a random 
event to identify significant, robust peptides. Any proteins with Mascot score > 
30 in either mock pChIP (Digoxigenin or no antibody) were considered non-
specific ChIP contaminants, and removed from the dataset. In addition, we 
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used further stringent criteria for each pChIP, i.e. mascot score > 30 to 
demarcate specific associated proteins from non-specific proteins. The pChIP 
were done on native chromatin and MS analysis was accordingly performed. 
Due to the non-quantitative nature of the analysis, we first looked at the total 
dataset to obtain overview of the MS run and then later performed each pChIP 
data analysis separately.  
 
We identified 4655 proteins from the 6 different MS samples and included 
major groups of proteins including transcription factors, metabolic proteins, 
Zinc finger, Ring finger proteins and splicing factors. Table 8.1 shows the 
summary and number of proteins in each group. We also looked at different 
classes of enzymes important for regulation of several biological processes 
and saw a distinct enrichment for kinases, phosphatases and transferases. 
Table 8.1 lists the different classes of enzymes identified. Interestingly we 
observed about ~350 proteins enriched across all the different pChIP (except 
mock and Digoxigenin) with high mascot scores (>100) and involved in 
diverse processes. To keep our analysis unbiased, we did not filter these 
proteins and continued further analysis. 
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Table 8.1. Summary of proteins identified in pChIP on native chromatin. Five 
pChIP samples (S5p, Ring1b, H3K27me3, H2Aub and H3K36me3) and native input 
chromatin were analysed by MS. 4655 unique proteins were identified from the total 
dataset. Example of major classes of proteins and enzyme are listed below. 
 
8.4.9. H3K27me3 
H3K27me3 is a hallmark of repressive chromatin and is catalysed by 
Polycomb protein Ezh2. After performing H3K27me3 native pChIP, we 
identified 816 proteins. Comparing the depth of MS run, I first asked how 
many proteins were specifically enriched over input native chromatin (Fig. 
8.7). H3K27me3 pChIP specifically enriched for 278 proteins (overlap – 34% 
of H3K27me3 proteome). Gene ontology (GO) analysis identifies terms 
‘nucleosome disassembly’, ‘chromatin modification’, ‘ncRNA processing’ and 
‘cell cycle’ (Fig. 8.7). We identify additional proteins in H3K27me3 only (538 
proteins) that reflect on incomplete protein sequencing depth of input 
Total number of proteins in all pChIP dataset – 4655 proteins!
(S5p, Ring1b, H3K27me3, H2Aub, H3K36me3 and native input chromatin)!
!
!
Protein group ! ! ! !Number of proteins!
Transcription factors ! ! ! ! !104!
Metabolic proteins ! ! ! ! !212!
Zinc finger proteins ! ! ! ! !184!
Ring finger proteins ! ! ! ! !36!
Splicing factors ! ! ! ! !45!
!
Enzymes classes !
All kinases ! ! ! ! ! !363!
Serine/Threonine kinases ! ! ! !102!
Phosphatases! ! ! ! ! !99!
Methyl transferases ! ! ! ! !57!
Acetyl transferase ! ! ! ! !22!
!
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chromatin. A few examples of proteins enriched in H3K27me3 are listed in the 
Fig. 8.7.  
 
Figure 8.7. Summary of proteins identified in H3K27me3 pChIP using native 
chromatin. Proteins identified in H3K27me3 native pChIP were contrasted with input 
native chromatin proteins as plotted as Venn diagram. Examples of proteins enriched 
in H3K27me3 are also represented and include transcriptional components, 
chromatin remodellers and Polycomb proteins. Significant GO terms enriched and 
their p-values are represented as purple bar plots. 
Input chromatin (native)!
H3K27me3!
278! 538!1792!
H3K27me3 proteins!
Transcription components - RNAPII subunits, Supt16, Paf1 
complex, Exosome components.!
Pluripotency factors – Oct4, Sox2, Esrrb, Paf1, Dppa2 and  
Dppa4!
Chromatin remodellers – Brca2, Ctcf, Dnmt3a, Hdac2, Hmga1, 
Smarcb1, Mta2, Rybp, Smarcd3, Smarcc2;, Wdr82, Arid1a, 
Smarca1, Chd4, Hdac1 (cell cycle proteins)!
Polycomb proteins – Jarid2, Ezh2, Suz12, Eed and Cbx 
protein subunits!
DNA duplex unwinding
DNA packaging
ncRNA processing
regulation of gene expression
response to DNA damage stimulus
protein phosphorylation
cell cycle
DNA replication
nucleosome disassembly
cell division
chromatin modification
purine ribonucleoside triphosphate catab...
Percentage (%)
(Observed proteins/Total proteins)
0 20 40 60 80 100
5e-05
5e-06
1e-06
9e-07
2e-07
5e-08
1e-08
1e-08
6e-09
5e-11
4e-13
2e-15
Gene Ontology terms (p-value < 10-5)!
Chapter 8 Extending pChIP using Native chromatin and 
Gradient pChIP for crosslinked chromatin 
 
 220 
8.4.10. H2Aub 
H2Aub is also a repressive mark, catalysed by protein Ring1b (PRC1 
subunit). Performing H2Aub native pChIP, we identify 1255 proteins and 
comparing the depth over input native chromatin, H2Aub pChIP specifically 
enriches for 610 proteins (overlap – 49% of H2Aub proteome). Performing 
gene ontology (GO) analysis, terms enriched with H2Aub include ‘DNA 
metabolic processes’, ‘chromatin modification’, ‘gene silencing by miRNA’ and 
‘negative regulation of expression’ (Fig. 8.8). Similar to H3K27me3 pChIP, 
additional proteins are identified in H2Aub only (645 proteins) reflecting low 
sequencing depth of input chromatin.  
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Figure 8.8. Summary of proteins identified in H2Aub pChIP using native 
chromatin. Specificity and robustness of H2Aub native pChIP was analysed by 
contrasting with input native chromatin proteins and plotted as Venn diagram. 
Examples of proteins enriched in H2Aub are also represented and include Polycomb 
proteins, some transcriptional components and chromatin remodellers. Significant 
GO terms enriched and their p-values are represented as cyan coloured bar plots. 
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8.4.11. H3K36me3 
H3K36me3 is present in gene bodies and is hallmark of transcriptional 
elongation characterised by open chromatin. From the H3K36me3 native 
pChIP, we identified 1020 proteins. Comparing the overlap with proteins from 
input native chromatin, we identify 490 proteins (overlap – 48% of H3K36me3) 
enriched over input chromatin, Performing gene ontology (GO) analysis, 
enriched terms included ‘RNA processing’, ‘GTP metabolic processes’, 
‘mRNA transport’, ‘chromatin modification’ terms and ‘mRNA catabolic 
processes’ (Fig. 8.9). Consistent with low input native chromatin sequencing 
depth, we identified 530 proteins in H3K36me3 only (912 proteins). Examples 
of proteins enriched in H3K36me3 are listed in the Fig. 8.9.  
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Figure 8.9. Summary of proteins identified in H3K36me3 pChIP using native 
chromatin. Proteins identified in H3K36me3 native pChIP were first contrasted with 
input native chromatin proteins and plotted as Venn diagram. Examples of enriched 
are also represented. Significant GO terms enriched and their p-values are 
represented as orange coloured bar plots. 
8.4.12. RNAPII-S5p 
From the RNAPII-S5p native pChIP, we identified 1731 proteins which include 
~350 proteins having high mascot scores across all pChIP experiments. I first 
asked whether RNAPII-S5p pChIP specifically enriches for proteins from input 
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native chromatin. Using the MS with intermediate depth, RNAPII-S5p pChIP 
specifically enriched for 819 proteins of 2070 proteins detected in input 
chromatin (overlap – 47% of RNAPII-S5p proteome). Performing gene 
ontology (GO) analysis, I observed that the proteome enriched for with 
RNAPII-S5p pChIP was enriched for ‘mRNA metabolic processes’, 
‘transcription’, ‘gene silencing ’, ‘chromatin modification’ terms and ‘blastocyst 
formation’ (Fig. 8.10). The identification of additional proteins in RNAPII-S5p 
only (912 proteins) reflects on incomplete protein sequencing depth of the 
more complex input chromatin. A few examples of proteins enriched in 
RNAPII-S5p are listed in the Fig. 8.10.  
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Figure 8.10. Summary of proteins identified in RNAPII-S5p pChIP using native 
chromatin. Proteins identified in RNAPII-S5p native pChIP were contrasted with 
input native chromatin proteins as plotted as Venn diagram. Examples of proteins 
enriched in RNAPII-S5p are also represented. Significant GO terms enriched and 
their p-values are represented as barplots. 
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(overlap – 56% of Ring1b proteome). Performing gene ontology (GO) 
analysis, terms enriched with Ring1b included ‘Ribonucleoprotein complex 
biogenesis’, ‘ATP metabolic processes’, ‘chromatin modification’ and ‘gene 
silencing’ (Fig. 8.11). Similar to RNAPII-S5p native pChIP, we identified 
additional proteins in Ring1b only (715 proteins) reflects on protein 
sequencing depth of input chromatin. A few examples of proteins enriched in 
Ring1b are listed in the Fig. 8.11.  
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Figure 8.11. Summary of proteins identified in H2Aub pChIP using native 
chromatin. Specificity and robustness of Ring1b native pChIP was analysed by 
contrasting with input native chromatin proteins and plotted as Venn diagram. Protein 
examples include Polycomb proteins, quite a few transcriptional components, 
pluripotency factors and chromatin remodellers. Significant GO terms enriched and 
their p-values are represented as green coloured bar plots. 
 
8.4.14. Gradient pChIP for crosslinked chromatin 
Formaldehyde crosslinks all interactions within 2Å spacer arm including DNA-
protein, protein-protein, RNA-protein and interactions dependent on chromatin 
states. With formaldehyde crosslinking, it is often taken into account that 
protein-protein interactions and further sub-interactions distant from chromatin 
are also crosslinked. In DNA-ChIP, these sub-interactions are less visible due 
to population effects and PCR amplification, whereas with pChIP, these 
interactions represent the pathway and range of protein-proteins interactions 
associated with the chromatin state chromatin state immunoprecipitated. 
Reducing these sub-interactions would facilitate the identification of most 
robust and direct chromatin interactors by pChIP in crosslinked chromatin. 
Therefore it is essential to purify the nucleo-histone complexes (only DNA, 
histones and interactors) without diluting/reducing the protein amounts while 
maintaining the sensitivity and detection limit.  
8.4.15. Strategy for clarifying crosslinked chromatin to obtain 
nucleo-histone complexes and protein/DNA fractions 
I first started by using the original DNA-ChIP protocol that included an 
additional step of using salt gradient to fractionate DNA-protein complexes 
from DNA-only and protein-protein only complexes (Gilmour and Lis 1984; 
Gilmour and Lis 1985; Solomon et al. 1988; Orlando et al. 1997). This 
additional step is removed from DNA-ChIP protocols primarily to save time 
without much effect on DNA yields (Schwartz et al. 2005). In addition, there 
have been reports that the analyses of specific gradient fractions can bias 
DNA-ChIP results for specific short DNA fragments (termed PRE-Polycomb 
Repressive Elements) in D.melanogaster (Schwartz et al. 2005).  
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Briefly, crosslinked chromatin was prepared as described (section 2.2.1.1). 
Density of fixed chromatin was adjusted to 567.8mg/ml (i.e. 1.42g/cm3) using 
Cesium Chloride (CsCl2) followed by ultra-centrifugation at high speed 
(40,000rpm, 72hrs, 4°C). The resulting gradient was collected in 10 (or 11) 
different fractions representing different densities of input chromatin, and 
excess salt from the fractions was subsequently removed by dialysis. After 
performing appropriate quality control experiments (see next section 8.3.7) 
and confirming good separation of nucleo-histone fractions from DNA-only 
and protein-only, DNA-ChIP and PChIP were accordingly performed using 
RNAPII antibodies (and other antibodies). After confirming the appropriate 
fractionation by different assays (see next section 8.1.7), DNA-ChIP (qRT-
PCR) and pChIP (western blotting and MS) was performed using RNAPII 
antibodies to observe occupancy of RNAPII and its chromatin-bound 
interactome. 
 
Figure 8.12. Overview of steps involved in Gradient-pChIP. Input chromatin was 
prepared as previously described (section 2.2.1.1). Input chromatin was fractionated 
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by salt gradient (CsCl2) to obtain 10 different fractions representing DNA-only 
fractions, Nucleo-histone fractions and protein-only fractions (Schwartz et al. 2005).  
8.4.16. Nucleo-histone complexes are well separated from DNA-
only and protein-only fractions. 
In the original DNA-ChIP protocols, the distribution of DNA (Agarose gel 
electrophoresis) and proteins (Coomassie staining or western blotting) across 
different fractions was collated along with density measurements (scintillation 
counter) to determine fractions containing nucleo-histone complexes while 
separating DNA-only and protein-only fractions (Gilmour and Lis 1984; 
Solomon et al. 1988; Orlando et al. 1997). The fractions were accordingly 
pooled together based on DNA and protein distributions for further ChIP 
assays and also for determining any biases either resulting from biological 
phenomenon (Schwartz et al. 2005) or inefficient gradient separation (Orlando 
et al. 1997). 
8.4.17. Quality control for gradient fractions (Agarose gel, 
Coomassie and western blotting) 
To optimise the gradient ChIP, I first compared the distribution of chromatin 
obtained from 11 different fractions on 1.2% Agarose gel (Fig. 8.13 Agarose 
gel). Loading a low volume of input chromatin (10μl), we observed a good 
gradient separation of chromatin across different fractions. Fractions 1-3 
consisted of very short DNA fragments that migrated the fastest and were 
quite smaller. Fractions 4-8 consisted of bulk DNA, with maximum intensity in 
fraction 5. Fractions 9-11 consisted of very little DNA intensity and 
corresponding towards much bigger DNA fragments (>10kb; Data not shown).  
 
Next, I observed the distribution of selected proteins by western blotting 
including 11 different fractions and unfractionated sample. Samples were first 
denatured by boiling samples in custom Laemmli buffer (95°C for 10min) and 
subsequently separated by electrophoresis (15% SDS-PAGE gel). Western 
blot using anti-S5p and anti-Oct4 antibody was performed (Fig. 8.13; Western 
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blot). RNAPII-S5p was robustly identified and enriched in the nucleo-histone 
fractions (top band; Fractions 4-8) and highest intensity was observed in 
fractions 6 and 7 (similar to unfractionated sample Lane 2). We also observed 
low intensity of S5p in fractions 9-11. Very little or no RNAPII-S5p was 
observed in fractions 1-3 (DNA-only fractions). Consistent with Agarose gel 
results (Fig. 8.13 A), we observed nucleo-histone complexes in fractions 4-8, 
DNA-only in fractions 1-3 and protein-only in fractions 9-11. We observed very 
faint blotting for Oct4 protein and Oct4 protein was predominantly enriched in 
nucleo-histone fractions (fractions 4-8). 
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Figure 8.13. Distribution of DNA and western blotting after salt gradient 
fractionation. Eleven different fractions representing range of densities were 
obtained after CsCl2 gradient separation. 10μl of different DNA fractions (after 
reverse-crosslinking) were loaded on 1.2% Agarose gel to observe the distribution of 
DNA. 10μl of reverse crosslinked protein sample (denatured at 60°C o/n and 100°C 
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10min in custom Laemmli buffer) was loaded on 15% SDS-PAGE gel to perform 
western blotting with anti-S5p antibody and anti-Oct4 antibody to observe protein 
distribution.  
 
I next performed a basic visual comparison of the DNA and protein distribution 
from our OS25-mES cells to the distribution of D.melanogaster - Schneider L2 
cells being aware of the differences in genome, transcriptome, proteome and 
their regulation between both organisms (Schwartz et al. 2005). Remarkably 
the distribution of gradient separation was similar between the two Agarose 
gels (Figure 8.13 and 8.14). The bulk DNA in both the cells was enriched 
across middle fractions (4-8 in our cells and densities-1.48-1.30 in Schneider 
cells).  
 
Figure 8.14. Similar distribution of DNA (chromatin) densities observed 
between D.melanogaster (Schwartz et al. 2005) and our mES cell chromatin. 
Brief comparison between published D.melanogaster DNA distribution across 
different density gradient fractions and our mES cell chromatin gradient fractions.  
8.4.18. Distribution of active, PRC-repressed and silent genes 
across the different fractions. 
I next looked at the distribution of specific genes across the different fractions 
to ensure that bulk nucleo-histone fractions contained most of the chromatin 
regions. Reverse crosslinking the input chromatin from different fractions and 
purifying the DNA, I next compared the distribution of two active, four PRC-
repressed and two silent gene promoters across the 10 different fractions 
Drosophila Schneider-L2 cells!
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using qRT-PCR (Fig. 8.15). In principle, all gene promoters are similarly 
enriched in unfractionated chromatin sample, therefore after fractionation 
gene promoters should only be enriched in nucleo-histone fractions. 
Consistently we observe fractions 4,5,6,7 and 8 containing bulk of the DNA 
(chromatin) and have similar pattern of enrichment for different gene 
promoters (active, PRC-repressed and silent; Fig. 8.15). X-axis represents the 
different fractions from 1-10; Y-axis represents relative enrichment (arbitrary 
units) and is calculated by using CT values for each fraction normalized to CT 
values for fraction 1. 
 
It has been reported that gradient fractionation in D.melanogaster Schneider 
L2 cells biases DNA-ChIP results more specifically for short fragments called 
Polycomb Response Elements (PRE) (Schwartz et al. 2005). PREs have only 
been identified in D.melanogaster as short motifs that act as platform for 
Polycomb proteins to bind and regulate the chromatin architecture (Ringrose 
and Paro 2007; Pirrotta and Li 2012). It was reported that binding of Polycomb 
and accessory proteins on small PRE motif dynamically shifts the local 
density and upon gradient centrifugation PRE motifs are well detected across 
nucleo-histone fractions (Schwartz et al. 2005). In our mES cells, we didn’t 
observe any bias for PRC-repressed genes (promoter region primers) or for 
active or silent genes (Fig. 8.15). I also looked for coding region primers for 
active, PRC-repressed, silent genes and observed no bias (data not shown). 
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Figure 8.15. Confirming the abundance of different DNA regions preferentially 
in nucleo-histone fractions. DNA was obtained by reverse crosslinking chromatin 
and qRT-PCR was performed for 10 different chromatin fractions using primers 
spanning Promoter regions of two active, four PRC-repressed and two inactive 
genes. Nucleo-histone fractions (4,5,6,7 and 8) consisted of most of the DNA for all 
primers, very little DNA was observed in protein-only fractions 9 and 10. Pattern of 
enrichment for all primers was consistent across the different fractions. Differential 
levels of enrichments (Y-axis bars) are representative of different DNA amounts of 
the genes in the different fractions. Relative enrichment was calculated relative to 
fraction 1 and y-axis represents arbitrary units of enrichments. 
 
8.4.19. Considerations for Gradient pChIP  
To perform DNA-ChIP on gradient chromatin, we pooled fraction 1-3 together 
to form a DNA-only fraction, Fractions 4-8 to form a nucleo-histone fraction 
and fractions 9-11 to form a Protein-only fraction. To perform DNA-ChIP, we 
first quantified the concentration of DNA from 3 different pooled fractions 
(DNA yields ranging 10-50 μg). DNA concentration was used as a measure of 
chromatin volume for DNA-ChIP and pChIP.  
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8.4.20. DNA-ChIP for RNAPII modifications on gradient samples. 
To observe the distribution and enrichment of RNAPII between the three 
different fractions, I first performed RNAPII-S5p DNA-ChIP on the three 
different fractions across a panel of promoter (P) and coding region (C) 
primers of two active, four PRC-repressed and two silent genes (Fig. 8.16). 
Robust enrichment of RNAPII-S5p is only observed in nucleo-histone fractions 
(Fig. 8.16; middle graph) and RNAPII-S5p is enriched at promoters and 
coding regions of active and PRC-repressed genes. These enrichments are 
consistent with previous results (Figs. 3.6 and 4.4) (Stock et al. 2007b; 
Brookes et al. 2012).  
 
There was very little signal observed for RNAPII-S5p in DNA-only fractions 
with no significant enrichment (levels similar to mock DNA-ChIP). These 
results are consistent as input chromatin (of DNA-only fractions) had much 
lower starting material compared to nucleo-histone fractions (also see Fig. 
8.15). We observed high levels of background (mock) in the Protein-only 
fractions and RNAPII-S5p enrichment levels were comparable to the 
background levels (Fig. 8.15 bottom panel; Grey bars). These results validate 
the specific enrichment of bulk chromatin in the nucleo-histone fractions and 
use of nucleo-histone fractions for further analysis. 
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Figure 8.16. Occupancy of RNAPII-S5p DNA-ChIP measured on three 
chromatin fractions by gradient ChIP. Occupancy of RNAPII-S5p (light and dark 
blue was measured on three different chromatin fractions (DNA-only, nucleo-histone, 
Protein-only) by gradient DNA-ChIP and qRT-PCR at promoters (P) and coding (C) 
regions of panel of two active, four PRC-repressed and two inactive genes. Light and 
dark grey bars represent background enrichment levels as measured by control 
immunoprecipitation (Mock). Enrichment is expressed relative to input DNA using 
total amount of DNA in qRT-PCR.  
 
0!
10!
20!
30!
S5p (P)!
Mock (P)!
S5p  (C)!
Mock (C)!
0!
3!
6!
9!
S5p (P)!
Mock (P)!
S5p  (C)!
Mock (C)!
0!
0.4!
0.8!
1.2!
S5p (P)!
Mock (P)!
S5p  (C)!
Mock (C)!
RNAPII-S5p!
(DNA only fraction)!
RNAPII-S5p!
(Nucleo-histone fraction)!
RNAPII-S5p!
(Protein only fraction)!
Re
lat
ive
 e
nr
ich
m
en
t o
ve
r i
np
ut
!
Oct4! Sox2! Gata4!Msx1!Hoxa7!Math1! Gata1! Myf5!
Active! PRC-repressed! Silent!
Chapter 8 Extending pChIP using Native chromatin and 
Gradient pChIP for crosslinked chromatin 
 
 237 
To compare the occupancy of other RNAPII modifications, I performed DNA-
ChIP with RNAPII-S7p and S2p on the nucleo-histone fractions. Consistent 
with previous results (Figs. 3.6 and 4.4), the patterns of enrichment for 
RNAPII modifications are quite similar (Stock et al. 2007b; Brookes et al. 
2012). RNAPII-S7p is enriched at promoter and coding regions of active 
genes and no enrichment is observed across PRC-repressed or silent genes. 
RNAPII-S2p is also enriched at active genes with higher levels of enrichment 
in coding regions compared to promoters.  
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Figure 8.17. Occupancy of different RNAPII modifications across a panel of 
active, PRC-repressed and silent genes in nucleo-histone fraction by gradient 
DNA-ChIP in mES cells. Occupancy of RNAPII-S5p (light and dark blue), -S7p (light 
and dark green) and -S2p (light and dark red) as measured by DNA-ChIP and qRT-
PCR at promoters (P) and coding (C) regions of panel of two active, four PRC-
repressed and two inactive genes. Light and dark grey bars represent background 
enrichment levels as measured by control immunoprecipitation (Mock). Enrichment is 
expressed relative to input DNA using total amount of DNA in qRT-PCR.  
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8.4.21. MS analysis of pChIP gradient samples and next steps 
I have performed pChIP with RNAPII modifications (S5p, S7p and S2p) on 
nucleo-histone fractions and these samples are currently being analysed by 
MS (Guido Mastrobuoni and Stefan Kempa at MDC-Berlin). In addition we are 
also processing RNAPII-S5p pChIP done on DNA-only and protein-only 
fractions to quantify the differences in protein identified.  
 
In parallel, we are performing DNA-ChIP and pChIP experiments on nucleo-
histone fractions using RNAPII modifications and Polycomb proteins to 
identify candidate proteins important for RNAPII-Polycomb interplay in mES 
cells. 
8.5. Discussion 
8.5.1. Diversity of native chromatin and pChIP proteins  
PRC-repressed chromatin is marked by bivalent chromatin modifications 
along with RNAPII-S5p and Polycomb proteins that catalyse repressive 
histone marks. We have performed DNA-ChIP for histone modifications, 
Polycomb proteins and RNAPII modifications on native chromatin in mES 
cells. Reassuringly, the pattern of enrichment for histone modifications, 
Polycomb and RNAPII modifications are similar between crosslinked 
chromatin and native chromatin that suggests the specificity of our DNA-ChIP 
and chromatin preparation. We believe that there are some important 
considerations for robust DNA-ChIP in native chromatin in mES cells. Firstly, 
the extent of nucleosomal preparation i.e. micrococcal nuclease treatment is 
essential and requires optimisation. We observe that 5-min digestion (2U/ml 
MNase) robustly gives bands corresponding to primarily mono-nucleosomes 
and di-nucleosomes and rarely any poly-nucleosomes. Secondly, a well-
characterised antibody against non-transient chromatin interactor is essential 
for a robust DNA-ChIP signal. Thirdly, we observe a good consistent yield of 
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DNA in native chromatin across different replicates that further add 
robustness to our protocol. 
 
The diversity of native chromatin proteins has already been highlighted and 
discussed in Chapter 3. We observe an average of >2000 proteins detected 
from native input chromatin consistently across different runs in intermediate 
depth MS run. We observe a distinct enrichment for proteins with known 
association on chromatin including master stem cell regulators, TFs and 
several enzymes that modify histones and other chromatin proteins. Our 
pChIP samples analysed by MS were pooled from two immunoprecipitations 
done on same chromatin. The pooling of samples allows greater, better 
protein identification and enhances the MS peptide sequencing depth.  
 
We have demonstrated the specificity of our pChIP and associating proteins 
on chromatin with different histone modifications, Polycomb proteins and 
RNAPII modifications. In our analysis, we observed ~300 proteins that were 
consistently detected across all pChIP runs (except mock). A naïve 
interpretation is that these proteins are non-specific due to their abundance in 
all experiments. However, the other possibility is that chromatin is marked by 
these proteins consistently (with subtle difference in stoichiometry or 
composition). Interestingly, important chromatin regulators belong to this 
group. The pChIP analysis on native chromatin was performed on normal 
chromatin and therefore was qualitative and not quantitative. Therefore, 
effective comparison between multiple pChIP runs was not possible. We 
strongly believe that in addition to quantitative analysis (e.g. SILAC) with 
complementary experimental setup, it is essential to perform systems biology 
analysis to unravel and detect patterns of protein associations to different 
proteins. 
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8.5.2. Gradient separation of chromatin fractions 
In conclusion, I have adapted and optimised conditions for gradient fractions 
and purification of nucleo-histone fractions for our mES-OS25 cells. 
Performing quality control experiments, I observed enrichment of DNA in 
fractions 4-8 consistent with enrichment for histones and other proteins (Fig. 
8.13 and data not shown) by Coomassie staining of proteins. From our 
preliminary analysis of chromatin, we did not observe any biases as reported 
with D.melanogaster cell lines (Schwartz et al. 2005). Since promoters of 
PRC-repressed genes have high occupancy of RNAPII-S5p, Polycomb 
proteins and bivalent histone modifications, we hypothesised that density 
gradient bias would be most apparent in differently sized PRC-repressed gene 
promoters. Testing promoter primers on input chromatin for two active, four 
PRC-repressed and two inactive genes, we observed no specific enrichment 
for either of the gene promoters. We cannot completely exclude the effect of 
fractionation without performing genome-wide analysis on different fractions. 
 
We have also demonstrated the robustness of our nucleo-histone fractionation 
and confirmed specificity by performing DNA-ChIP on all fractions (DNA-only, 
protein only and nucleo-histone fractions). The gradient fractionation (DNA-
ChIP and pChIP) offers specific advantages including increased yields of DNA 
and protein after immunoprecipitation. Secondly, non-specific background in 
both DNA and pChIP is massively reduced. Thirdly, due to fractionation, we 
enrich for chromatin state in our nucleo-histone fractions (compared to 
unfractionated sample) increasing the sensitivity and detection potential of 
pChIP-MS.
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9. Discussion 
9.1. Thesis overview 
PRC-repressed genes encode for important developmental regulator, 
metabolic, signalling and lineage specification genes that exist with bivalent 
chromatin architecture along with Polycomb proteins and unusual RNAPII 
(S5p+S7p-S2p-) in mES cells. The chromatin state of these genes resolves 
into monovalent chromatin configurations upon lineage specification, 
suggesting the RNAPII and Polycomb proteins in mES cells maintain these 
genes in a poised state for future activation. In this thesis, I have investigated 
the chromatin landscape of mES cells from the point of view of RNAPII 
modification; I developed a novel unbiased strategy, called “Proteome-ChIP”, 
to explore the proteome associated with RNAPII-bound chromatin in mES 
cells.  
 
The work in this thesis highlights the dynamic and complex nature of RNAPII 
gene regulation network in mES cells. In Chapter 3, I investigated the 
chromatin proteome extracted using different methods and their relevance to 
appropriate biological questions specifically in the context of stem cells. While 
optimising pChIP conditions, I have demonstrated that proteins associated 
with chromatin bound by RNAPII can be qualitatively and quantitatively 
enriched from input chromatin (Chapters 3 and 4). Using a combination of 
simple logics and advanced systems biology approach, we comprehensively 
dissect and unravel the RNAPII-chromatin bound proteome in mES cells and 
shed light on the dynamic RNAPII regulation and the complex integration of 
chromatin and RNA processing events that coincide on chromatin. From our 
datasets, we uncover novel RNAPII biology, S5p-associated processes and 
new knowledge of RNAPII specific stem cell processes (Chapters 5 and 6). I 
also investigated the versatility of pChIP to capture and uncover different 
interaction types (protein-protein, RNA-protein and DNA-protein) in Chapter 7. 
Lastly, extending and performing pChIP on native chromatin extracts and 
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fractionated chromatin, I have explored the robustness and potential of 
applying pChIP on different kinds of chromatin preparations to uncover novel 
chromatin association fundamental for control of gene regulation.    
 
9.2. From research objectives to research findings 
9.2.1. Proteome-ChIP as tool to unravel chromatin-bound proteome 
Chromatin is composed of DNA wrapped round a histone octamer forming 
nucleosome monomers that are further associated by linker histone H1 
establishing a higher level of chromatin organization (Fischle et al. 2003). The 
chromatin provides a platform for sequence-specific factors, chromatin 
remodellers, transcription factors, transcriptional machinery and other factors 
to access DNA and coordinate a range of regulatory and mechanistic 
programs that govern the cellular viability and response to external cues. This 
coordinated interplay on chromatin is tightly regulated and signals cascades 
of downstream processes that feedback and further regulate chromatin 
processes. To capture globally the proteome and many of these interactions, I 
initially used crosslinked chromatin extracts (Fig. 3.3) that chemically fixes 
and captures all types of interactions (DNA-protein, RNA-protein and protein-
protein interactions); note that independent evidence shows that even newly-
made RNAs are preserved and can be specifically purified after our RNAPII 
ChIP (K.J. Morris, our laboratory; unpublished work), implying that when 
interpreting the proteome isolated after ChIP, it is important to consider that 
some proteins may be immunoprecipitated through their association with 
RNA, and not necessarily through associations with chromatin or the RNAPII 
itself. To enrich specific interactions from all the possible interactions present 
in chromatin extracts, I performed pChIP using highly specific RNAPII 
antibodies (S5p and S7p: Fig 3.12 and Fig 3.13). Using high-throughput MS, 
we identify a large number of protein interactors by detecting unique and 
specific peptides corresponding to intact protein; this is an unique opportunity 
offered by MS detection, which unlike western blot analyses, does not require 
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detection or preservation of the whole protein, only that some peptides survive 
the assay until their ultra-sensitive detection by MS. 
 
The ability to detect specifically and robustly chromatin-bound interactions is 
inherently linked to coupling the crosslinked chromatin preparation with my 
optimised pChIP protocol and aided by high-throughput detection of peptides 
by MS. In the literature, there have been other studies and methods to capture 
major protein interactions on chromatin including “PICh”, “mChIP” and “iChIP” 
(Dejardin and Kingston 2009; Hoshino and Fujii 2009; Lambert et al. 2009; 
Lambert et al. 2010). These methods have been quite useful in studying 
abundant proteins but have often required large amounts of starting material. 
In addition, issues concerning low sample recovery, sample heterogeneity, 
and impossibility of amplifying protein samples prior to their MS analysis affect 
these methods. Some of these methods require probes against specific DNA 
sequence or require random insertion of tagged constructs; that makes them 
less appealing for use in stem cells. We have demonstrated that coupling 
pChIP protocol to crosslinked chromatin and appropriate MS conditions, 
combined with enrichment for chromatin compartments associated with 
specific proteins (such as RNAPII) allows robust qualitative and quantitative 
detection of proteins, overcoming the issues of the other methods. 
 
Another determinant in chromatin proteomics methods is low abundance of 
proteins reflected by weak Coomassie staining (Fig. 3.9) that often 
discourages further investigation into the proteins. However the sensitivity of 
MS to detect peptides (instead of whole proteins) and coupling with pChIP like 
methods allow identification and protein dependencies to RNAPII 
modifications. Tandem MS/MS provides qualitative information on proteins, 
i.e. whether a peptide is detected or not and the measure of its detection 
(Mascot score). In label-free proteomics, no inference can be reached for 
peptides that are not detected. Additionally label-free proteomics does not 
provide any information on quantitative aspects including relative abundance 
per cell or relative abundance to input and/or reference sample. This is a 
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major issue for low abundant proteins as between different runs of the same 
sample; peptides are often missed due to detection limits. Additionally, 
identified proteins (and their Mascot scores) cannot be cross-compared 
between different runs due to high variability and limited normalization 
measures. To tackle these issues, multiple replicates are often performed for 
consistent detection of peptides. We started initially with label-free methods 
and further coupled pChIP to SILAC method (MS) to obtain both qualitative 
and quantitative knowledge of proteins dependencies. Coupling pChIP with 
SILAC and MS reduces the need for replicates as inherently we label the cells 
with heavy and light stable amino acid isotopes. In addition, a robust pChIP-
SILAC ratio is only obtained when the same peptide is detected across both 
the samples (after mixing). This criterion imposes additional stringency to our 
robust protein detection, as peptides need to be detected in both heavy and 
light pChIP samples (a form of replication) and therefore are quantified 
relative to each other. Another advantage of SILAC method is SILAC-MS 
software often re-scans the MS spectra to make sure that peptides in both the 
heavy and light labelled pChIP samples and this is quite critical for low 
abundant proteins.  
 
To understand the RNAPII regulation and its chromatin proteome, we coupled 
crosslinked chromatin, pChIP with SILAC-MS to understand and unravel the 
chromatin proteome. Performing pChIP-SILAC, we realised that several steps 
in our protocol could significantly impact the final protein (peptide) detection 
by MS. Additionally, SILAC pChIP experiments designed in complimentary 
fashion (forward and reverse) yield most robust and consistent protein 
identification and ratios. The aspects that affect pChIP-SILAC include 
biological, technical, experimental variability and limitations of current 
technologies. Some of these include efficiency of SILAC labelling, efficient 
immunoprecipitation of chromatin complexes, reverse-crosslinking, protein 
elution and steps leading to MS processing. We measured, optimised and 
improved these steps leading to detection of large cohorts of proteins; 
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however further improvement is required and will also be aided by 
technological advancements in the field of chromatin proteomics.  
9.2.2. RNAPII chromatin landscape 
RNAPII plays an important role in mES cells and it interacts with a range of 
proteins during transcription, non-transcriptional processes and importantly 
cascades a range of additional interaction on chromatin. We performed 
RNAPII-pChIP (S5p) and were astonished to observe such a dynamic range 
of RNAPII interacting proteins captured by pChIP. RNAPII-S5p is present at 
promoters and coding regions of actively transcribing genes and this S5p 
mark is present in initiating, elongating and terminating RNAPII (Fig. 5.1). By 
performing RNAPII-S5p pChIP, we capture protein interactions occurring 
during distinct stages of transcription, non-transcriptional process and 
importantly mES cell specific processes highlighting the potential of pChIP 
method. These cohorts include capping enzyme, chromatin remodellers, 
general transcription factors, TAFs and other proteins associated at promoters 
or with transcription initiation. We also identified chromatin remodellers, 
splicing, polyadenylation, co-transcriptional machinery and proteins 
(phosphatases, export factors) involved in transcription termination. By 
applying RNAPII-S5p pChIP, we not only identify the known RNAPII 
interactors but also enrich for novel interactions and important stem cell 
specific processes. Our laboratory previously identified Polycomb proteins 
associating with RNAPII-S5p only in mES cells, and our pChIP dataset 
independently captures and extends our understanding of the RNAPII-
Polycomb interplay. In addition, we uncover novel processes associated with 
RNAPII including cell cycle, DNA replication and metabolism. 
 
Gene expression is mES cells is tightly regulated whereby cells maintain their 
ability to self-renew and pluripotency while retaining capability to differentiate 
upon appropriate cues. In mES cells, master regulators (Oct4, Sox2, Nanog, 
Klf4, etc.) maintain appropriate control of gene expression by restricting or 
activating the expression of genes. Many master regulators directly or 
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indirectly interact with RNAPII to mediate this control. The novel association of 
RNAPII (S5p+S7p-S2p-) at important developmental regulator genes along 
with Polycomb proteins further highlights the importance of RNAPII regulation 
and its interplay in mES cells. From our single unbiased S5p-pChIP, we 
uncover many of these associations on chromatin including Polycomb 
proteins, chromatin remodellers (Hmt, Hat, Hdac etc.), master regulators 
(Oct4, Sall4) and proteins important for pluripotency (Mediator, TAFs, Esrrb, 
Paf1). The cohorts of chromatin interactions captured by single pChIP 
highlights the plethora and vastness of information contained within one 
pChIP run. The next challenge is to further dissect these interactions asking 
which proteins associate during active transcription, identifying novel non-
transcriptional processes and the protein cohorts involved in the processes. 
Additionally, understanding whether chromatin components come together at 
the same time at certain genes or whether these interactions occur at subset 
of genes governed by temporal regulation would provides us with addition 
layer of knowledge on RNAPII regulation in stem cells.  
9.2.3. Active transcription and RNAPII proteome 
During transcription, the Rpb1-CTD of RNAPII undergoes distinct post-
translational modifications on serine residues at position 5 (S5p), 7 (S7p) and 
2 (S2p) that demarcate transcription initiation, transition to elongation and 
transcription elongation, respectively. Genome-wide ChIP-Seq distributions of 
RNAPII modifications at actively transcribing genes (Fig. 5.8) clearly highlight 
the presence of S5p peaking at promoter and also present throughout the 
body of a gene. S7p follows a similar pattern to S5p, peaking predominantly at 
the promoter with lower levels than at the promoter at coding regions. S2p 
levels are enriched at body of genes increasing towards 3’ end of genes (Fig. 
5.8 and (Brookes et al. 2012). The three different RNAPII modifications 
provide robust markers for distinct transcriptional stages. We applied this 
knowledge to identify and unravel protein dependencies during the distinct 
stages of transcription and also identify non-transcriptional processes with 
dependencies to distinct RNAPII modifications, in particular S5p which we 
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knew is associated with Polycomb repression in mES cells. To unravel the 
dependencies in both qualitative and quantitative manners, we required a 
comprehensive and complementary experimental setup. Our experimental 
strategy (Fig. 5.2) was designed to unravel the protein dependencies using 
two unbiased approaches (universe and pairwise; forward and reverse), with 
several replicates inbuilt within the experimental setup. Additional information 
associated with affinity and stoichiometry of interaction relative to RNAPII 
protein was also encoded in our experimental setup. It is pertinent to mention 
that our biological question is complex and involves three distinct 
modifications occurring on a single protein at its CTD, which is highly 
repetitive. Therefore our comprehensive experimental setup was devised to 
robustly identify proteins and their dependencies to RNAPII modifications.  
 
The universe and pairwise approach experiments were designed to be 
complimentary to each other and the combinatorial data analysis robustly 
unravels the dependencies. The simple classification analysis provides an 
unbiased and effective measure of understanding the protein dependency to 
RNAPII modifications based solely on directionality of pChIP-SILAC ratios 
(Figs. 5.12, 5.13 and 5.14). Using just the directionality (not the magnitude) of 
pChIP-SILAC ratios, we uncover novel protein associations exclusively with 
RNAPII-S5p including Polycomb proteins, DNA replication and cohort of 
chromatin remodellers. Not surprisingly, we observe that most proteins 
identified are associated with a combination of RNAPII modifications and are 
involved in transcription including co-transcriptional processing, splicing, 
polyadenylation and termination. Our simple classification not only robustly 
identifies the known interactions but also highlights novel protein components 
that co-associate with RNAPII-occupied chromatin during transcription. The 
simple classification does not inform well about proteins that have pChIP-
SILAC ratios close to Rpb1 ratio (example Paf1 or histones; Fig. 5.17). These 
proteins being so close to Rpb1 ratios are affected significantly by 
normalization and therefore their pChIP dependencies are not simply inferred 
from directionality of ratios. In addition, information pertaining to stoichiometry 
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or affinity of interaction relative to Rpb1 is not utilised by simple classification 
and therefore the need for a systems biology approach is apparent to extract 
information from our comprehensive experiment. 
 
Clustering methods are conventionally used partition datasets whereby 
groups of objects that are more similar to each other are distinguished from 
groups of objects that are dissimilar. Clustering is a type of explorative data 
mining that relies on discontinuity of objects and the partitioning is based on 
an iterative process of finding and grouping discontinuity. Our comprehensive 
RNAPII pChIP experiment was designed to unravel the protein dependencies 
to RNAPII modifications (S5p, S7p and S2p) and the simple analyses showed 
a continuum of protein association during transcription process. To attempt to 
unravel in more depth the information encoded in the pChIP-SILAC ratios, we 
applied a novel systems biology approach (Borislav Vangelov and Mauricio 
Barahona) including novel clustering and network algorithm that detects 
patterns within a continuous dataset. We applied conventional PCA (Principle 
Component Analysis) and other ‘à la PCA’ methods; as expected from the 
complexity of our datasets that study different variants of the same protein 
(RNAPII) that co-exist in a continuous process (transcription), these methods 
did not partition the dataset robustly (data not shown). Another incentive in 
applying our systems approach to pChIP-SILAC ratios is that machine 
learning methods can detect and unravel patters inherently embedded in the 
pChIP-SILAC ratios, making them completely unbiased and free of any literary 
influence. This aspect is especially critical as information on directionality, 
stoichiometry and affinity of interactions relative to RNAPII is clearly 
uncovered in the pChIP network (Fig. 6.5). The identification of all detected 
RNAPII subunits within same cluster and in direct connections highlights the 
sensitivity and specificity of method to detected and cluster proteins. In 
addition, we not only robustly identify the protein association as discovered by 
simple classification (Fig. 5.12) but also partition, in unexpected ways, sub-
clusters within the S5p-only proteins and common proteins. Remarkably, we 
uncover novel components involved in transcription process including 
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detection of U1 spliceosome subunits, metabolic proteins associated with both 
S5p&S2p and ribosomal proteins that further suggest the idea of transcription-
coupled nuclear translation (Iborra et al. 2004; David et al. 2012). We also 
observe reduced detection of ribosomal proteins after treatment with 
Flavopiridol (transcriptional elongation block) in preliminary RNAPII-S5p 
pChIP experiments (data not shown). The clustering method detects and 
performs a gradient separation of the pChIP proteins that range from high 
levels of S5p only (Clusters 1-3; no S7p or S2p) to proteins with high levels of 
both S5p and S2p (Cluster 8). It is worthwhile to note that two sub-clusters 
were obtained enriched for both S5p&S2p, containing splicing factors, mRNA 
processing factors and components of co-transcription machinery. We believe 
that these sub-partitioning (cluster 7 and 8) are due to stoichiometry 
differences and abundance of export factors in cluster 8.  
 
The quantitative information from RNAPII-pChIP also includes protein 
information and PTM’s of histones and other chromatin-bound proteins, such 
as Rpb1-CTD itself. This is an avenue I hope to explore and further ask if 
existing and novel PTM can be identified in Rpb1-CTD. Further to explore 
histones, PTM’s on histones and their respective dependencies to RNAPII 
modifications and across genome. These analyses require optimising, 
processing and running MS to specifically identify PTM’s and further re-
analysing MS spectra by different software’s to proof-read the modifications.   
9.2.4. RNAPII-S5p and novel protein associations. 
Analysing our comprehensive experimental setup by either the simple 
classification or the systems biology approach, we uncover novel proteins 
associations exclusively with RNAPII-S5p (no S7p or S2p). These interactions 
are identified due to directionality (enrichment) of pChIP-SILAC ratios, affinity 
of interaction relative to Rpb1 or stoichiometry of association relative to Rpb1. 
The S5p-only interactions on chromatin mediate different important biological 
processes including many stem cell specific processes. The clustering and 
network sensitively detects further patterns within pChIP-SILAC ratios and we 
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uncovered three different clusters enriched for RNAPII-S5p only. 
Reassuringly, we identify Polycomb proteins and DNA replication in Cluster 2 
along with many novel chromatin remodellers and silencing proteins. 
Intriguingly, we also observe some metabolic proteins and isomerases 
associating with RNAPII-S5p (Cluster 3). Most surprisingly, the clustering 
identified a highly robust core S5p partition (Cluster 1, Fig. 6.9) consisting of 
16 proteins that would not have been detected as important RNAPII-S5p 
associated proteins by conventional methods. Cluster 1 includes stem cell 
specific proteins (including Utf1) that are down regulated upon early 
differentiation to neuronal or cardiac precursors (Carmelo Ferrai, our 
laboratory; data not shown). Most remarkably, these proteins are robustly 
detected in pChIP experiment and are relatively abundant in stem cells. Using 
the pChIP network, we can now zoom in, explore connections and design 
robust hypothesis-driven experiments to unravel the mechanistic association. 
We identify Polycomb proteins linked with Ogt and replication proteins 
(Cluster 2; Fig. 6.8) and now we can ask if all three protein complexes occur 
at the same time on distinct cohorts of genes or whether one complex 
interacts with other complexes distinctly and on different genes. Utf1 is a stem 
cell specific transcription factor and, in our pChIP analyses, it is strongly 
associated with RNAPII-S5p. This knowledge allows us to identify genomic 
regions where Utf1 and RNAPII-S5p co-associate and also the other protein 
cohorts that bind to both these proteins. The association of many silencing 
factors (clusters 1, 2 and 3) with RNAPII-S5p hints at the complex regulation 
of RNAPII and suggests that RNAPII-S5p as a wider chromatin regulator that 
may not only be restricted to actively transcribing genes, Polycomb genes but 
could also be associated with heterochromatin marks (H3K9me3), tandem 
repeats (satellites) and interspersed repeats (LINE, SINE) and cascading a 
local regulation at these regions. 
 
I have demonstrated that by coupling pChIP and SILAC-MS on crosslinked-
chromatin, we can unravel and dissect RNAPII chromatin proteome. 
Performing native pChIP and gradient pChIP, I hope to push the technological 
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envelope and apply these methods for highly specific questions, i.e. protein 
cohorts that coexist with ‘RNAPII-S5p and Polycomb’, ‘RNAPII-S5p and 
replication’. Comparing published datasets (Chapter 7) with pChIP-proteins 
and identifying the type of interaction highlights the versatility and applicability 
of our approach. These dataset comparisons provide a cost effective 
bioinformatic way to identify candidates and design appropriate experiments.  
9.3. Future research directions 
In this thesis, I have focussed on RNAPII chromatin proteome and regulation 
in mES cells; uncovering novel association of RNAPII-S5p with important 
biological processes and in addition identifying additional components of 
transcription machinery. Applying pChIP, we have identified several mES cell-
specific proteins involved in transcription regulation and non-transcriptional 
processes. One of the future aims is to differentiate mES cells to neuronal (or 
myogenic) differentiation and perform pChIP on differentiated cells. This 
systems biology comparison would allow us to understand the differences in 
transcriptional machinery between the cell types, in the pluripotent and post-
replicated states, to further unravel regulatory changes in chromatin 
processes and gene regulation upon lineage. We can further ask whether 
specific chromatin factors (TFs, chromatin remodellers) regulate the 
chromatin landscape upon lineage specification or are replaced by neuronal 
or myogenic-specific chromatin factors. The most important aim would be 
unravel and understand if the same or different S5p-only processes associate 
upon lineage specification, mapping genome-wide S5p occupancy and 
identifying the chromatin proteome by pChIP.  
 
The Rpb1-CTD is highly repetitive and each residue can be subjected to a 
range of PTM’s. Using the Native, gradient RNAPII-pChIP and optimised MS 
conditions (different peptide cleavers, MS run time, PTM-specific MS 
analysis), I would hope to detect novel modifications on the Rpb1-CTD. From 
our native pChIP, we already identify major classes of enzymes (kinases, 
phosphatases, acetyl-transferases, etc.) and exploring these proteins would 
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highlight potential candidates that modify Rpb1-CTD among other targets. To 
further obtain insights on the interplay between DNA replication and RNAPII-
S5p in mES cells, we can perform cell synchronisation either using drugs to 
arrest cell cycle stages (Azuara et al. 2006) or by elutriation (Banfalvi 2011). 
Using the different cell cycle fractions, we can ask whether the RNAPII-S5p 
and DNA replication association is restricted to specific cell cycle stages and 
its proteome composition by pChIP. We can further extend this analysis and 
ask if interesting proteins and their association are cell cycle regulated. With 
native and gradient chromatin, we have a low complexity, highly concentrated 
sample that allows us to sensitively capture only the strongest interaction on 
chromatin (or nucleo-histone fractions). I aim to perform DNA-ChIP and pChIP 
against RNAPII modifications and Polycomb proteins in these low complexity 
samples to identify candidate proteins that mediate or maintain the RNAPII-
Polycomb interplay. Additionally using Polycomb knockout cell lines (Ezh2-/-, 
Ring1b-/-) I would be able to test the functional consequence of the 
interactions. Finally, pChIP can be applied to study any chromatin process of 
interest by choosing appropriate combinations of antibodies that help contrast 
different chromatin states. 
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